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Dissertation Abstract
Many advances have and are being made with the advent of modern sciences. One area that re-
mains resistant to significant advances is the recovery of the mammalian central nervous system
(CNS) after injury. Considerable efforts were placed on understanding the cellular and biochemi-
cal changes occurring after injury and during wound healing. Aside from cataloging the changes
that occur, little progress is being made in understanding the molecular cascades associated with
the control of the healing process. The present series of studies define the global changes that oc-
cur after injury. They also define CNS repair mechanisms by identifying genetic networks that
underlie the temporal changes of retinal wound healing. Gene expression changes in the injured
rat retina were analyzed with microarray technology, genetic linkage analysis of gene expression,
and higher-level bioinformatic analyses. This work yielded three complementary insights. First,
groups of functionally related genes underlie the early, delayed, and sustained responses of
wound healing. For example, transcriptional factors such as Fos and Egr1 define the early re-
sponse, whereas, glial reactive markers such as Gfap and Cd81 define the sustained response.
Second, three specific genomic loci modulate coordinated changes in gene expression in mouse
brains: regulatory loci on chromosomes 6, 12, and 14. Of the three only the regulatory locus on
chromosome 12 specifically modulates the expression of a group of genes involved in early
wound-healing events (mainly, the regulation of transcription, differentiation, apoptosis, and pro-
liferation). Third, candidate genes Id2 and Lpin1 are current modulators for the network con-
trolled by the chromosome 12 locus. Higher levels of Id2 and Lpin1 correlated with higher levels
of the survival gene Crygd, and with lower levels of acute phase genes Fos and Stat3, reactive
gliosis genes Gfap and Cd81, and apoptotic gene Casp3. In this body of work I have moved be-
yond cataloging changes in the transcriptome to identifying candidate genes modulating the reti-
nal response to injury. During this process I developed an integrated approach of gene expression
profiling and higher-level bioinformatic analyses to define genetic networks. This work not only
advances our understanding of the molecular networks controlling the CNS response to injury,
vbut may also form the basis for interventions that can rescue injured neurons and re-establish lost
CNS connections.
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1Chapter 1
Introduction
2Retinal Wound Healing
The retina responds to injury and chronic stress by activating a complex series of cellular events
that collectively preserve the structure and function of the retina. This wound-healing response
can result in permanent cellular changes that can lead to secondary complications and the loss of
visual function. This protective mechanism may be a significant barrier to therapeutic measures
designed to preserve visual function such as cell transplantation, gene therapy, and bioinic
implants. Defining the molecular changes that underlie the retinal healing is key to finding
pathways that can be targeted to modulate the complications of retinal repair.
The retina is a complex tissue made of different cell types segregated into distinct cellular
layers with associated functional properties. The transduction of light to a neural signal occurs at
the back of the retina within the photoreceptors. The signal is processed by bipolar, amacrine and
horizontal cells. The signal is relayed to the brain by the retinal ganglion cells. The sensory and
processing functions of the neural retina are guarded by the supporting glial cells. The two major
retinal glial cells are the Muller cells and the retinal pigment epithelium (RPE). Retinal glial cells
maintain homeostasis and the blood-retinal barriers. Muller cells extend radially spanning nearly
the entire thickness of the neural retina from the internal limiting membrane to the external
limiting membrane. As these cells span the retina they interact with virtually all the retinal cell
types [Sarthy and Ripps, 2001]. RPE cells lie at the back of the eye between the neural retina and
the choroid. This location allows the RPE to closely associate with the outer segments of
photoreceptors in addition to serving as a barrier protecting the neural retina from the choroidal
circulation [Zhao et al., 1997]. Together, Muller and RPE cells are well positioned to be exposed
to degenerative changes in neural cells and to play a key role in the wound healing response.
Wound-Healing Animal Models
Studies in animal models have provided information about the cellular response to retinal injury.
Stephen J. Ryan’s group described the histological features of the inflammatory response to a
3penetrating injury that disrupts the sclera and the retina [Gregor and Ryan, 1986; Cleary and
Ryan, 1979]. Others have described the neuronal and glial response after retinal breaks induced
with scrapes [Miller and Oberdorfer, 1981; Maclaren, 1996] and laser photocoagulation lesions
[Humphrey et al., 1993]. Steven K Fisher’s group examined the cellular response to the
separation of the neural retina from the RPE layer in a model of retinal detachment in cats
[Anderson et al., 1983]. The breakdown of the blood-retinal barrier (BRB) using non-invasive
mechanism was produced by Peter A. Campochiaro’s group using intravenous sodium iodate or
intravitreal injection of epinephrine [Campochiaro et al., 1986]. The response of glial cells was
also studied when specific neuronal cells were damaged. Optic nerve crushes target the cell death
of retinal ganglion cells which is preceded by the activation of retinal glia [Bahr, 1991]. Targeted
cell death of photoreceptors in albino animals by fluorescent light also activates retinal glia. As a
general survey of the retinal response to injury, this introduction describes the wound healing
response to a mechanical disruption of the retina. The retinal glial cells undergo temporal and
spatial changes that can be divided into three major phases: an early acute phase (minutes, hours),
a delayed subacute phase (days) and late chronic phase (days, weeks) (Figure 1.1).
Wound Healing Phases
The immediate consequences of trauma include hemorrhage, the formation of a toxic
environment, and the activation of glial cells. Direct mechanical trauma to the retina interrupts
the blood-retinal barriers, intrudes on the vitreous, and disrupts the subretinal contents into the
neural retina [Postel and Mieler, 1999; Gregor and Ryan, 1982]. The flow of fluid and
metabolites into the retinal microenvironment creates a highly acidic and toxic environment
[Liang and Godley, 2003; Sherry and Townes-Anderson, 2000]. The initial glial responses to
injury are simply normal glial properties operating in an abruptly altered environment. For
example, the Muller cells attempt to restore ionic and glutamate balance of the extracellular
environment; and, RPE cells phagocytize debris and fragmented cells [Bringmann et al., 2000;
Sherry and Townes-Anderson, 2000; Zhao et al., 1997]. The increased physiological demands on
4Figure 1.1.Cellular response to retinal injury. This schematic describes the wound healing
response to a mechanical disruption of the retina (for example, a retinal tear). The retinal glial
cells undergo temporal and spatial changes that can be divided into three major phases: an early
acute phase (minutes, hours), a delayed subacute phase (days) and late chronic phase (days,
weeks).
5glial cells result in the swelling of glial cells. Serum factors released from the blood stream and
vitreous material are known to activate the release of pro-inflammatory cytokines from glia cells,
and activate the early activation of signaling cascades involved in proliferation and survival
[Geller et al., 2001; Takeda et al., 2002; Izumi et al., 2002]
The subacute phase is characterized by inflammatory responses and phenotypic changes
in glial cells. The early release of cytokines by damaged cells and activated glial cells recruit
inflammatory cells from the blood stream to the site of injury [Zhou et al., 2005; Zhou and
Maren, 2003; Szabo et al., 1991]. Blood derived neutrophils and macrophages as well as
endogenous microglia infiltrate the lesion as early as day 1 after injury and peak at day 3 [Zhou et
al., 2005; Zhou and Maren, 2003]. Together the inflammatory cells clear fragmented cells and
foreign material, and release additional inflammatory factors (cytokines, chemokines, and nitric
oxide synthetase). The peak of inflammatory factors prolongs the wave of inflammatory cells and
results in edema [Limb et al., 1991; Fisher et al., 1991]. The inflammation and edema can cause
further breakdown of the blood-retinal barrier [Vinores et al., 2001; Behar-Cohen et al., 2000].
The loss of retinal cells and the exposure to components of the blood and the vitreous
trigger a reactive state in glial cells that includes changes in cell shape, molecular content, and
cellular behavior. The loss of retinal cells caused by the initial trauma and cell death activates
morphological changes in glial cells. For example, Muller cells enlarge their cell body and extend
their processes into the area of cell loss [Lewis et al, 2003; Marc et al., 2003]. RPE cells change
shape from cuboidal to fibroblas-like and macrophage-like [Grierson et al., 1994]. One of the
defining characteristics in the activation of glial cells in the retina is a reorganization of
cytoskeletal content. The most obvious change is an elevation in intermediate filaments. For
Muller cells the levels of glial fibrillary acidic protein (GFAP) and vimentin increase
dramatically. In response to injury the RPE cells upregulate cytokeratins and vimentin [Lewis
and Fisher, 2003; Stroeva and Mitashov, 1983; Zhao et al., 1997].
Glial cells can also migrate and proliferate. Migration can be activated by vitreal and
blood components [Vidaurri-Leal et al., 1984; Gregor and Ryan, 1982; Campochiaro et al., 1986;
6Kim and Arroyo, 2002]. The collagen from the vitreous and the fibronectin from serum provide a
rich substrate for migration. In addition, cytokines (specifically platelet-derived growth factor
and transforming growth factor) released from the bloodstream and infiltrating cells are
chemotactic and mitogenic for glial cells [Kim and Arroyo, 2002; Campochiaro et al., 1986;
Vinores et al., 1992]. Blood contents also stimulate the proliferation of glial cells. Experimental
models of retinal proliferation have demonstrated that hemoglobin and iron stimulate glial cell
proliferation even in the absence of direct mechanical trauma to the retina [Burke and Smith,
1981]. Inflammation and cell proliferation resolve within the first week as the response to injury
enters its chronic phase [Ryan et al., 1994; Fisher et al., 2001; Behar-Cohen et al., 2000].
During the late phase, glial cells remain reactive and participate in the local and global
remodeling of the retina. Cells that migrate into the wound, vitreal space, and subretinal space
transform the hemorrhage with fibrocellular membranes consisting of collagenous components
and cellular components. With time, these membranes may contract, causing significant
problems, including retinal detachment [Ryan et al., 1994; Fisher et al., 2001; Behar-Cohen et al.,
2000; Grierson et al., 1994]. The formation of ectopic fibrocellular membranes in the retina is
clinically referred as proliferative vitreoretinopathy [Chaum, 1995; Pastor et al., 2002]. There is
also a change that occurs within the retina itself. Muller cells in the vicinity of the lesion activate
expression of GFAP, extend their process, and increase in size. These changes continue in a late
chronic activation of Muller cells that spreads distally to include eventually large extents of the
retina [Lewis and Fisher, 2003; Bignami and Dahl, 1979; Humphrey 1993; Song et al., 2003;
Berhar-Cohen et al., 2000; MacLaren, 1996; Miller and Oberdorfer, 1981]. Histologically this is
seen by a sustained reactivity of GFAP in the cell bodies and process of Muller cells. The global
upregulation of GFAP and hypertrophy in Muller cells are a common end point of the retinal
response to various forms of injury including tears, toxic injuries and optic nerve damage. In
addition to the cellular remodeling of glial cells display, neural cells neural cells activate a series
of signaling pathways that culminate in neuronal migration, elaboration of new neurites and
synapses, and rewiring of retinal circuits [Marc et al., 2003; Fisher et al., 2005; Jones et al.,
72003]. These structural changes are long lasting and represent at the present irreversible changes
[Marc et al., 2003; Fisher et al., 2005; Grierson et al., 1994].
Consequences of Retinal Healing and Remodeling
As with many biological processes the activation of glial cells may be a two-edged sword. The
activation of glial cells is important in limiting the damage and in protecting neurons and
photoreceptors from the initial consequences of injury. In addition to maintaining homeostasis
and restoring the blood-retina barrier, glial cell activation can mediate neural cell survival. Muller
cell activation, induced by argon laser photocoagulation, slows photoreceptor cell death in the
dystrophic retina of RCS rats [Chu et al., 1998]. Similarly, preconditioning with bright lights
protects against light damage [Liu et al., 1998]. Injury-induced benefits are due to the release of
neurotrophic factors from normal storage in glial cells [Mervin, 1999; LaVail, 1992]. In the
therapy of retinal degenerations, injury-induced treatments have been proposed. Limited, short-
lived, detachment of neural retina is part of a surgical procedure (macular translocation) for
treating age-related macular degeneration [Fujii et al., 2002]. In traumatic injuries, however, the
excessive and chronic activation of retinal glial cells contributes to negative remodeling of the
retina with scar formation, neural cell death, and rewiring of the retina. These changes negatively
alter the architecture and function of the retina. The clinical relevance of retinal healing and
remodeling is substantial. The formation of fibrocellular membranes can lead to complications
such as detachments, cell death, and ultimately visual impairment. The remodeling that occurs
during wound healing can have unintended consequences affecting clinical strategies including
surgical procedures, prosthetic implants, stem cell therapies, and gene rescue therapies [Behar-
Cohen et al, 2000; Radner et al., 2001; Kinouchi et al., 2003].
While our knowledge of the morphological and cellular changes of reactive glial cells is
extensive, a select few of the phenotypic changes has been related to molecular makers and
regulatory mechanisms. Even when molecular markers have been identified we do not know (1)
the context in which the molecular change occurs, (2) the relationship to global changes across
8the retina, and (3) the mechanisms that control these changes. Cataloguing the molecular changes
that underlie the retinal healing response. Applying high level bioinformatics to these data can
further reveal the mechanisms that control glial cell activation and cellular remodeling. This
knowledge will be important in modulating glial cells during injury and therapeutic intervention,
and perhaps in modulating glial cells in the survival of genes during retinal degenerations.
Gene Expression Profiling
One of the key factors in defining a cellular phenotype is the selective expression of specific
genes as RNA transcripts. This collection of transcribed genes is known as the cell’s
transcriptome. Changes in gene expression levels contribute to specific phenotypic changes.
Increased levels of Gfap mRNA in the retina, for example, precede and correlate with increased
levels of GFAP immunoreactivity in Muller cells [Cao et al., 1997]. Defining the transcriptome-
wide changes that occur after retinal injury can reveal the molecular pathways that modulate
retinal healing.
Transcriptome-wide analysis is feasible with DNA microarray technology. Microarray
technology is a recent addition to the techniques exploiting a potent feature of complementary
nucleic strands to form a duplex. Microarrays, like Southerns and Northerns, use complementary
oligonucleotides to probe the levels of specific RNA transcripts. In 1995, Schena and colleagues
overcame the technical limitation of probing multiple gene targets by spotting complementary
DNAs (cDNAs) into glass slides. A year later, Lockhart and colleagues monitored transcript
expression using small, high-density arrays containing tens of thousands of synthetic
oligonucleotides.  They synthesized short nucleic probes on slides using a combination of
photolithography and oligonucleotide chemistry. The advent of cDNA and oligonucleotide
microarray opens the opportunity to profile transcriptome-wide changes that occur in the injured
retina.
9The basic microarray technique involves RNA extraction, amplification, hybridization,
and analysis. After RNA extraction, the RNA is copied, while incorporating either fluorescent
nucleotides or a tag that is later stained with fluorescence [Butte, 2002]. The labeled,
complementary RNA (cRNA) is then hybridized to a microarray for a period of time, after which
the excess is washed off and the microarray is scanned under laser light.  The fluorescence
emitted from thousands of genes is recorded by a computer. Relative intensity units are placed
into spreadsheets for comparisons among biological replicates and among experimental
conditions. The analysis measures significant expression changes and extracts patterns of
expression [Butte, 2002]. Significant expression changes are determined using fold changes
(experimental condition versus control experiment) and statistical analyses (for example,
Student's Test and Analysis of variance). The true power of microarray analysis comes from the
analysis of many hybridizations to identify common patterns of gene expression. Statistical
methods that identify similar patterns of expression are generally referred as “cluster analysis”
[Quackenbush, 2001]. To interpret the results from the analysis of hundreds of genes across
multiple experiments, it is helpful to generate intuitive visual representations. A commonly used
approach relies on the creation of “dendograms” or “heat maps” in which each column of the
matrix represents an experimental condition, and each row represents the expression pattern for a
particular gene. In this dissertation, we use microarray technology to better understand the
biology of retinal healing by defining the temporal changes in gene expression after retinal injury
and by relating these changes to the inflammatory, proliferative, and remodeling phases of retinal
healing.
Genetics of Gene Expression
Defining groups of genes with similar patterns of expression is not an endpoint in the analysis but
a beginning. Gene expression profiles can be supplemented by higher-level analyses aiming at
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discovering the networks controlling transcript expression. One approach combines gene
expression profiling with genetic linkage analysis to reveal the location of genetic elements that
modulate expression levels in a genetically variable population [Davarsi, 2003; Broman, 2005].
Genetic analysis of gene expression is called “expression genetics” or “genetical genomics”
[Broman, 2005]. Expression genetics has been used to identify genes underlying complex traits,
including gene expression, disease, and behavior [Morley et al., 2004; Cheung et al., 2003;
Hubner et al., 2005; Chesler et al., 2005; Bystrykh et al., 2005]. These studies showed that gene
expression is highly variable and heritable and that the expression variability correlates to one or
more regions of the genome. Some of these loci modulate genes within the interval (cis-acting)
but most loci modulate genes at different genomic locations (trans-acting). The integrated gene
expression profiling and linkage analysis has identified genes that predispose hypertension
(Cd36), asthma (C5), and atherosclerosis (ABCG5 and ABCG8) [Aitman et al., 1999; Karp et al.,
2000; Berge et al., 2000]. These studies illustrate the combined power of gene expression
profiling and linkage analysis to study gene expression regulation at a greater scale and depth
than is possible using either technique alone.
Of interest to the vision community is the regulatory loci that control gene expression in
the CNS. Chesler and colleagues [2005] defined genome-wide regulatory loci that modulate gene
expression in mouse forebrains. For their expression genetics study, Chesler and colleagues relied
on a genetically variable population derived from the C57BL/6 and DBA/2J mouse strains, the
BXD recombinant inbred (RI) mouse strains. This reference population is of interest because the
parental and BXD RI strains have considerable phenotypic differences related to CNS
development and pathology. Chesler and colleagues documented that loci modulating gene-
expression phenotypes are also related to neurological phenotypes, and that distinct regulatory
loci modulate functionally related genes. For example, a group of genes involved in synaptic
regulation forms a network modulated by distinct regulatory loci. Chesler and colleagues made
their regulatory locus data publicly available at GeneNetwork (www.genenetwork.org). They
also integrated their expression genetics data with the mapping for more than 650 phenotypes
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previously obtained from the BXD RI mouse strains. The GeneNetwork data can be valuable in
identifying unknown molecular interactions. Based on gene expression covariance and the
sharing of loci, the GeneNetwork data predicted an association between the nuclear protein P2P-4
and nuclear repressor PUM2. PUM2 pull-down methods combined with RT-PCR confirmed that
PUM2 does indeed bind P2P-R mRNA [Scott et al., 2005]. In regards to retinal healing, the
GeneNework data are of interest because the BXD RI mouse strains segregate phenotypic
differences in audiogenic seizures, hearing loss, and neurogenesis in the adult hippocampus
[Willott and Erway, 1998; Kempermann and Gage, 2002; Neumann and Collins, 1991].
Moreover, brains and spinal cords of C57BL/6 are resistant to neurotoxicity, whereas the brains
and spinal cords of DBA/2J are more susceptible to neurotoxicity [Schauwecker and Steward,
1997; Inman et al., 2002]. Together these studies suggest that genetic variations between the
C57BL/6 and DBA/2J alter the expression and function of master regulators of the CNS healing
response. Mining the expression genetics data at GeneNetwork is expected to identify gene-
expression phenotypes and regulatory loci that modulate the early events of the CNS healing
response.
The ultimate goal of expression genetics is to identify the genes underlying polygenic
traits and to gain a better understanding of their physiology and biochemistry. The BXD RI
strains are an ideal genetic system to identify candidate genes. Each BXD RI strain was derived
by inbreeding for over 20 generations an F1 cross between C57BL/6 and DBA/2J strains [Taylor
et al., 1999]. The genome for each BXD RI strain is a unique recombination of the C57BL/6 and
DBA/2J genomes. Since the parental genomes are sequenced and the segregation of BXD RI
strains chromosomes is mapped, we have a complete map of all the candidate genetic variants
responsible for the regulatory locus. A standard procedure to identify the best candidate gene is to
define the polymorphic genes whose function is relevant to the phenotype [Abiola et al., 2003].
For example when the age-related maculopathy susceptibility locus was found, Hageman and
colleagues [2005] focused on immune-associated genes to explain the aberrant complement
activation seen in patients with macular degeneration. Higher resolution linkage mapping defined
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the complement factor H gene as the polymorphic gene that predisposes individuals to age-
related macular degeneration. In our case, a candidate gene must be relevant to the biology of
CNS healing, namely, is the gene known to be involved in CNS healing events and/or does its
transcript change after trauma? The search for master regulators of CNS healing is facilitated by
the growing collection of gene expression data that survey the CNS during development and after
injury. These analyses can be further complemented with computational tools that examine the
promoter sequence and the protein sequence of candidate modulators to determine if there are
potential direct interactions between the candidate modulators and downstream targets [Segal et
al., 2005]. The convergence of gene expression profiling, expression genetics, and bioinformatics
offers a novel and comprehensive approach to discover molecular pathways controlling retinal
healing.
Aims of the Dissertation
The goal of this research is to define the molecular mechanisms that control the complex cellular
events of retinal healing. The hypothesis is that the phenotypic changes that retinal cells undergo
as part of the healing process are controlled by changes in their gene expression profile. This
hypothesis is addressed by implementing an experimental design that integrates gene expression
profiling, expression genetics, and bioinformatics. The experimental design to define master
genes of retinal healing is outlined in the following aims:
Aim 1 (Chapter 2): Define the temporal profiles of gene expression after retinal injury using
microarray technology, and relate these profiles to the known cellular changes of retinal healing.
Aim 2 (Chapter 3) Define regulatory loci that modulate wound-healing genes in mouse brains.
We will mine expression genetics data by Chesler and colleagues (2005) to identify the genomic
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region that modulates genes expression in forebrains from mouse strains derived from the
C57BL/6 and DBA/2J strains, the BXD recombinant inbred strains.
Aim 2 (Chapters 3 and 4). Define candidate upstream modulators within a regulatory loci by an
integrated bioinformatic approach that combines databases that catalogue single-nucleotide
polymorphisms, gene expression profiling of developing and injured CNS, and functional
domains within promoters and proteins.
Aim 4 (Chapter 4): Test the effect of candidate gene dosage on wound healing using animal and
cell culture systems.
14
Chapter 2
Temporal Changes in Gene Expression
After Injury in the Rat Retina
Permission to reproduce by Association for Research in Vision and Ophthalmology
Vázquez-Chona F, Song BK, Geisert EE. Temporal changes in gene expression after injury in the
rat retina. Invest Ophthalmol Vis Sci. 2004; 45:2737-46.
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Abstract
Purpose: The goal of this study was to define the temporal changes in gene expression after reti-
nal injury and to relate these changes to the inflammatory and reactive response. A specific em-
phasis was placed on the tetraspanin family of proteins and their relationship with markers of re-
active gliosis.
Methods:  Retinal tears were induced in adult rats by scraping the retina with a needle. After dif-
ferent survival times (4 hours, and 1, 3, 7, and 30 days), the retinas were removed; mRNA was
isolated, prepared, and hybridized to Affymetrix RG-U34A chips. Microarray results were con-
firmed by using RT-PCR and correlated to protein levels.
Results:  Of the 8,750 genes analyzed, approximately 393 (4.5%) genes were differentially ex-
pressed. Clustering analysis revealed three major profiles. 1) The early response was character-
ized by the upregulation of transcription factors. 2) The delayed response included a high percent
of genes related to cell cycle and cell death. 3) The late, sustained profile clustered a significant
number of genes involved in retinal gliosis. The late, sustained cluster also contained the
upregulated crystallin genes. When we examined the tetraspanins Cd9, Cd81, and Cd82, they
were also associated with the late, sustained response.
Conclusion: The use of microarray technology allows us to define complex genetic changes un-
derlying distinct phases of the cellular response to retinal injury. The early response clusters
genes associated with the transcriptional regulation of the wound-healing process and cell death.
Most of the genes in the late, sustained response appear to be associated with reactive gliosis.
16
Introduction
In response to local injury, the retina responds with a characteristic series of changes at the site of
injury. A secondary series of changes then spreads to involve the entire retina, often resulting in
progressive degenerative changes and the formation of scar tissue [Ryan et al., 1994; Postel and
Mieler, 1999; Gregor and Ryan, 1982; Fisher et al., 2001; Humphrey et al., 1993; Behar-Cohen et
al., 2000]. These responses of the retina to injury can be divided into an early acute phase, a de-
layed subacute phase, and a late chronic phase [Ryan et al., 1994; Fisher et al., 2001; Behar-
Cohen et al., 2000].
The early phase, which occurs within the first few hours after injury, is characterized by
hemorrhage [Ryan et al., 1994; Gregor and Ryan, 1982; Humphrey et al., 1993], alterations in the
glutamatergic system [Sherry and Townes, 2000], changes in ionic balance [Szabo et al., 1991],
and the beginning of cell-death cascades [Grimm et al., 2000; Yoshimura et al., 2003]. It is dur-
ing this early phase that the first changes in the transcriptome occur with upregulation of the im-
mediate early genes [Grimm et al., 2000; Yoshimura et al., 2003]. The retina then undergoes a
series of delayed cellular responses that last for days. Among these responses is a generalized in-
flammatory reaction in which damaged cells release pro-inflammatory cytokines that recruit pe-
ripheral blood components [Ryan et al., 1994; Gregor and Ryan, 1982; Behar-Cohen et al., 2000].
Many retinal cells experience cell-type-specific responses: dedifferentiation, degeneration, mi-
gration, hypertrophy, and proliferation [Fisher et al., 2001; Grimm et al., 2000; Bringmann and
Reichenbach, 2001; Sahel et al., 1991]. For example, Müller glial cells and the retinal pigmented
epithelium (RPE) enter a reactive state in which they change protein expression, proliferate, and
migrate into the wound and vitreal space [Fisher, et al., 2001; Behar-Cohen et al., 2000; Bring-
mann and Reichenbach, 2001; Grierson et al., 1994]. Inflammation and cell proliferation resolve
within the first week as the response to injury enters its chronic phase [Ryan et al., 1994; Fisher
et al., 2001; Behar-Cohen et al., 2000]. During the late phase, RPE and Müller cells remain reac-
tive and participate in structural remodeling of the retina. Cells that migrate into the wound and
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vitreal space replace the hemorrhage with fibrocellular membranes. With time, these membranes
may contract, causing significant problems, including retinal detachment [Ryan et al., 1994;
Fisher et al., 2001; Behar-Cohen et al., 2000; Grierson et al., 1994].
Progress in understanding the mechanisms controlling secondary injury has been signifi-
cant. Gains have come about by focusing on individual molecules [Humphrey et al., 1993; Big-
nami and Dahl, 1979; Clarke and Geisert, 1998; Song et al., 2003] or groups of molecules
[Sherry and Townes, 2000; Szabo et al., 1991; Grimm et al., 2000; Geller et al., 2003] and their
participation in specific processes of the retinal healing response. However, many of the mo-
lecular events associated with activation of this response remain unknown. In the present study,
we used microarray technology to catalogue the expression of thousands of genes after retinal
injury. Our first approach was discovery-driven using the power of microarray to define the
global patterns of gene expression changes. The second approach was hypothesis-driven focusing
on the role of Cd81 (whose product is involved in proliferation and gliosis [Clarke and Geisert,
1998; Song et al., 2003; Dijkstra et al., 2000; Geisert et al., 1996; Sullivan and Geisert, 1998])
and markers of reactive gliosis, including the cytoskeletal protein glial fibrillary acidic protein
(GFAP, [Ryan et al., 1994; Humphrey et al., 1993; Bringmann and Reichenbach, 2001; Bignami
and Dahl, 1979; MacLaren, 1996; Miller and Oberdorfer, 1981]).
Methods
Animals and Surgery
We used a total of 59 male Sprague-Dawley (albino) rats (270-330 gm) and 2 Long Evans (pig-
mented) rats (350-400 gm), the latter to examine the RPE response to retinal injury (Table 2.1).
We anesthetized 47 albino rats and 2 pigmented rats by intraperitoneal injection of a mixture of
xylazine (13 mg/kg) and ketamine (87 mg/kg), then induced a retinal tear in both eyes of each rat.
For this purpose, we used a 27-gauge needle to penetrate the pars plana, then scraped the superior
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Table 2.1. Experiments and distribution of animals.
Experiment Rats Survival time
Gene expression Albino: 30 injured, 6 control 4 hours, and 1, 3, 7, and 30 days
Protein expression Albino:  6 injured, 6 control 7 days
Histology Albino: 8 injured,  3 control 1, 3, 7, and 30 days
RPE response Pigmented: 2 injured 7 days
For the gene expression study, we used six animals per experimental condition to obtain three
independent retinal samples with four retinas per sample. For each experimental condition in the
protein expression study, we processed 3 independent retinal samples with two animals per
sample. For histology of injured retina, we used two animals per experimental condition.
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temporal retina medially to laterally, as previously described [Clarke and Geisert, 1998; Song et
al., 2003; MacLaren, 1996; Miller and Oberdorfer, 1981]. Care was taken to prevent lens and
sclera damage. Twelve control animals received no injury. All animals were sacrificed by intrap-
eritoneal injection of a mixture of xylazine (26 mg/kg) and ketamine (174 mg/kg). All protocols
used in this study were approved by the Animal Care and Use Committee of the University of
Tennessee Health Science Center and were in accordance with the ARVO Statement for the Use
of Animals in Ophthalmic and Vision Research.
Microarray Expression Profiles
Arrays, Sample Preparation, and Hybridization. Using the rat RG-U34A oligonucleotide array
(Affymetrix, Santa Clara, CA), we examined gene expression levels in the normal rat retina, and
injured rat retinas with 4 hours and 1-, 3-, 7-, and 30-day survival time (Table 2.1). Retinas used
for expression studies were dissected and examined under a stereomicroscope, SXZ12 (Olympus,
Japan), and immediately processed. Nissl-stained sections of the eyecups showed that our retinal
dissections included both the neural retina and RPE. We collected retinas from 36 animals—6
animals per experimental condition. For each experimental condition, we processed 3 independ-
ent retinal samples with 2 animals per sample. Thus, we collected 18 biological replicates and
performed 18 hybridizations (Appendix B, Table B.1). For total RNA extraction, we used the
TRIzol method (Life Technologies, Carlsbad, CA) and confirmed the integrity of RNA with the
Agilent 2100 bioanalyzer (Agilent Technologies, Palo Alto, CA). We synthesized, labeled, and
hybridized cRNA onto arrays at Genome Explorations (Memphis, TN) according to standard
Affymetrix methods previously described by Rogojina et al. [2003].
Data Extraction and Normalization. We measured gene expression levels with Microar-
ray Suite 5.0 (MAS 5.0; Affymetrix) and Robust Multi-array Average (RMA, [Irizarry et al.,
2003]) algorithms. Signals were log transformed (base 2) and the mean intensity for each mi-
croarray was normalized to 8 (log2 scale, [Rogojina et al., 2003]).
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Statistic and Clustering Analyses. We determined statistical significance of expression
changes using Student’s t-test statistics. To determine the expected proportion of significant
false-positives, we used the false discovery rate of Benjamini and Hochberg [Reiner et al., 2003].
Significantly expressed genes were clustered with CLUSFAVOR 6.0 [Peterson, 2002] using
principal component analysis (PCA). Averages are expressed as standard error means (SEM).
Minimal Information to Annotate a Microarray Experiment (MIAME) Compliance. For
further discussion on experimental design and other details of methods, see Appendix A,
MIAME report. The raw MAS 5.0 data set is publicly available at Gene Expression Omnibus
(GEO, www.ncbi.nlm.nih.gov/geo) as the group series GSE1001 (for individual accession num-
bers see Appendix B, Table B.1).
One-Step Reverse Transcription-Polymerase Chain Reaction
Using fluorescent, one-step reverse transcription-polymerase chain reaction (RT-PCR), we veri-
fied microarray expression changes for early-response genes Fos and Fosl1, delayed-response
genes Il1b and Irf1, and delayed-persistent response genes Cryab, Crygd, Cd81, and Gfap (nu-
cleotide sequences shown in Appendix B, Table B.2). We performed primer design, one-step RT-
PCR reaction, and RT-PCR analysis as previously described by Rogojina et al. [2003]. To elimi-
nate genomic contamination, we treated total RNA with RQ1 RNase-Free DNase (Promega,
Madison, WI). We performed RT-PCR reactions in the iCycler (BioRad, Richmond, CA) using
the reagents in the SYBR Green RT-PCR kit (Applied BioSystems, Warrington, UK). To deter-
mine the relative change in gene expression, we compared the number of cycles (Ct) needed to
reach the midpoint of the linear phase using the iCycler analysis software. All observations were
normalized to the housekeeping gene Rps18.
Protein Expression and Localization
To determine the levels of protein expression in normal retinas and those at 7 days after injury,
we used rabbit polyclonal antibody against GFAP (Thermo Shandon, Pittsburgh, PA) mouse
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monoclonal antibody AMP1 that recognizes CD81 [Geisert et al., 1996], and rabbit polyclonal
antibodies against crystallins a, b, and g (provided by Dr. Sam Zigler, National Institute of
Health). The secondary antibodies were peroxidase-conjugated goat anti-rabbit IgG, goat anti-
mouse IgG, and goat anti-mouse IgG (Jackson ImmunoResearch Laboratories, Inc., East Grove,
PA), all of which had minimal cross-reactivity with rat serum proteins. We compared protein
expression in injured retinas to control retinas using a previously described immunoblot method
[Clarke and Geisert, 1998; Song et al., 2003; Geisert et al., 1996].
Indirect immunohistochemical methods were used to define the cellular localization of
GFAP and crystallins in sections of normal and injured retinas. Injured rats had survival times of
1 day, 3 days, 7 days, and 30 days after retinal injury (Table 2.1). We anesthetized 8 injured rats
and 3 control rats, processed tissue, and followed immunohistochemical methods as previously
described [Clarke and Geisert, 1998; Song et al., 2003; Geisert et al., 1996]. For fluorescent
microscopy, we used fluorescein-conjugated donkey anti-rabbit IgG (Jackson ImmunoResearch
Laboratories, Inc.). To identify RPE cells, we used a rhodamine-conjugated lectin from
Phaseolus vulgaris (PHA-E; Sigma-Aldrich, St. Louis, MO), and mouse monoclonal anti-
cytokeratin antibodies (CBL 234 and MAB 3412; Chemicon, Temecula, CA). We labeled nuclei
with a fluorescent Nissl counterstain, Hoechst 33342 (Sigma-Aldrich), and examined the sections
with the Bio-Rad MRC-1024 confocal laser scanning microscope.
Results
Glial and RPE Response to Retinal Injury
To characterize the local and global response, we examined the distribution of retinal glia and
RPE cell markers. In normal retinas, anti-GFAP labeled astrocytes and Müller cell endfeet at the
ganglion cell layer (GCL; Figure 2.1A). PHA-E lectin stained the normal RPE, choroid, and outer
segments (OS, Figure 2.1B)—a pattern similarly described by Cho et al. [2003].
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Figure 2.1. The cellular response of the rat retina to injury. Retinas labeled with anti-glial fibril-
lary acidic protein (GFAP; A, D, G, and J), lectin from Phaseolus vulgaris (PHA-E; B, E, H, and
K), and Hoechst nuclear staining (C, F, I, and L). The figure illustrates 4 regions of retina: nor-
mal retina (A - C), retina 3 days after injury (D - F), and two different retinas 30 days after injury
(G - I and J - L). In normal retinas, anti-GFAP labeled astrocytes and Müller cell endfeet at the
ganglion cell layer (GCL; A). PHA-E lectin stained the normal RPE, choroid, and outer segments
(OS, B). At 3 days after injury, cells invading the retinal tear (F, arrow) labeled with anti-GFAP
(D, arrow) or PHA-E lectin (E, arrow); whereas, near the injury anti-GFAP labeled mainly
Müller cells and astrocytes at the GCL (D). At 30 days after injury, two cellular responses were
observed at the site of injury. In one response, the cells filling the tear (I, arrows) were mainly
glia cells (H, arrow heads). In the second response, RPE cells mainly filled the tear (K and L,
arrows). In some instances, epiretinal membranes with glia (G, arrow) and RPE cells (H, arrow)
formed over the retinal surface. Panels A - C are of the same magnification with scale bar in C
representing 50 µm. Panels D - L are of the same magnification with the scale bar in L
representing 50 µm.
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After injuiry, the local response involved glia and RPE cells. As early as 3 days after injury, cells
invading the retinal tear were labeled with anti-GFAP (Figure 2.1D, arrow) or PHA-E lectin
(Figure 2.1E, arrow). Levels of GFAP and PHA-E labeling continued to increase so that by 30
days after injury, two cellular responses were observed at the site of injury. In one response, the
cells filling the tear (Figure 2.1I, arrow heads) were mainly GFAP-positive glia cells (Figure
2.1H, arrow heads). In the second response, RPE cells mainly filled the tear (Figure 2.1K and 1L,
arrows) and glia cells formed a well-defined membrane separating the scar from the neural retina
(Figure 2.1J). RPE cell response following retinal injury was consistent with the distribution of
pigmented cells in injured Long Evans rats (Data not shown). In some instances, epiretinal mem-
branes with glia (Figure 2.1G, arrow) and RPE cells (Figure 2.1H, arrow) formed projecting into
the vitreous. Thus, local response to retinal injury involved glia and RPE cells in a manner con-
sistent with previous studies [Song et al., 2003; Loiu et al., 2002].
In addition to the local response, we observed the spread of GFAP immunoreactivity
throughout the retina. During the first 3 days after injury, GFAP labeling was limited to Müller
cells adjacent to the injury and to astrocytes at the ganglion cell layer (Figure 2.1D). At 7 and 30
days after injury, we observed a global GFAP labeling of the retina localized to astrocytes at the
ganglion cell layer, and to Müller cell processes (Figure 2.1G and 2.1J). Near the site of injury,
GFAP labeling showed that the Müller cell processes became thicker and extended into the
subretinal space, whereas GFAP labeling of peripheral Müller cells extended from the ganglion
cell layer to the photoreceptor layer.
Microarray Expression Profiles
In our analysis of microarray data, we used two different tactics: a discovery-driven approach and
a hypothesis-driven approach. In the discovery-driven approach, we defined different patterns of
gene expression across the data set, clustering genes that might be functionally related. The hy-
pothesis-driven approach focused on the gene expression of Cd81 and its relationship with reac-
tive gliosis markers, particularly Gfap. This approach allowed us to concentrate on one aspect of
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the injury response to define the relationships within the tetraspanin family and markers of the
reactive glial response.
Quality Controls. The expression profiles (n = 18 arrays) met a strict set of quality-control
parameters (Table 2.2). Housekeeping genes displayed consistent values and 5’ to 3’ ratios of less
than 3. The average percentage of “Affymetrix present” calls across all arrays was 40.0 ± 1.1%.
The intensity profiles (log2 scale) for all the arrays showed a normal distribution with a mean at
6.59 ± 0.04 and an average standard deviation (s2) of 2.32 ± 0.04. Comparison of expression pro-
files among arrays from independent replicates of the same experimental group (n = 3 ar-
rays/group) showed a within-group average correlation of 0.92 ± 0.01. Our quality controls are
consistent with published microarray data [Yoshimura et al., 2003; Matzilevich et al., 2002; Di
Giovanni et al., 2003]. Together, these results indicate integrity of starting RNA, and efficiency
of first-strand cDNA synthesis and hybridization.
Data Extraction and Normalization. For temporal analysis of the data and comparison
between data extraction methods, the mean intensity for each microarray was normalized to 8
(log2 scale). This transformation yielded MAS 5.0 signal intensities ranging from 1 to 18 relative
units of fluorescence. To determine a “present” signal threshold in our system, we plotted the co-
efficient of variation versus the averaged signal value and determined the threshold signal yield-
ing stable coefficients of variation. From this analysis, the “present” signal threshold was set at
8.64. Below this threshold, signals displayed coefficients of variation greater than 10%, while
their variance increased exponentially (Appendix B, Figure B.1). Using this criterion, 4,480
(50.9%) of the genes met the “present” criterion in at least one condition and were considered for
further analysis. We compared the “present” expression signals to RMA values and found an av-
erage correlation of 0.92 ± 0.01 (Appendix B, Table B.3).
To further analyze the reliability of our “present” signals, we compared fold changes ob-
tained with normalized MAS 5.0 and RMA to fold changes obtained with RT-PCR (Table 2.3).
Using RT-PCR, we measured expression changes for Fos, Fosl1, Il1b, Irf1, Cryab, Crygd, Cd81,
and Gfap at 4 hours, 3 days, and 30 days after injury. For these genes, fold changes measured
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Table 2.2. Microarray expression profiles after an experimentally induced retinal tear.
Survival time
Parameters Control 4 hours 1 day 3 days 7 days 30 days Combined
Average  group quality controls
Actb 3'/5' signal ratio 1.84±0.09 1.90±0.09 2.08±0.07 2.43±0.44 2.03±0.05 2.14±0.05 2.07±0.08
Gapdh 3'/5' signal ratio 1.11±0.24 0.84±0.02 0.86±0.02 1.21±0.15 1.03±0.12 1.05±0.01 1.02±0.05
Array signal mean 6.62±0.09 6.65±0.05 6.55±0.07 6.59±0.04 6.66±0.20 6.50±0.03 6.59±0.04
Array signal distribution (s2) 2.30±0.08 2.30±0.03 2.38±0.05 2.33±0.02 2.21±0.21 2.41±0.01 2.32±0.04
Affymetrix % present 37.0±1.8 37.9±1.4 43.2±1.2 42.2±3.6 38.2±5.5 41.8±0.3 40.0±1.1
Correlations 0.89±0.02 0.94±0.01 0.95±0.00 0.92±0.01 0.89±0.02 0.94±0.00 0.92±0.01
Differentially expressed genes
“Present” in at least one condition; fold
change > |±1.7|; and t-test, P < 0.02
113 127 125 40 127 393
False discovery rate (FDR, %) 17.5 16.5 18.0 39.0 14.0 21.0±5.1
Three biological replicates were used per group. Averages are expressed as means ± SEM. MAS
5.0 signals were transformed into the log2 scale. To determine temporal changes in gene expres-
sion, mean intensities were normalized to 8 (log2 scale) and a signal “present” threshold was set
at 8.64 (log2 scale). The false discovery rate (FDR) of Benjamini and Hochberg [Reiner et al.,
2003] was used to determine the expected proportion of false positives. While array expressions
at 7 days post-injury displayed lower number of genes with significant expression changes and
higher FDR, the three 7-day arrays met the quality controls, and the expression of house keeping
genes (e.g., Gapdh, Actb, Ubc, Hprt, Sdha, and Rpl41) was consistent with expression found in
the other experimental conditions. Thus, there was no empirical data (technical nor biological) to
exclude any data from the 7-day experiments.
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Table 2.3. Transcript changes confirmed with real-time RT-PCR.
Time Log2 Fold ChangeGene point RT-PCR MAS 5.0 RMA
Fos 4h 1.9† 2.1† 1.2†
3d 0.3 0.1 (0.2)
30d 0.1 0.2 0.0
Fosl1 4h 6.5† 5.4† 2.3†
3d 2.7† 0.5 0.5
30d 1.3† (0.3) (0.2)
Il1b 4h 2.1† 2.0† 1.4*
3d 2.0* 1.2* 1.2*
30d 0.5 0.1 0.7
Irf1b 4h 1.0* 1.9* 1.0
3d 1.2† 2.3* 1.5*
30d 0.1* 1.1* 0.2
Cd81 4h 0.2 0.1 (0.1)
3d 1.0* 1.0* 1.2*
30d 1.3† 0.9* 0.7*
Cryab 4h 0.5* 0.8 0.9
3d 2.0† 2.7* 2.6*
30d 0.5* 2.4* 2.0*
Crygd 4h (0.4)* (0.7) (0.5)
3d 2.7† 2.7† 1.8†
30d 1.9* 3.1* 1.5*
Gfap 4h 1.6† 0.4 0.4
3d 2.1† 3.5† 2.8*
30d 2.3† 4.1† 3.8†
Fold changes measured with real-time RT-PCR were compared to those measured with the mi-
croarray U34A. Microarray signals were analyzed using Microarray Suite (MAS) 5.0 and robust
multiarray average (RMA). Fold change represents Log2 (injured/normal expression). Values in
parentheses represent negative fold changes. Statistical significance compared population means
between the control and each survival time (4h, 3d, and 30d): *P < 0.05 and †P < 0.01.
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with normalized MAS 5.0 and RMA values were highly similar (r = 0.89). Both MAS 5.0 and
RMA fold changes were similar in magnitude and direction to fold changes obtained with RT-
PCR. However, RT-PCR fold changes had higher correlations with normalized MAS 5.0 (r =
0.76) than with RMA (r = 0.58). Together, the high correlation between normalized MAS 5.0
values and RMA values and the similarity between microarray fold changes and RT-PCR fold
changes confirm the reliability of our “present” signals, which eliminate genes with low expres-
sion signals. Thus, we have used the normalized MAS 5.0 values for our subsequent analysis.
Discovery-Driven Analysis
The overall goal of our discovery-driven approach was to define groups of genes with similar ex-
pression patterns. The first step in the analysis defined 393 genes with significant changes in ex-
pression levels (fold change > 1.7 and P < 0.02; Table 2.2). These differentially expressed genes
represented an average false discovery rate of 21.0 ± 5.1%. Collectively, these genes displayed a
range of dynamic expression changes across survival time. The second step involved clustering
the 393 genes into groups according to the similarity of their expression profiles. Using principal
component analysis, we identified 194 upregulated genes having transcription changes that con-
formed to one of three major profiles: an early response (Figure 2.2A), a delayed response (Fig-
ure 2.2B), and a late, sustained response (Figure 2.2C). Early response genes displayed a tran-
sient surge in expression following the retinal tear, whereas delayed response genes showed
moderate upregulation at 4 hours and a delayed transient peak at either 1 or 3 days after injury. In
contrast, late, sustained genes displayed peak upregulation at either 3 or 7 days and sustained
over-expression at 30 days after injury. A complete list of upregulated genes organized by clus-
ters is found in Appendix B, Table B.4.
The distribution of genes by functional category revealed that genes within clusters were
functionally related (Figure 2.2D). For instance, 75% of the upregulated transcription genes
clustered in the early response profile. Additional functional groups represented in the early re-
sponse included cell proliferation, apoptosis, and cell-survival mechanisms. Genes
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Figure 2.2. Gene expression profiles after retinal injury. Differentially expressed genes (n = 194)
were clustered into 3 major profiles: an early response (A), a delayed response (B), and a late,
sustained response (C). Genes were clustered using principal component analysis. Early-response
genes displayed a transient surge in expression after injury. Genes fitting the delayed-response
profile had a transient peak in expression at either 1 or 3 days after injury. Genes within the third
expression profile had a late expression peak (i.e., at either 3 or 7 days) and sustained over-
expression at 30 days after retinal injury. A complete list of upregulated genes organized by
clusters is found on Appendix B, Table B.3. The distribution of genes by functional category re-
veals that those within each expression profile are functionally related (D).
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highly represented in the delayed response profile included those regulating cell cycle, cell death
and survival, neural development, and gliosis. A high percentage of late, sustained genes were
associated with the reactive responses of the retina:  gliosis, inflammation, stress response, neu-
ronal degeneration, and tissue remodeling. A summary and expanded version of the distribution
of genes by clusters and functional category are shown in Figure 2.3 and Appendix B, Table B.5,
respectively.
One unexpected finding was the clustering of the crystallin genes with the retinal reactive
marker Gfap. All the crystallins in the microarray—Cryaa, Cryab, Cryba1, Cryab4, Crybb2,
Crybb3, Crygc, Crygd, and Cryge—displayed strong, sustained upregulation (Appendix B, Table
B.5, category 7). To confirm our findings, we examined the mRNA and protein expression of
selected crystallins. We measured the mRNA expression of Cryab and Crygd, using RT-PCR.
Cryab mRNA levels showed a moderate fold increase of 1.42 ± 0.11 at 4 hours after injury, a ro-
bust upregulation of 4.13 ± 0.12 at 3 days, and a moderate fold change of 1.46 ± 0.04 at 30 days
(Figure 2.4A). Crygd mRNA showed an initial down-regulation of 1.34 ± 0.03, followed by sig-
nificant changes to 6.36 ± 0.25 at 3 days and 3.64 ± 0.41 at 30 days (Figure 2.4A). Our microar-
ray and RT-PCR measurements showed agreement in the direction of change of Cryab and Crygd
(Figure 2.4A). Moreover, the mRNA expression of Cryab and Crygd across time displayed a
pattern of expression that was similar to that of genes in our late, sustained profile, with a delayed
peak at 3 days and strong, sustained upregulation even after 30 days.
To extend our crystallin gene findings, we measured the protein levels of the crystallins a,
b, and g, using a quantitative immunoblot method (Figure 2.4B). The immunoreactivity of the
crystallins significantly increased to 7.1 ± 0.39, 6.8 ± 0.66, and 11.1 ± 2.4, respectively, at 7 days
after injury. Taking this analysis one step further, we defined the localization of the reactivity of
crystallins a, b, and g in normal and injured retinas. In normal retinas, we observed labeling of
crystallins a, b, and g mainly at the ganglion cell layer (Figure 2.4C, 4E, and 4G). The crystallins
had well-defined patterns of immunoreactivity at the site of injury and within the layers of the
retina. At 7 and 30 days following injury, crystallin immunoreactivity was seen throughout
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Early Delayed Late
Transcription
Fos, Fosl1, Egr1, Nr4a1, Cebpd, 
Isl1, Nfkb1,Stat3, Irf1, Zfp36,
Atf3, Cbfb, Crem, and Rnf4
Cell cycle & growth
Akap12, Pak3, Btg2, Ssecks322, Arhgap7, Igf1, Igfals, and Insig1 
Apoptosis & neurodegeneration
Bax, Casp3, Ctsl, Litaf, Tnfrsf21, Mx3, Apobec1, Vdac1, A2m, and Spinc2
Stress response & cell survival
Btg2, Eef1a2, Parp, Snca, Apoe, Mt1a, Sod2, Dnajb9, Hspa1a,Cp, Clu, Cryab, and Gsta1
Inflammatory response
Cxcl10, Il2r, Ptgs2, RT-BM1, Il6r, Cish3, Cst4, 
Ctsc, Il1b, Lman1, and Pros1, 
Fcgr3, Gtpi, Ifitm3l, RT1Aw2, C1qb, C1r, C1s, C3, Cd48, 
Cd74, Edn2, RT1.C/E, RT1.Da u, RT1.Mb, Scyb13, and Snn 
Cebpd, Nfkb1,Stat3, Irf1, and Zfp36
Gliosis & Neural development
Cstb, Jag1, Ania4, Cntn1, Vcam1, and Ninj1 
A2m, Anxa5, Apoe, Cd81, Cp, Clu, Cntf,  Cryab, Dpysl4,
Gfap, mrf-1, Pea15, Pmp22, S100a1, and Sparc 
Structure & tissue remodeling
Krt1-14, Plat, Tpm3, IMPG2, and Lim2
Tubb1, Fuca, Lip1, Arpc1b, Bfsp1, Ctsh, Ctss, Fmod, Grifin,
Lyz, Mgp, Myo5b, Nedd4a, and Tpm3
Akap11, D123, Dlg1, Itgb1, Lcn2, Ptn, Ywhae,
Ywhaq, Abi2, Nap1l1, and Vhl 
Cd82, Ppap2b, and Prkr
Figure 2.3. Temporal distribution of genes and functional categories after retinal injury. Location
of genes describes relative gene expression peaks: early expression corresponds to peak expres-
sion at 4 hours; delayed expression corresponds to peak expression at 1 or 3 days; and late ex-
pression corresponds to peak expression at 7 or 30 days. For specific expression profiles see Ap-
pendix B, Table B.4.
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Figure 2.4. The crystallins a, b, and g were dramatically upregulated after retinal injury. The mi-
croarray expression changes for Cryab and Crygd (A, gray bars) were confirmed with RT-PCR
(A, white bars). Immunoblots show increased levels of crystallin a, b, and g proteins (B). Crys-
tallin a, b, and g expression in normal retinas (C, E, and G, respectively) and injured retinas 7
days after injury (D, F, and H, respectively) was localized by immunohistochemistry. In normal
retina, crystallin immunoreactivity was present mainly at the ganglion cell layer (GCL; C, E, and
G). Seven days after injury, there was a strong crystallin immunoreactivity throughout the scar
spanning the retinal tear and protruded into the vitreal space (data not shown). High immunore-
activity levels for crystallins a (D), b (F), and g (H) were found immediately adjacent to the ret-
ina at GCL and outer segment layer (OS). No staining was seen when secondary antibody control
was used (data not shown). Asterisks denote significant changes from the normal (t-test, *P <
0.05, **P < 0.01).
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the scar that spanned the retinal tear and protruded into the vitreal space. Immediately adjacent to
the injury, strong crystallin immunostaining was present at the ganglion cell layer and the photo-
receptor layer (Figure 2.4D, 4F, and 4H; 7-day retinas shown). Moderate levels of immunoreac-
tivity were also observed throughout the inner plexus layer, the inner nuclear layer, and the RPE.
The well-defined pattern of crystallin mRNA upregulation by microarray and RT-PCR as well as
the increase of crystallin protein and crystallin localization in the retina by immunohistochemical
methods validate our discovery-driven observations that crystallins displayed strong, sustained
transcription in response to injury in the rat retina.
Hypothesis-Driven Approach
The primary interest of our laboratory is the role of CD81 in the healing response of the retina.
We specifically examined the relationships between Cd81, other tetraspanins, and markers of re-
active glia. Our microarray data showed that Cd81 was moderately upregulated at 4 hours, to
1.05 ± 0.1, and significantly increased to 1.99 ± 0.2 and 1.88 ± 0.1 at 3 and 30 days, respectively
(Figure 2.5A, gray boxes). RT-PCR confirmed the sustained upregulation of Cd81 mRNA after
retinal injury (Figure 2.5A, white boxes). Our analysis showed that Cd81 clustered in the late,
sustained profile, along with the tetraspanins and several glial reactive markers (see Appendix B,
Table B.4, genes 126-194). We used a second round of PCA to define further the associations
between Cd81 and the late, sustained profile genes. The subclusters were visualized by plotting
the first two components (Figure 2.5B). Cd81 clustered tightly with tetraspanins Cd9 and Cd82,
as well as with the genes for associated proteins MHC class I (RT1Aw2 and RT1.Dau) and MHC
class II (RT1.C/E). Together, these genes displayed persistent changes after retinal injury, with
peak expression occurring at 3 days after injury. Tetraspanins Cd37, Cd53, and Cd151 were pre-
sent in the normal retina, but their expression remained constant following injury. Among the
glial reactive markers, Anxa5, Cntf, Pea15, Pmp22, S100a1, and Sparc clustered tightly with
Cd81, whereas Clu, Cryab, Gfap and A2m formed a separate cluster within the late sustained pro-
file (Figure 2.5B).
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Figure 2.5. Cd81 clustered into the late-response profile along with tetraspanins and glial reac-
tive markers. RT-PCR confirmed the sustained upregulation of Cd81 after injury (A). A second
round of principal component analysis was used to define further the associations between Cd81
and the genes within the late-response profile. The subclusters were visualized by plotting the
first two components (B). Cd81 clustered tightly with tetraspanins Cd9 and Cd82, as well as with
the genes for associated proteins MHC class I (RT1Aw2 and RT1.Dau) and MHC class II
(RT1.C/E). Asterisks denote significant changes from the normal (t-test, *P < 0.05, **P < 0.01).
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Discussion
Our microarray analyses describe both a local reactive response at the site of retinal injury as well
as changes occurring across the entire retina. As with injuries in other parts of the central nervous
system (CNS), a local glial response is identified by the dramatic upregulation of the cytoskeletal
protein GFAP [Ridet et al., 1997]. In the retina, this occurs in both Müller cells and astrocytes
[Fisher et al., 2001; Humphrey et al., 1993; Bringmann and Reichenbach, 2001; 21]. Reactive
Müller glia cells hypertrophy, proliferate, and form a protective barrier around the damaged area
[Humphrey et al., 1993; Bringmann and Reichenbach, 2001; MacLaren, 1996]. Studies done in
our laboratory [Song et al., 2003] and by others [Humphrey et al., 1993; MacLaren, 1996] have
identified the spread of GFAP reactivity over the entire retina even after a modest local insult.
This global GFAP response has been observed in association with various types of injury, in-
cluding retinal detachment [Fisher et al., 2001], mechanical injury [Clarke and Geisert, 1998;
Song et al., 2003; MacLaren, 1996; Miller and Oberdorfer, 1981] laser lesions [Humphrey et al.,
1993], and optic nerve injury [Bignami and Dahl, 1979], as well as after transplantation of retinal
cells [Behar-Cohen et al., 2000]. Widespread spatial changes have also been reported for CD81
[Song et al., 2003], heat shock protein 27 [Strunnikova et al., 2001], clusterin [Wong et al.,
2001], and NF-kB [Geller et al., 2003; Wu et al., 2002]. Therefore, by examining changes over
the entire retina, we measured in a consistent way the local and global response to the retinal tear.
The initial set of differentially expressed genes included 393 genes, 4.5% of the genes in
the RG-U34A chip. Using clustering analysis [Peterson, 2002; Di Giovanni et al., 2003; Heyer et
al., 1999], we discovered three major expression profiles: an early response, a delayed response,
and a late, sustained response. Genes within each of the profiles were functionally related. The
early response profile reflects rapid transcription of the immediate early genes as well as genes
involved in cell proliferation, apoptosis, and cell survival. Genes highly represented in the de-
layed profile included those with functions relating to the cell cycle, cell death and survival, neu-
ral development, and gliosis. Within the late, sustained profile, a high percentage of genes were
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associated with the reactive response of the retina:  gliosis, inflammation, stress response, neu-
ronal degeneration, and tissue remodeling. The clustering of functionally related genes during
retinal wound healing suggests that genes within a profile may be co-regulated. Others have
identified transcriptional networks controlling clusters of genes expressed during the cell-cycle
progression in yeast Saccharomyces cerevisiae [Heyer et al., 1999, Spellman et al., 1998]. Spell-
man and associates also found that genes in a given cluster share common regulatory motifs in the
promoter region [Spellman et al., 1998]. Ongoing work in our laboratory reveals that selected
genes within a cluster may be under the control of a common regulatory network [Geisert EE, et
al. IOVS 2003 44: E-Abstract 2967].
The temporal regulation of genes and functional groups we observed is consistent with
previous studies of gene expression in the retina [Grimm et al., 2000; Yoshimura et al., 2003],
brain [Matzilevich et al., 2002], and spinal cord [Di Giovanni et al., 2003]. For example, early
gene expression of the transcription factors c-Fos, Fosl1 (Fra-1), Nfkb1, Stat3, Egr1 (Krox-
24/NGFI-A), Cebpd, Atf3, and Irf1 has been reported in response to retinal ischemia [Yoshimura
et al., 2003], photopic injury [Grimm et al., 2000], and retinal detachment [Fisher et al., 2001;
Geller et al., 2003]. Moreover, the progression of gene expression changes in our study reflects
the biochemical, cellular, and morphologic changes previously reported [Ryan et al., 1994; Fisher
et al., 2001; Humphrey et al., 1993; Sherry and Townes, 2000; Szabo et al., 1991; Grimm et al.,
2000; Yoshimura et al., 2003; Bringmann and Reichenbach, 2001; Grierson et al., 1994; Sahel et
al., 1991; Geller et al., 2003]. An initial inflammatory response [Ryan et al., 1994; Humphrey et
al., 1993; MacLaren, 1996] and change in ionic balance [Sherry and Townes, 2000; Szabo et al.,
1991] are followed by a series of cellular responses that include RPE and Müller cell reactivity
and proliferation, and cell death [Fisher et al., 2001; Grimm et al., 2000; Bringmann and
Reichenbach, 2001; Grierson et al., 1994; Sahel et al., 1991]. During the late response, the reac-
tive RPE and Müller cells participate in structural remodeling of the retina, including the forma-
tion of fibrocellular membranes [Ryan et al., 1994;Fisher et al., 2001; Behar-Cohen et al., 2000;
Grierson et al., 1994]. Our analysis demonstrates that microarray clustering analysis can identify
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components of biochemical complexes and cellular pathways involved in the response of the
retina to injury.
Given the importance of Müller cells, astrocytes, and microglia in the response of the
retina to injury, genes associated with reactive gliosis are of particular interest. In this study, a
significant group of gliosis-related genes clustered with Gfap in the late, sustained profile (Figure
2.3). Several of these gliosis-related factors, including Cp [Chen et al., 2003], CNTF [Wang et
al., 2002], ApoE [Anderson et al., 2001], CLU [Wong et al., 2001] Anxa5 [Yoshimura et al.,
2003], S100 [Sahel et al., 1991], and SPARC [Gilbert et al., 1999], are known to be expressed by
reactive Müller and RPE cells. Whereas mrf-1, Pea15, and Pmp22 genes were unexpectedly
upregulated in the retina, although they are expressed by reactive glia elsewhere in the nervous
system [Tanaka et al., 1998; Trencia et al., 2003; Atanasoski et al., 2002]. Potential factors con-
trolling glial activation in the retina include cytokines and inflammatory transcription factors.
Cytokines and their receptors that are upregulated in our microarray data and are thought to play
a key role in the modulation of glial cell function include IL-1b, IL-6R, and CNTF [Wang et al.,
2002; Acarin et al., 2001]. The actions of these cytokines in glia cells are mainly mediated by the
transcription factors STAT3 and NF-kB [Acarin et al., 2001]. For example, intravitreal injections
of CNTF or IL-6 activate STAT3 in Müller cells [Wang et al., 2002]. Among the reactive glia
genes targeted by STAT3 include Gfap, A2m, Fos, Irf1, and Stat3 [Wang et al., 2002; Acarin et
al., 2001; Horvath, 2001]. In addition, Müller cells show NF-kB activation within hours after
retinal detachment [Geller et al., 2003]. Noteworthy, NF-kB also modulates the expression of
Gfap as well as Il1b and Il6 [Acarin et al., 2001]. Together, these data suggest that STAT3 and
NF-kB mediate signaling pathways involved in the glial response to retinal injury.
One novel revelation in our analysis was the profound upregulation of crystallins a, b,
and g (Figure 2.2). Traditionally, crystallins have been thought to be lens-rich proteins involved
in lens development and maintenance. However, recent studies suggest that crystallins have
broader roles and are expressed beyond lens tissue [Yoshimura et al., 2003; Horwitz, 2003; Piati-
gorsky, 1998; Alge et al., 2002; Sakaguchi et al., 2003; Xi et al., 2003]. Gene-sequence homol-
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ogy studies of crystallins show that members of this family display considerable homology with
genes involved in the stress response [Horwitz, 2003; Piatigorsky, 1998]. For instance, the a-
crystallins belong to the small heat-shock protein family and may act as molecular chaperones
[Horwitz, 2003; Piatigorsky, 1998]. In cultured RPE, aB-crystallin upregulation confers resis-
tance to stress-inducible apoptosis [Alge et al., 2002]. A recent gene expression study confirmed
the increased expression of selected a, b, and g crystallin transcripts in the rat retina after ische-
mia-reperfusion injury [Yoshimura et al., 2003]. Similarly, we found that the mRNA of all ten
crystallins represented in the microarray displayed strong, sustained upregulation after retinal in-
jury. These results are consistent with the increased crystallin protein expression confirmed by
Sakaguchi and colleagues using mass spectrometry after exposing rat retina to light injury
[Sakaguchi et al., 2003]. Furthermore, the temporal and spatial expression of crystallins is similar
to that of GFAP, implicating this family of proteins in both the local and global response of the
retina to trauma. Notably, studies of gene expression in the brain [Matzilevich et al., 2002] and
spinal cord [Di Giovanni et al., 2003] using the identical microarray platform (RG-U34A) did not
find a similar upregulation in crystallins a, b, and g in response to trauma. While crystallin ex-
pression in normal mouse retina displays animal-to-animal variation [Xi et al., 2003], studies af-
ter retinal detachment [Yoshimura et al., 2003], light injury [Sakaguchi et al., 2003], and our reti-
nal tear consistently report the upregulation of crystallins. The coordinated upregulation of crys-
tallins after injury is a potentially important part of the retinal wound-healing process that merits
further investigation. Defining the response of the crystallin family to injury illustrates the power
of microarray technologies and the discovery-driven approach.
Microarray technology, combined with gene expression profiling, offers the potential to
identify cellular pathways and molecular complexes that are important in the regulation of retinal
responses to trauma and disease [Grimm et al., 2000; Yoshimura et al., 2003]. Our laboratory is
defining the role of CD81 in reactive gliosis in the retina [Clarke and Geisert, 1998; Song et al.,
2003], brain [Sullivan and Geisert, 1998], and spinal cord [Dijkstra et al., 2000]. CD81 is part of
a molecular complex within the plane of the membrane that links adhesive interactions into sec-
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ond-messenger cascades [Boucheix et al., 2001; Hemler, 2001]. Using microarray technology, we
monitored gene expression changes for Cd81 and the entire family of tetraspanins (e.g., Cd9,
Cd37, Cd53, Cd63, Cd81, Cd82, and Cd151) [Boucheix et al., 2001; Hemler, 2001]. In addition,
we specifically mined the data to define changes in molecules known to associate with tet-
raspanins to determine if the members of the tetraspanin complex are co-regulated. Our analysis
indicates that similar patterns of expression are shared by the tetraspanin genes Cd9, Cd81, and
Cd82, as well as genes for the major histocompatibillity complex (MHC) receptors RT1Aw2,
RT1.Dau, and RT1.C/E (Figure 2.3). Tetraspanins CD81, CD9, and CD82 are known to associate
with MHC receptors in a number of different cell types, including lymphocytes, endothelial cells,
and oocytes [Boucheix et al., 2001; Hemler, 2001; Szollosi et al., 1996]. For instance, CD81 and
CD82 interact with MHC class I and II in antigen-presenting cells to modulate signaling through
MHC molecules and antigen presentation [Szollosi et al., 1996]. Defining the temporal expres-
sion of tetraspanins and molecules to which they complex allows us to focus on the specific role
of CD81 in the retina, its potential molecular associations, and its role in the reactive response.
The present study catalogued the time course of expression changes in response to a reti-
nal injury. By surveying the expression patterns of 8,750 genes, we defined an early, a delayed,
and a late, sustained response to retinal injury and demonstrated that within each profile, genes
participate as functional units involved in different aspects of the healing response. Within the
late response profile, we identified a host of glial reactive genes as well as crystallins, a previ-
ously overlooked family of proteins in the injured retina. In profiling the expression of tet-
raspanins, we identified CD9, CD81, and CD82 as potential organizers of molecular complexes
regulating proliferation and the glial activation response. Our finding that crystallins and tet-
raspanins can act in functional units highlights the fact that the function, or therapeutic interven-
tion, of a gene can be regulated at the gene expression level. However, we are limited in our abil-
ity to link crystallins or tetraspanins to specific cell populations or specific pathways. Future re-
search using single-cell studies and genetically-altered animals will help dissect the molecular
pathways and networks regulating gene expression.
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Abstract
Purpose: The present study defines genomic loci underlying coordinate changes in gene expres-
sion following retinal injury.
Methods: A group of acute phase genes expressed in different nervous system tissues was defined
by combining microarray results from injury studies from rat retina, brain and spinal cord. Ge-
nomic loci regulating the brain expression of acute phase genes were identified using a panel of
BXD recombinant inbred (RI) mouse strains. Candidate upstream regulators within a locus were
defined using single nucleotide polymorphism databases and promoter motif databases.
Results: The acute phase response of rat retina, brain, and spinal cord was dominated by tran-
scription factors. Three genomic loci control transcript expression of acute phase genes in brains
of BXD RI mouse strains. One locus was identified on chromosome 12 and was highly correlated
with the expression of classic acute phase genes. Within the locus we identified the inhibitor of
DNA binding 2 (Id2) as a candidate upstream regulator. Id2 was upregulated as an acute phase
transcript in injury models of rat retina, brain, and spinal cord.
Conclusion: We defined a group of transcriptional changes associated with the retinal acute in-
jury response. Using genetic linkage analysis of natural transcript variation, we identified regu-
latory loci and candidate regulators that control transcript levels of acute phase genes.
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Introduction
To understand the global consequences of retinal injury, several laboratories monitored the tran-
scriptome with microarray techniques [Vazquez et al., 2004; Yoshimura et al., 2003; Ahmed et
al., 2004; Wilson et al., 2003; Chen et al., 2004]. Changes in transcripts were analyzed to define
the key regulatory events following retinal injury. In an earlier study, we defined a temporal
grouping of changes related to the biochemical and cellular response to retinal injury [Vazquez et
al., 2004]. This type of analysis, defining gene clusters that occur after injury, is not an endpoint
in the analysis but a beginning. The growing number of bioinformatic resources provides an op-
portunity to further analyze and interpret the changes in the transcriptome after retinal injury. We
can now examine the transcriptome data from injured retina by using not only various injury
models [Vazquez et al., 2004; Yoshimura et al., 2003; Ahmed et al., 2004; Wilson et al., 2003;
Chen et al., 2004] but also combining data from different regions of the central nervous system
(CNS) [Matzilevich et al., 2002; Dash et al., 2004; Di Giovanni et al., 2003; Chesler et al., 2005].
Our previous analysis of rat retina identified three major transcript phases after injury: an
early acute phase (within hours), an intermediate subacute phase (within 1 to 2 days), and a late
chronic phase (within 3 days to weeks; [Vazquez et al., 2004]). The early acute phase is charac-
terized by the transient upregulation of immediate-early genes, mainly transcription factors and
activating cytokines. The intermediate subacute phase is characterized by the expression of cell-
cycle and cell-death genes. The late chronic phase is characterized by the expression of genes in-
volved in neuronal and glial structural remodeling. Similar changes were described in injury
models in the rat retina [Yoshimura et al., 2003; Ahmed et al., 2004; Wilson et al., 2003; Chen et
al., 2004], brain [Matzilevich et al., 2002; Dash et al., 2004], and spinal cord [Di Giovanni et al.,
2003]. For example, the early acute genes Fos, Jun, Egr1, and Nfkb1, as well as the late chronic
genes Gfap, A2m, Apoe, and Hsp27, display transcript changes resulting from virtually any
trauma or stress throughout the CNS [Vazquez et al., 2004; Yoshimura et al., 2003; Ahmed et al.,
2004; Wilson et al., 2003; Chen et al., 2004; Matzilevich et al., 2002; Dash et al., 2004; Di Gio-
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vanni et al., 2003]. The similarities of coordinate changes in the retina, brain, and spinal cord in-
dicate the presence of common transcriptional networks controlling the CNS response to injury.
GeneNetwork (www.genenetwork.org, [Chesler et al., 2005; Bystrykh et al., 2005]) is a
powerful analytical tool to define transcriptional networks and regulators in CNS tissues. At the
heart of this analysis is a unique population, the recombinant inbred (RI) strains of mice. One
group of mice were derived by inbreeding for over 20 generations the F1 crosses between
C57BL/6 (B) and DBA/2J (D) mouse strains. Each BXD RI strain has a shuffled genome con-
sisting of a unique recombination of the C57BL/6 and DBA/2J genomes, forming a segregating
population of mice. These RI mouse strains, the associated microarray databases, and the genetic-
analysis tools at GeneNetwork allow one to explore regulatory loci and networks built around
any transcript [Chesler et al., 2005; Bystrykh et al., 2005]. The best way to think about the ge-
netic linkage mapping is at the transcript level. If there is specific variability in transcript abun-
dance among members of a segregating population, then it is possible to map transcript abun-
dance to a specific chromosomal locus (for methodology, see [Chesler et al., 2005; Bystrykh et
al., 2005]). One example of this type of analysis was presented by Chesler and colleagues
[Chesler et al., 2005] where a group of genes involved in synaptic vesicle regulation forms a net-
work with distinct regulatory loci. The concept of genetic analysis of transcript data is called
“expression genetics” or “genetical genomics” (for an overview see [Broman, 2005]). Of interest
to the vision community is the comprehensive analysis of regulatory loci controlling gene expres-
sion of the mouse brain. Both retina and brain are tissues derived from the neural tube. Thus, they
share similar cell types with similar transcriptional regulation. For example, the transcription
factor STAT3 plays an important role in activating cortical astrocytes [Acarin et al., 2001] and
retinal Muller glial cells [Wang et al., 2002]. Thus, it may be possible to use available genetic
analyses of brain transcript data to define genetic networks and regulatory loci for the retina. To
identify genomic loci and potential candidate genes controlling changes in the rat retina, we
turned to our publicly available database. The GeneNetwork database was generated using RI
mouse strains and a similar data set is not currently available for the rat. Since the rat is closely
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related to the mouse and since transcriptional expression in the normal and injured CNS is highly
conserved across rodent species [Natale et al., 2003], we have chosen to use this mouse database
to further analyze the changes in gene expression that occur following injury to the rat CNS.
Here we describe a method to define regulators of retinal wound healing that uses pub-
lished and publicly available microarray data, transcript regulatory loci databases, and bioinfor-
matic resources. As a starting point, we define regulators that control the expression of acute
phase genes after a mechanical injury to the rat retina [Vazquez et al., 2004]. First to eliminate
retina-specific genes and to increase the power of our analysis, we extract a group of acute phase
genes that are common to injured rat retina, brain, and spinal cord. Second, we determine the
regulatory loci controlling the expression of acute phase genes in mouse brains using GeneNet-
work. Third, we use computational tools to predict the candidate upstream regulator. This unique
combination of analytical tools provides, for the first time, an analysis of retinal microarray data
that predicts genetic networks and their candidate upstream regulators.
Methods
Meta-analyses of Microarray Data Sets
We performed meta-analyses of previous experimental data (Table 3.1) to select a group of can-
didate genes for a common response to injury in neural tissues. We previously published CNS
microarray analyses that examined the transcriptome response of injured rat retina and brain, the
transcriptome of cultured human and rat astrocytes, and the regulatory loci controlling transcript
expression in the mouse brain [Vazquez et al., 2004; Matzilevich et al., 2002; Dash et al., 2004;
Chesler et al., 2004; Yang et al., 2004]. To complement our analysis of reactive CNS genes, we
obtained publicly available data that examined the transcriptome response of injured rat spinal
cord, the transcriptome of developing mouse retina, as well as the transcriptome of cultured
mouse neurons, mouse astrocytes, and rat microglia [Di Giovanni et al., 2003; Duker et al.,
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Table 3.1. Data used to define acute phase genes.
Tissue Reactive response 
inducer
Species Microarray 
Platform
Experimental conditions GEO number or reference
Injured retina Retinal tear Rat U34A 4 h; and 1, 3, 7, & 30 d Vazquez et al., 2004
Injured brain Cortical impact Rat U34A 3 h Matzilevich et al., 2002
Injured spinal cord Cord contusion Rat U34A 4 h Di Giovanni et al., 2003
Optic nerve head astrocyte Cell culture Human U95Av2 Cell culture Yang et al., 2004
Cortical astrocyte Cell culture Rat U34A Cell culture GSM34300
Brain microglia Cell culture Rat U34A Cell culture Duke et al., 2004
Neuron Cell culture Mouse U74Av2 Cell culture Kraft et al., 2004
Developing retina Development Mouse U74Av2 P0, P4, P8, P10, P12, P14,P21, & adult Dorell et al., 2004
Adult forebrain Genetic variation Mouse U74Av2 C57BL/6, DBA2/J, F1, & 32 BXD RI 
strains
Chesler et al., 2005
We performed a meta-analysis of previous experimental data to select a group of acute phase
genes that are part of a common response to injury in neural tissues. Previously, we examined
transcript levels in injured retina, injured brain, cultured astrocytes, and in forebrains from a
panel of 35 BXD RI strains [Vazquez et al., 2004; Matzilevich et al., 2002; Dash et al., 2004;
Chesler et al., 2004; Yang et al., 2004]. Microarray data sets describing transcript levels in in-
jured spinal cord, cultured microglia, cultured neurons, and developing retina were obtained from
publicly available published studies [Di Giovanni et al., 2003; Duker et al., 2004; Moran et al.,
2004; Kraft et al., 2004; Dorell et al., 2004]. All datasets are available online either at Gene Ex-
pression Omnibus (GEO,www.ncbi.nlm.nih.gov/geo) or at the author's or journal's website.
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2004; Moran et al., 2004; Kraft et al., 2004; Dorell et al., 2004]. Table 3.1 makes clear the source
and availability of each microarray data set. The use of microarray datasets involved three differ-
ent meta-analyses. First, a group of acute phase genes commonly expressed throughout the CNS
was defined by directly comparing microarray data from injured rat retina, brain, and spinal cord.
For this analysis, we obtained the raw data (CEL files), determined signal values using Microar-
ray Suite 5.0 (MAS 5.0; Affymetrix, Santa Clara, CA), transformed signals to a log scale (base
2), and normalized microarray mean intensity to 8 as described previously [Vazquez et al., 2004].
These transformations yielded signal intensities ranging from 1 to 18 relative units of fluores-
cence. Further analyses included only transcripts with medium to high abundance (that is, signals
greater than 8.64 [Vazquez et al., 2004]). To determine significant differences, we used Student’s
t-test (P < 0.05) and changes greater than 2-fold. The second meta-analysis determined if an acute
phase gene was expressed in cultured astrocytes, cultured microglia, and cultured neurons, as
well as in the developing retina. An acute gene was considered present in a tissue if it displayed
medium to high abundance [Vazquez et al., 2004]. In the third meta-analysis, we used GeneNet-
work to examine transcript regulation in mouse forebrains. Transcriptome analyses with Af-
fymetrix RG-U34A and MG-U74Av2 survey about nine and twelve thousand targets (about 30
and 40 % of the rodent transcriptome; [Affymetrix NetAffex, June 2005 Annotation]).
Online Regulatory Locus Analyses
To define regulatory loci that control gene expression in mouse brain, we used GeneNetwork
[www.genenetwork.org], which is maintained by members of our group (E.J.C, L.L, K.F.M, and
R.W.W). Details on the methods, data, and analyses are available at GeneNetwork [Chesler et al.,
2005; Bystrykh et al., 2005]. Briefly, GeneNetwork is a suite of databases and analysis software
that identifies regulatory loci that control transcript abundance of nearly 12,000 genes in a panel
of 32 BXD RI mouse strains derived from C57BL/6 (B) and DBA/2J (D) mice, both parental
strains, and the F1 hybrid (a total of 35 isogenic lines [Chesler et al., 2005; Bystrykh et al.,
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2005]). Strain means for transcript abundance were generated from three to five Affymetrix
U74Av2 microarrays, and each individual array was hybridized to a pool of forebrain tissue taken
from three adult animals [Chesler et al., 2005]. To maximize strain-dependent expression vari-
ance or heritability, probe-set signals were measured by weighting the perfect-match (PM) probes
by their heritability [Manly et al., 2005]. Using quantitative genetic analysis and a genetic map
consisting of 779 fully genotyped markers, GeneNetwork correlates the mean abundance of each
transcript to genotypes at locations throughout the mouse genome. The average distance between
adjacent markers is approximately 4 megabases (Mb). Here, we examined the regulation of acute
phase genes in mouse brains using GeneNetwork and the weighted-by-heritability transforms
[UTHSC Brain mRNA U74Av2 HWT1PM, December 2003]. Variability across strains was
measured using analysis of variance (ANOVA) testing the between-strain variance compared
with the total variance for 100 arrays from 35 mouse strains. The degrees of freedom for the be-
tween-group and total variance are 34 and 99. Strain-specific variation is significant (p < 0.05)
when F34,99 > 1.5.Whole genome maps for all transcripts are replicated and recomputed using a
variety of transforms and analytical methods in GeneNetwork, including simple and composite
interval mapping, multiple-trait clustering, and principal component analysis. We also confirmed
the strength of a candidate upstream regulator using the cerebellum GeneNetwork database
[SJUT Cerebellum mRNA M430 MAS5, January 2004]. Since gene names may differ across
species and multiple probe sets may be available in the U74Av2 microarray, we include the probe
set identifier when referring to genes analyzed with GeneNetwork. We confirmed gene identity
of a probe set using Affymetrix NetAffex [June 2005 Annotation] and Ensembl AffyProbe [v33]
databases.
Online Bioinformatic Resources
To identify candidate genes within a regulatory locus, we located genes within the appropriate
genomic interval using the Genome Browser [Mouse May 2004 assembly]. Single nucleotide
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polymorphisms (SNPs) were identified by comparing genome sequences in the Celera SNP
(Celera Discovery Systems, CA; [July 2003 Assembly]), Ensembl Mouse SNPView [v33], and
Entrez SNP databases. Once the SNPs were identified, a computational approach was used to
determine if the SNP within the Id2 promoter (rs4229289, for sequence variation and genomic
context see Ensembl Mouse SNPView) was within a transcription factor binding site. First, we
determined whether the rs4229289 SNP was located within a highly conserved region using Ge-
nome Browser Conservation tool [Mouse May 2004 Assembly]. Second, we obtained a highly
conserved sequence around the rs4229289 SNP from the alignment of mouse, rat, and human se-
quences using Genome Browser Conservation tool [May 2004 Assembly]. Alignments with other
species were not available. Third, we located putative transcription factor binding sites within the
conserved region using the vertebrate TRANSFAC database available through MOTIF database
and using the default cut-off score [Knuppel et al., 1994].
Several online databases provide transcript data or transcript distribution in the CNS.
Gene Expression Omnibus (GEO) is a high-throughput gene expression abundance data reposi-
tory, as well as a curated, online resource for gene expression data browsing, query, and retrieval
[www.ncbi.nlm.nih.gov/geo]. Retina Developmental Gene Expression describes the gene expres-
sion profile of thousands of genes in the developing postnatal mouse retina that were analyzed by
hybridization to Affymetrix Mu74 Av2 [www.scripps.edu/cb/friedlander/gene_expression/;
Dorell et al., 2004]. Mouse Retina SAGE Library provides serial analysis of gene expression tags
or in situ hybridization images for a limited number of transcripts expressed in the developing
and adult mouse retina [https://bricweb.partners.org/cepko/default.asp; Blackshaw et al., 2004].
Gene Expression Nervous System Atlas (GENSAT) maps the transcript distribution in the mouse
CNS using in situ hybridization [www.ncbi.nlm.nih.gov/gensat].
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Results
Acute Phase Genes
In our continuing efforts to understand the retinal response to injury, we concentrated on the tran-
scriptome changes that occur within hours after retinal injury: the acute phase genes. We know
that there is a sequence of changes leading to reactive gliosis and remodeling of the retina
[Vazquez et al., 2004]. To make our analysis more robust and generalized for CNS injury, we
combined our injured rat retina data with results from injured rat brain and spinal cord. In these
three data sets, 30 genes demonstrated a significant change in expression level (Table 3.2; P <
0.05; change > 2-fold; 4 h postinjury). All of the common changes in the three data sets were
upregulated after injury. No common down-regulated transcripts were observed in injured retina,
brain, and spinal cord. These acute phase genes can be expressed in a wide range of neural cells
including astrocytes, microglia, and neurons (Table 3.2). These results suggested a generalized
group of transcript changes that occurs in the CNS after injury.
The acute phase genes belong to several transcript categories including transcription, cy-
tokines, cell adhesion, extracellular proteases, and metabolism. The major transcript group
(46.6%) was related to the regulation of gene expression including transcription factors and tran-
scription modulators. Based on gene expression dynamics, acute phase genes displayed either
transient or chronic expression changes after retinal injury (Table 3.2). For example, transcription
factors such as Crem, Egr1, Fos, Fosl1, Junb, Egr1, Ier3, Btg2, Atf3, and Nr4a1 were upregu-
lated, with a transient surge at 4 h. Other transcription factors such as Irf1, Stat3, Nfkb1, Id2, and
Cebpd displayed an upregulation at 4 h, followed by a smaller, but sustained, expression out to
30 days after retinal injury (Table 3.2).
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Table 3.2. Acute phase genes expressed in the injured CNS.
Name (alias) Astrocytic 
Expression
Microglial 
Expression
Neuronal 
Expression
Chronic 
Expression
Transcription
Atf3 Activating transcription factor 3 + + - -
Btg2 B-cell translocation gene 2 + - + -
Crem cAMP responsive element modulator - - - -
Egr1 Early growth response 1 (Krox-24/NGFI-A) + - + -
Fos FBJ osteosarcoma oncogene + + + -
Fosl1 Fos-like 1 + - - -
Junb Jun-B oncogene + - + -
Ier3 Immediate early response 3 (PRG1) + + + -
Nr4a1 Nuclear receptor subfamily 4a1 (NGFI-B/nurr7) + - + -
Cebpd CCAAT/enhancer binding protein delta + - + +
Id2 Inhibitor of DNA binding 2 (Idb2) + + + +
Irf1 Interferon regulatory factor 1 + + - +
Nfkb1 Nuclear factor kappa B p105 + + - +
Stat3 Signal transducer and activator of transcription 3 + - + +
Cytokine
Cxcl10 Chemokine (C-X-C motif) ligand 10 + + - +
Il1a Interleukin 1 alpha - + - -
Il1b Interleukin 1, beta - + - +
Scya2 Small inducible cytokine A2 (Ccl2) - + - -
Scya3 Small inducible cytokine A3 (Ccl3) + - - -
Cell adhesion/ECM
Cd44 Cd44 antigen + + - +
Icam1 intercellular adhesion molecule-1 + + - +
Plat Plasminogen activator tissue + + - +
Serpine1 Serine proteinase inhibitor-1 (Pai1) + - - +
Timp1 Tissue inhibitor of metalloproteinase-1 + + - +
Metabolism
Hmox1 Heme oxygenase + + + +
Mat2a Methionine adenosyltransferase IIa + - - -
Ptgs2 Prostaglandin synthase 2 (Cox-2) + - - -
Other
Ptpn16 Tyrosine phosphatase non-receptor type 16 (Dusp1/Ptp) + - + -
Adfp Adipose differentiation related protein + + - -
Ifrd1 interferon-related developmental regulator 1 + - + -
Symbol
Acute phase genes displayed transcript changes in injured retina, brain, and spinal cord. Astro-
cytic, microglial, and neuronal expressions refer to moderate to high transcript levels in cultured
astrocytes [Yang et al., 2004; Kraft et al., 2004], microglia [Duker et al., 2004; Moran et al.,
2004], neurons [Kraft et al., 2004]. Chronic expression describes expression in rat retina from 3
to 30 days after injury [GEO data set GSE1001; Vazquez et al., 2004].
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Regulatory Locus Analyses
The grouping of genes with similar transcript expression changes suggested the presence of
common upstream modulators. To begin defining regulatory mechanisms controlling the retinal
injury response, we tested the hypothesis that acute phase genes share common regulatory loci
(Figure 3.1). Transcriptome-wide regulatory loci for the mouse brain were mapped previously by
our group [Chesler et al., 2005] and can be replicated and recomputed using the databases and
genetic-analysis tools at GeneNetwork. We used the mouse brain transcriptome and genetic
analysis at GeneNetwork to define common regulatory loci for acute phase genes.
A genome-wide scan estimates the association of transcript abundance variability against
genetic markers across the mouse genome. For example, the abundance variability of Id2 was
high in brains from BXD RI mouse strains (F34,99 = 5.2; probe set 93013_at for Id2 mRNA). In
the genome-wide scan (Figure 3.1A), the correlation of Id2 variability across the mouse genome
is indicated by the likelihood ratio statistic curve (LRS, blue line). At chromosome 12, 10-30 Mb
distal to the centromere, Id2 variation correlated highly with genetic markers D12Mit209,
D12Nyu7, Rrm2, D12Mit234, and D12Mit242 (Figure 3.1A; LRS = 44). In a second example,
Fos displayed variation (F34,99 = 1.5; probe set 160901_at) that also correlated with genetic mark-
ers that span a region of chromosome 12 at 10-30 Mb (Figure 3.1A, LRS = 13). The correlation
of Fos and Id2 expression to a chromosomal interval on chromosome 12 suggested that this locus
contains one or more polymorphic genes that affect the levels of both transcripts.
In the group of acute phase genes, a number of transcripts had a common regulatory locus
on chromosome 12. These included Fos, Nr4a1, Id2, Egr1, Crem, Junb, Ccl3, and Ptpn16, all of
which shared a strong correlation to the locus on chromosome 12, 10-30 Mb (Figure 3.1B; LRS >
10; probe sets 160901_at, 102371_at, 93013_at, 98579_at, 160526_at, 102362_at, 102424_at,
and 104598_at, respectively). By aligning genome-wide scans, we identified a strong band of
regulatory loci (Figure 3.1B). Most of the genes (Fos, Nr4a1, Egr1, Crem, Junb, Ccl3, and
Ptpn16) regulated by this genomic location are found outside the regulatory locus, termed
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Figure 3.1. Acute phase genes share regulatory loci. We used the genetic analysis of transcript
expression at GeneNetwork [www.genenetwork.org] to define genomic loci that control tran-
script abundance variability in mouse brains. At the heart of this analysis is a unique population,
the recombinant inbred (RI) strains of mice. One group of mice were derived by inbreeding for
over 20 generations the F1 crosses between C57BL/6 (B) and DBA/2J (D) mouse strains. Each
BXD RI strain has a shuffled genome consisting of a unique recombination of the C57BL/6 and
DBA/2J genomes, forming a segregating population. These RI mouse strains, the associated mi-
croarray databases, and the genetic-analysis tools at GeneNetwork allow one to explore regula-
tory loci and networks built around any transcript [Chesler et al., 2005; Bystrykh et al., 2005].
The best way to think about the genetic linkage mapping is at the transcript level. If there is spe-
cific variability in transcript abundance among members of a segregating population, then it is
possible to map transcript abundance to a specific chromosomal locus. Genetic linkage maps (A-
C) show that a group of acute phase genes is controlled by a regulatory locus on chromosome 12.
A: Individual genome-wide maps for Id2 and Fos display linkage of transcript variability (y-axis)
to loci across the mouse genome (x-axis). Genetic analysis of transcript data from brain tissue
was determined in a panel of BXD RI mouse strains [Chesler et al., 2005]. Maps were generated
by linking transcript variability against 779 genetic markers that are interspaced along the mouse
genome by an average of 4 Megabase pairs (Mb). The alternating white and blue columns repre-
sent chromosomes. The linkage between transcript variation and genetic differences at a particu-
lar genetic locus is measured in terms of likelihood ratio statistic (LRS, solid blue line). Dashed
horizontal lines mark transcript-specific significance thresholds for genome-wide P < 0.05 (sig-
nificant, blue) and genome-wide P < 0.63 (suggestive, green). Orange triangle indicates gene lo-
cation. B: Multiple parallel genome-wide maps display linkage using color hues with yellow and
red bands representing suggestive and significant LRS. A common regulatory locus on chromo-
some 12 is identified for selected acute phase genes. Within this locus, there is a genomic ele-
ment modulating the expression of acute phase genes such as Fos, Junb, and Egr1. Individual and
multiple genome-wide maps were generated using tools at GeneNetwork. Orange triangles indi-
cate gene location. Linkage maps were generated using the Interval Mapping and Cluster Tree
tools at GeneNetwork [UTHSC Brain mRNA U74Av2 HWT1PM, December 2003].
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“trans-regulatory locus.” One of the genes, Id2, lies within the regulatory locus (orange arrow-
head, chromosome 12 at 20.1 Mb; Figure 3.1A and 3.1B). This is termed a “cis-regulatory locus”
for Id2. Transcripts genetically linked to the same regulatory locus are part of a genetic network
[Chesler et al., 2005]. In this case, Fos, Nr4a1, Id2, Egr1, Crem, Junb, Ccl3, and Ptpn16 are part
of a genetic network that is controlled by the regulatory locus on chromosome 12, 10-30 Mb. In
addition to the regulatory locus on chromosome 12, we identified two additional loci that may
regulate transcript levels of acute phase genes (Figure 3.2). These regulatory loci were located on
chromosomes 6 and 14. In some cases, transcripts correlated to multiple regulatory loci. For ex-
ample, Fos and Nr4a1 were genetically linked to regulatory loci on chromosomes 6 and 12,
whereas, Nfkb1 and Scya2 correlated with regulatory loci on chromosomes 6 and 14. The genetic
relationships between transcript variation and genomic loci defined three genetic networks con-
trolling the expression of acute phase genes in mouse forebrains (Figure 3.2). The regulators for
these genetic networks are located within the regulatory loci on chromosomes 6, 12, and 14.
Evaluating Candidate Upstream Regulators
Once a regulatory locus was identified, the third step in our analysis refined the genomic location
responsible for the mapping to this chromosomal interval. Within each regulatory locus, a ge-
nomic element generates the variation in expression of acute phase genes. Ultimately, the ge-
nomic differences between the C57BL/6 and DBA/2J mice underlie the transcript abundance
variability observed in BXD RI mouse strains. Since the BXD RI mouse strain haplotypes are
finely mapped and the parental genomes are sequenced, we have thorough SNP maps for the 35
strains [Chesler et al., 2005]. SNPs affecting the expression of acute phase genes may be found in
a number of genomic elements including promoters, enhancers, exons, or introns. These genomic
elements may affect the transcript levels of the upstream regulator. Hundreds or even thousands
of SNPs may lie within a regulatory locus. Simple rules help select a candidate gene. A candidate
gene lies within the regulatory locus, displays SNPs, and is functionally relevant to the genes cor-
relating to the regulatory locus. Biological significance of SNPs can be queried using
53
Figure 3.2. Genetic networks controlling acute phase transcripts. Genetic networks were derived
from transcripts sharing regulatory loci in mouse brains. As shown in Figure 3.1, acute phase
transcripts Fos, Egr1, Nr4a1, Junb, Stat3, Id2, Crem, Ptpn16, and Scay3 are controlled by a ge-
nomic locus on chromosome 12. We also showed in Table 3.2 that these transcripts are part of a
common phase response to injury in retina, brain, and spinal cord. Transcripts genetically linked
to the same regulatory loci and highly regulated in injured CNS are hypothesized to be part of a
genetic network. In this diagram, lines connecting specific genes to loci represent a correlation
between transcript expression and the regulatory locus. The diagram also illustrates two networks
controlled by genomic loci on chromosomes 6 and 14.
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programs that predict whether SNPs affect known DNA binding sites or protein sequence motifs
[Knuppel et al., 1994]. The vast biological content within online resources provides a powerful
tool to identify the regulatory element controlling the expression of genes within a biological
pathway, in our case the response of the transcriptome to retinal injury. We present our analysis
of candidate regulators for several of the loci. We conclude with evidence for a strong candidate
gene for the regulatory locus on chromosome 12.
The regulatory locus on chromosome 14, 35-65 Mb, modulates the transcript variability
of transcription factors Stat3, Nfkb1, and Irf1; cytokines Il1b and Scya2; and development-related
gene Adfp (Figure 3.3A; probe sets 102736_at, 103486_at, 161281_f_at, 161443_r_at, 93858_at,
98427_s_at, and 99099_at). This is a trans-regulatory locus for these genes, as they all lie outside
this locus. A genomic element within the locus is a trans-regulator for these acute phase genes.
Within this locus, there were 315 positional candidate genes (Figure 3.3B and 3.3C). A simple
procedure to weigh the relevance of a positional gene is to determine whether it displays signifi-
cant transcript variability in BXD RI mouse strains and whether its variability maps to its gene
location—that is, does the gene display a cis-regulatory locus? Highly variable transcripts in-
cluded Rnase4, AW045965, M6a, Boct, Dad1, Ctsb, Cnih, and Ndrg2 (F34,99 > 4). Of these,
Rnase4, AW045965, M6a, Boct, Boct, Cnih, and Ndrg2 linked strongly to the regulatory locus on
chromosome 14 (LRSs > 17; Figure 3.3D, data for Ndrg2 shown, probe set 96088_at). To further
evaluate the role of these positional genes, we determined whether their self-regulatory role ex-
tended to the cerebellum of BXD RI mouse strains. Rnase4, AW045965, M6a, and Ndrg2 dis-
played significant cis-regulatory loci on chromosome 14, 35-65 Mb (LRSs > 12, data not shown;
probe sets 96038_at, 100073_at, 104456_at, and 161610_at). These data suggested that the regu-
latory role of the locus on chromosome 14 is conserved across CNS tissues. Rnase4, AW045965,
M6a, and Ndrg2 are candidate upstream regulators because they display cis-regulatory loci.
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Figure 3.3. Evaluating candidate genes within chromosome 14 locus. A: The transcript variabil-
ity of Adfp, Scya2, Irf1, Nfkb1, Il1b, Stat3, and Cxcl10 in brains from BXD RI mouse strains is
genetically linked to a regulatory locus on chromosome 14. This network was generated by com-
paring genome-wide scans that measure the linkage of transcript variability across the mouse ge-
nome, as described in Figure 3.1. These transcripts are also upregulated as acute phase transcripts
in retina, brain and spinal cord (Table 3.2). Transcripts genetically linked to the same regulatory
loci and highly regulated in injured CNS are hypothesized to be part of a genetic network. B: The
combined genome-wide map shows that their transcript expression has a strong genetic linkage to
a locus within chromosome 14. The genome wide scan, zoomed at chromosome 14, shows the
genetic linkage (y-axis, likelihood ratio statistic [LRS]) across the chromosome (x-axis,
Megabase pairs [Mb]). The locus (35 to 65 Mb) includes 315 genes, some of which have a high
or low single nucleotide polymorphism (SNP) density. SNP density is denoted by the height of
the orange lines on the x-axis. Several rules may help in selecting candidate gene responsible for
this regulatory locus. The first rule is there have to be SNPs present within the coding or regula-
tory region of the gene of interest. As a first approximation we used SNP density that is displayed
at the bottom of panel B and D. The second rule is a high degree of transcript abundance vari-
ability in the BXD RI strains (illustrated in C). C: Transcript abundance variability in normal
forebrains of BXD RI mouse strains is due to genetic polymorphisms between the parental
C57BL/6 and DBA/2J mouse strains. The graph illustrates transcript abundance variability (y-
axis) for genes (dots) within the 35 to 65 Mb interval of chromosome 14 (x-axis). For a transcript
to be mapped its abundance must vary across the BXD RI mouse strains. The higher the variation
in transcript abundance the more likely that the gene is a candidate. Furthermore we expect that
the variability is due to a polymorphism in the candidate gene, suggesting that the polymorphic
gene is modulating its own expression level (that is, a “cis-regulatory locus”). We measured tran-
script variability using an analysis of variance (ANOVA) that tests the between-strain variance
compared with the total variance for 100 arrays from 35 mouse strains. The degrees of freedom
for the between-group and total variance are 34 and 99. Strain-specific variation is significant (p
< 0.05) when F34,99 > 1.5. In the graph, each dot represents a gene with its variability measured by
the ANOVA F-statistic (y-axis) and its genomic location within chromosome 14 described in Mb.
Rnase4, AW045965, M6a, Boct, Dad1, Ctsb, Cnih, and Ndrg2 are polymorphic genes that dis-
played significant transcript variability and cis-regulatory loci in normal forebrains of BXD
mouse strains. D: The third criterion identifies the genes that display self regulation across CNS
tissues. For example, the transcript variability of Ndrg2 (red circle in C) displayed a cis-
regulatory locus in brain (LRS=38, probe set 96088_at) and cerebellum (LRS=13, probe set
1448154_at_A) of BXD RI mouse strains. Here we illustrate linkage of Ndrg2 transcript vari-
ability in BXD RI mouse strains across chromosome 14. Red triangle indicates gene location.
Rnase4, AW045965, and M6a also displayed cis-regulatory loci in brain and cerebellum (data
available at GeneNetwork). E: The fourth criterion deals with the biology of the system. Meta-
analyses of transcript levels during retinal development and retinal injury can help determine if a
candidate gene is a potential regulator in the retina. For example in murine models of retinal de-
velopment, Ndrg2 displayed moderate transcript levels as early as postnatal day 4 and was highly
expressed in the adult retina. In contrast, Rnase4, AW045965, and M6a were absent from birth
through adult stages. Normalized expression data for Ndrg2 (y-axis) during murine retinal devel-
opment (x-axis) is available at Retina Developmental Gene Expression [Dorell et al., 2004].
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Identifying polymorphic genes also helps to identify the candidate upstream regulator.
Sequences for Rnase4, AW045965, M6a, and Ndrg2 had multiple SNPs between the C57BL/6
and DBA/2J strains. For example, Ndrg2 had a high density of SNPs: 7 within the promoter
(Celera SNPs IDs mCV23555818, mCV23556083-5, mCV23556089-91), and 25 within exons
and introns (Celera SNPs IDs mCV23555752, 756-8, 762-3, 768-70, 774-6, 780-1, 788, 792-4,
804-6, 811-2, 816-7). The presence of SNPs further supported the role of Rnase4, AW045965,
M6a, and Ndrg2 as candidate upstream regulators. The use of transcriptome data from develop-
ing mouse retina [Dorell et al., 2004; Blackshaw et al., 2004] or injured rat retina [Vazquez et al.,
2004] can be valuable in determining whether a candidate gene plays a role in controlling acute
phase genes in the retina. In murine models of retinal development [Dorell et al., 2004; Black-
shaw et al., 2004], Ndrg2 displayed moderate transcript levels as early as postnatal day 4 and was
expressed in the adult retina (Figure 3.3E; data available at Retina Developmental Gene Expres-
sion [Dorell et al., 2004] and Mouse!Retina!SAGE!Library [Blackshaw et al., 2004]). In contrast,
Rnase4, AW045965, and M6a were absent from birth through adult retinal stages [data available
at Retina Developmental Gene Expression]. Using a suite of computational tools and transcrip-
tome data from CNS gene regulation and development, we defined Ndrg2 (N-myc downstream
regulated gene 2) as a positional candidate that displayed a cis-regulatory locus in the mouse
brain and cerebellum and that has a high SNP density. At the present time, Ndrg2 is the best can-
didate gene for the regulatory locus on chromosome 14 and for potentially being a regulator of
retinal acute genes. Ndrg2 displays a conserved self-regulatory role in mouse brain and cerebel-
lum. It is expressed in the developing mouse retina during the critical time of cell proliferation
and cell specification. It also displays persistent transcript expression in the adult mouse retina.
The regulatory locus on chromosome 6 at 105-132 Mb also controls the expression of
acute phase genes such as Fosl1, Scya2, Nr4a1, Fos, Nfkb1, Icam1, and Timp1 (Figure 3.4A;
probe sets 102371_at, 102736_at, 160901_at, 99835_at, 101141_at, 98427_s_at, and 101464_at).
Within the locus, there were 315 positional genes (Figure 3.4B). Using the computational and
comparative techniques described above, Ccnd2 (Cyclin D2) best met the criteria for a candidate
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Figure 3.4. Evaluating candidate genes within chromosome 6 locus. A: The transcript variability
of Scya2, Nfkb1, Fosl1, Timp1, Fos, Nr4a1 and Icam1 in brains from BXD RI mouse strains is
genetically linked to the regulatory locus on chromosome 6. This network was generated by
comparing genome-wide scans that measure the linkage of transcript variability across the mouse
genome, as described in Figure 3.1. These transcripts are also upregulated as acute phase tran-
scripts in retina, brain and spinal cord (Table 3.2). Transcripts genetically linked to the same
regulatory loci and highly regulated in injured CNS are hypothesized to be part of a genetic net-
work. B: The combined genome-wide map shows that their transcript expression has a strong ge-
netic linkage to a locus within chromosome 6, 105 to 132 Mb. The genome wide scan, zoomed at
chromosome 6, shows the genetic linkage (y-axis, likelihood ratio statistic [LRS]) across the
chromosome (x-axis, Megabase pairs [Mb]). This locus includes over 200 positional genes, some
of which have a high or low single nucleotide polymorphism (SNP) density. SNP density is de-
noted by the height of the orange lines on the x-axis. Several rules may help in selecting candi-
date gene responsible for this regulatory locus. The first rule is there have to be SNPs present
within the coding or regulatory region of the gene of interest. As a first approximation we used
SNP density that is displayed at the bottom of panel B and D. The second rule is a high degree of
transcript abundance variability in the BXD RI strains (illustrated in C). C: Transcript abundance
variability in normal forebrains of BXD RI mouse strains is due to genetic polymorphisms be-
tween the parental C57BL/6 and DBA/2J mouse strains. The graph illustrates transcript abun-
dance variability (y-axis) for genes (dots) within the 105 to 132 Mb interval of chromosome 6 (x-
axis). The higher the variation in transcript abundance the more likely that the gene is a candi-
date. Furthermore we expect that the variability is due to a polymorphism in the candidate gene,
suggesting that the polymorphic gene is modulating its own expression level (that is, a “cis-
regulatory locus”). We measured transcript variability using an analysis of variance (ANOVA)
that tests the between-strain variance compared with the total variance for 100 arrays from 35
mouse strains. The degrees of freedom for the between-group and total variance are 34 and 99.
Strain-specific variation is significant (p < 0.05) when F34,99 > 1.5. In the graph, each dot repre-
sents a gene with its variability measured by the ANOVA F-statistic (y-axis) and its genomic lo-
cation within chromosome 6 described in Mb. Tulp3, Ccnd2, Tead4, and Atp2b2 are polymorphic
genes that displayed significant transcript variability and cis-regulatory loci in normal forebrains
of BXD mouse strains. D: The third criterion identifies the genes that display self regulation
across CNS tissues. For example, the transcript variability of Ccnd2 (red circle in C) displays a
strong cis-regulatory locus in the forebrain (LRS=25, probe set 97504_at) and cerebellum
(LRS=14, probe set probe set 1416122_at_A) of BXD RI mouse strains. Here we illustrate link-
age of Ccnd2 transcript variability in BXD RI mouse strains across chromosome 6. Red triangle
indicates gene location. Atp2b2, Tulp3, and Tead4 also displayed cis-regulatory loci in brain and
cerebellum (data available at GeneNetwork). The role of a candidate gene as a modulator of the
chromosome 6 and wound healing is further strengthen if its transcript is differentially expressed
in injured CNS. Ccnd2 displays increased transcript levels in injured rat retina [GEO data set
GSE1001, probe set rc_AA899106_at; Vazquez et al., 2004].
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upstream regulator. Ccnd2 displayed significant transcript abundance variability (F34,99 = 3.8,
Figure 3.4C, probe set 97504_at) and a strong cis-regulatory locus on chromosome 6 (LRS = 29,
Figure 3.4D) in brains from BXD RI mouse strains. We also observed a strong cis-regulatory lo-
cus for Ccnd2 in the cerebellum (LRS = 15; probe set 1416122_at_A; data not shown). Multiple
SNPs spanned the transcribed region of Ccnd2 (Celera SNP IDs mCV24153285, 558, 560, 570,
580-2, 592-4, 615-6). These data suggested that Ccnd2 controls the expression of classic acute
genes in the CNS of BXD RI mouse strains. In mouse retina, Ccnd2 is expressed during devel-
opment and adult stages [Mouse!Retina!SAGE!Library, probe set 97504_at; and GENSAT Image
14340]. Moreover, Ccnd2 displayed chronic upregulation in the injured rat retina [GEO data set
GSE1001, probe set rc_AA899106_at; Vazquez et al., 2004]. Several data defined Ccnd2 as the
best current candidate gene for the regulatory locus on chromosome 6 and for potentially being a
regulator of retinal reactive genes. It displays conserved self-regulatory role in mouse brain and
cerebellum. It is expressed in the developing mouse retina during the critical time of cell prolif-
eration and cell specification. It also displays chronic upregulation in the injured rat retina.
For the network defined by the regulatory locus on chromosome 12 (Figure 3.5A; probe
sets 93013_at, 161802_i_at, 161716_at, 160526_s_at, 104598_at, 102424_at, 102371_at, and
102362_i_at), the Inhibitor of DNA binding 2 (Id2) is the best current candidate upstream regu-
lator. First, the positional candidate Id2 (Figure 3.5B; probe set 93013_at) showed significant
variability and strong cis-regulatory locus in brains from BXD RI mouse strains (F34,99 = 5.2, Fig-
ure 3.5C; and LRS = 44, Figure 3.5D). In the cerebellum, we also observed a strong cis-
regulatory locus for Id2 (LRS = 13; probe set 1453596_at_A; data not shown). Second, while
several cis-regulated genes were located within the regulatory locus on chromosome 12 (for ex-
ample, Lpin1 [probe set 98892_at]), only Id2 was upregulated in rat retina, brain, and spinal cord
after injury (Table 3.2). In injured rat retina, Id2 also displayed a chronic upregulation even after
30 days postinjury (Table 3.2; [GEO data set GSE1001, probe set rc_AI230256_at]). Id2 was
also highly expressed during mouse retinal development at the time of high levels of cell prolif-
eration and remained present in adult mouse retina [Retina Developmental Gene Expression,
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Figure 3.5. Evaluating candidate genes within chromosome 12 locus. A: The transcript variabil-
ity of Id2, Crem, Egr1, Fos, Nr4a1, Junb, Ptpn16 and Icam1 in brains from BXD RI mouse
strains is genetically linked to the regulatory locus on chromosome 12. This network was gener-
ated by comparing genome-wide scans that measure the linkage of transcript variability across
the mouse genome, as described in Figure 3.1. These transcripts are also upregulated as acute
phase transcripts in retina, brain and spinal cord (Table 3.2). Transcripts genetically linked to the
same regulatory loci and highly regulated in injured CNS are hypothesized to be part of a genetic
network. B: The combined genome-wide map shows that their transcript expression has a strong
genetic linkage to a locus within chromosome 12, 10 to 30 Mb. The genome wide scan, zoomed
at chromosome 12, shows the genetic linkage (y-axis, likelihood ratio statistic [LRS]) across the
chromosome (x-axis, Megabase pairs [Mb]). This locus includes over 60 positional genes, some
of which have a high or low single nucleotide polymorphism (SNP) density. SNP density is de-
noted by the height of the orange lines on the x-axis. Several rules may help in selecting candi-
date gene responsible for this regulatory locus. The first rule is there have to be SNPs present
within the coding or regulatory region of the gene of interest. As a first approximation we used
SNP density that is displayed at the bottom of panel B and D. The second rule is a high degree of
transcript abundance variability in the BXD RI strains (illustrated in C). C: Transcript abundance
variability in normal forebrains of BXD RI mouse strains is due to genetic polymorphisms be-
tween the parental C57BL/6 and DBA/2J mouse strains. The graph illustrates transcript abun-
dance variability (y-axis) for genes (dots) within the 10 to 30 Mb interval of chromosome 12 (x-
axis). For a transcript to be mapped its abundance must vary across the BXD RI mouse strains.
The higher the variation in transcript abundance the more likely that the gene is a candidate.
Furthermore we expect that the variability is due to a polymorphism in the candidate gene, sug-
gesting that the polymorphic gene is modulating its own expression level (that is, a “cis-
regulatory locus”). We measured transcript variability using an analysis of variance (ANOVA)
that tests the between-strain variance compared with the total variance for 100 arrays from 35
mouse strains. The degrees of freedom for the between-group and total variance are 34 and 99.
Strain-specific variation is significant (p < 0.05) when F34,99 > 1.5. In the graph, each dot repre-
sents a gene with its variability measured by the ANOVA F-statistic (y-axis) and its genomic lo-
cation within chromosome 12 described in Mb. Lpin1 and Id2 are polymorphic genes that dis-
played significant transcript variability and cis-regulatory loci in normal forebrains of BXD
mouse strains.  D: The third criterion identifies the genes that display self regulation across CNS
tissues. For example, the transcript variability of Id2 (red circle in C) displayed a cis-regulatory
locus in the brain (LRS=44, probe set 93013_at) and cerebellum (LRS=14; 1453596_at_A) of
BXD RI mouse strains. Here we illustrate linkage of Id2 transcript variability in BXD RI mouse
strains across chromosome 12. Red triangle indicates gene location. Lpin1 also displayed cis-
regulatory loci in brain and cerebellum (data available at GeneNetwork). E: The structure of the
Id2 gene illustrates a SNP at the promoter region and four SNPs within the second intron. F: The
SNP within the promoter region (Ensembl SNPView ID rs4229289 and Celera SNP ID
mC22302957) is located within a highly conserved region and is adjacent to a nuclear transcrip-
tion factor Y (NF-Y) binding site (TRANSFAC ID M00185). Gene structure was obtained from
Ensembl Genome Browser. The TRANSFAC 5.0 database was accessed through the MOTIF
website. Highly conserved regions were defined using the Genome Browser Conservation tool
[Mouse May 2004 Assembly].
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probe set rc_AI230256_at; and Mouse!Retina!SAGE!Library, Mm.34871]. Third, we located one
SNP for Id2 within the promoter and four SNPs within the second intron (Figure 3.5D; Ensembl
gene ID ENSMUSG00000020644). An SNP within the promoter region of Id2 may alter the
ability of a transcription factor to modulate Id2 transcription.
We used in silico promoter analysis to define the transcription factor binding site affected
by the SNP (Ensembl SNPView ID rs4229289 and Celera SNP ID mC22302957). Located 320
base pairs upstream of the starting codon, the SNP consisted of an adenine-guanine (A/G) sub-
stitution between the DBA/2J and C57BL/6. The SNP was also located in a highly conserved re-
gion across mouse, rat, and human orthologs (Figure 3.5F). Using the MOTIF database
(www.motif.genome.jp), we determined that the SNP sits next to a CCAAT binding site
(TRANSFAC ID M00254), a likely binding site for nuclear transcription factor (NF)-Y
(TRANSFAC ID M00185). Based on the TRANSFAC 5.0 database available through the
MOTIF website, NF-Y binds to the CCAAT motif when the adjacent 3’-nucleotide is either G or
C as seen in the C57BL/6, rat, and human sequences for Id2 (Figure 3.5F). The nucleotide sub-
stitution of an A for a G/C may account for the lower Id2 levels seen in the DBA/2J and in all the
BXD strains carrying the DBA/2J haplotype. Several lines of evidence indicate that Id2 is a good
candidate gene for the regulatory locus on chromosome 12. Id2 is conserved and has a self-
regulatory role in mouse brain and cerebellum. It is expressed in the developing retina during the
critical time of cell proliferation and cell specification. It is upregulated immediately following
injury to rat retina, brain, and spinal cord.
Discussion
Discovering mechanisms controlling retinal wound healing from gene expression data is a prom-
ising and challenging task. The method of extracting genetic networks and gene regulation pre-
sented here involves (1) highlighting robust injury genes in multiple models of CNS trauma, (2)
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defining regulatory loci using genetic analysis of transcript data (that is, expression genetics
[Broman, 2005]) from CNS tissues, and (3) predicting candidate regulators using bioinformatic
resources that are available online. Using this approach, we defined a group of acute phase genes
that is commonly expressed in the retina, brain, and spinal cord after traumatic injury. Our ex-
pression genetic analyses revealed that regulatory loci on chromosomes 6, 12, and 14 control the
expression of acute phase genes in brains from BXD RI mouse strains. With the help of an array
of online bioinformatic tools, we identified three genetic networks and candidate upstream regu-
lators: Ndrg2, Ccnd2, and Id2.
Surprisingly, the changes controlled by these three loci are present in a variety of different
CNS tissues: retina, brain, and spinal cord. This begs the question, are the networks controlled by
the loci on chromosomes 6, 12 and 14 unique to the CNS? If one examines normal tissues, these
regulatory loci appear to be unique to the CNS. For example, expression genetics of hema-
topoietic stem cells from BXD RI mouse strains showed completely different sets of regulatory
loci [Bystrykh et al., 2005]. This is not surprising given the difference in expression patterns be-
tween CNS tissues and hematopoietic stem cells [Chesler et al., 2005; Bystrykh et al., 2005]. The
same is true of the liver where Schadt and colleagues [Schadt et al., 2003] identified a different
set of regulatory loci that did not correlate with our observations in the CNS. Although the speci-
ficity of expression-related regulatory loci in CNS, hematopoietic stem cells, and liver are differ-
ent in normal resting conditions, we cannot exclude the possibility that some regulatory mecha-
nism are similar following trauma. Based upon our current data the loci at chromosomes 6, 12
and 14 identified appear specific to the CNS.
Our method complements approaches that identify modules of co-regulated genes, shared
cis-regulatory motifs, and transcriptional factors binding to cis-regulatory motifs [Livesey et al.,
2000]. In reality, transcriptome changes during the wound-healing response are controlled by a
much more complex network [Ridet et al., 1997; Geller et al., 2001; Bringmann and Reichen-
bach, 2001]. Our method holds the potential for identifying members of genetic networks and
regulators that may include gene products involved in mRNA stability, heterochromatin remod-
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eling, transcriptional repression, and other regulatory mechanisms [Chesler et al., 2005; Bystrykh
et al., 2005; Schadt et al., 2003]. Indeed, even indirect modifiers of the transcriptional response to
injury that are not transcription factors can be identified using a genetic approach. Our analysis
suggests, for example, that the expression of acute phase genes is genetically linked to the tran-
script expression of three non-transcription factors including the hydrolase NDRG2, the cyclin
CCND2, and the dominant negative helix-loop-helix protein ID2.
Key to defining modulators of regulatory networks in BXD RI mouse strains is the ge-
netic differences between parental strains. Genetic differences between C57BL/6 and DBA/2J
strains provide a powerful system to study regulators and their targets, but this approach is lim-
ited to the detection of polymorphisms between these strains. For some genes believed to be in-
volved in the response of the CNS to injury there are no genetic differences between the BXD
parental strains. For example, STAT3 (a potent activator of acute phase genes such as Fos [May
et al., 2003; Yang et al., 2003]) has no SNPs in the coding or regulatory regions when the se-
quence of Stat3 of C57BL/6 strain is compared to that of the DBA/2J strain. Consequently, ex-
pression genetics of BXD RI mouse strains revealed no genetic linkage between the Stat3 locus
and genes known to be associated with its regulation such as Fos. To provide a fuller examina-
tion of the networks controlling retinal wound healing the BXD RI strains can be supplemented
by studying additional strains. Other RI strains of mice can be equally valuable. The BXA and
AXB RI strains were produced from crosses of the C57BL/6 (B) and A/J (A) mouse strains. Ge-
netic differences between these two strains can be used to map different regulatory loci. One
prime example of the use of the AXB RI strains comes from a study of horizontal cell density. A
two-fold difference in horizontal cell density was observed between C57BL/6 and A/J mouse
strains [Williams et al., 1998]. The genetic backgrounds of the A/J mouse strains and RI strains
derived from the C57BL/6 and A/J mouse strains make it possible to map genetic loci controlling
horizontal cell number and potentially the response of horizontal cells to retinal injury. Undoubt-
edly as more genetically diverse sets of strains become available, transcriptome-wide analysis
combined with genetic analysis will yield additional regulatory loci. This type of analysis and the
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development of additional expanded RI strains of mice hold great promise in the search for ge-
netic networks controlling complex biological processes such as wound healing in the retina and
CNS.
Typically, a candidate upstream modulator within regulatory loci will display (1) high
transcript variation that maps onto its transcript location, that is, a cis-regulatory locus, (2) poly-
morphisms between parental strains, and (3) a function related to CNS disease or expression
changes after CNS injury. Ndrg2, Ccnd2, and Id2 met the candidate gene criteria for the regula-
tory loci on chromosomes 14, 6, and 12, respectively. N-myc downstream regulated gene 2
(NDRG2) is found at high protein levels in neurogenic regions of the adult rat brain. In these re-
gions, NDRG2 localizes to GFAP-positive astrocytes or radial glia [Nichols, 2003]. In humans,
down-regulation of Ndrg2 is associated with glioblastoma [Deng et al., 2003]. High levels of
NDRG2 are often associated with senile plaques of Alzheimer’s patients and cellular processes of
dystrophic neurons [Mitchelmore et al., 2004]. Our meta-analyses of Ndrg2 using transcript data
from developing mouse retina showed that Ndrg2 is expressed during the time of cell prolifera-
tion and cell specification. These data suggest that NDRG2 may play a key role in the prolifera-
tion of glia cells and the degeneration of neurons.
A second likely upstream candidate of CNS injury is cyclin D2 (CCND2). Cyclin D2
phosphorylates the Rb protein of the RB-E2F complex. Cyclin D2 binding to the Rb protein al-
lows the transcription factor E2F to enter the nucleus and stimulate proliferation. During the de-
velopment of the cerebellum, cyclin D2 is a marker of proliferating granule cell precursors.
Granule neurons are the principal neuronal component of cerebellum, and mice deficient in cy-
clin D2 show decreases in the number of granule cells and stellate interneurons [Diaz et al., 2002;
Huard et al., 1999]. Our meta-analyses of Ccnd2 also indicated that Ccnd2 is moderately ex-
pressed in cultured astrocytes from the cortex and optic nerve, in the mouse developing retina,
and injured rat retina. The enhanced expression of cyclin D2 in the retina following trauma may
contribute to reactive responses such as cellular proliferation.
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The third and most promising upstream candidate of CNS injury is the inhibitor of DNA
binding 2 (ID2). Our analyses suggest that changes in Id2 expression are a common theme in
many reactive CNS tissues. Based on our meta-analyses of microarray data, Id2 is upregulated in
rat retina, brain, and spinal cord after mechanical injury. In rat models of glaucoma [Ahmed et
al., 2004], the dystrophic retina also upregulates Id2 [personal communication, Farid Ahmed and
Stanislav Tomarev, NEI, NIH]. We have confirmed upregulation of Id2 transcript in mouse retina
after a mechanical and toxic injury [Vazquez-Chona personal observation]. Optic nerve head as-
trocytes from patients suffering glaucoma display higher Id2 transcript levels than astrocytes
from non-glaucomatous patients [Yokota and Mori, 2002]. The role of ID2 as a positive regulator
of cell-cycle progression [Yokota and Mori, 2002; Toma et al., 2000] is consistent with the pro-
liferative response that occurs in retinal injury. A potential source for dividing cells in the inner
nuclear layer is the Muller cells [Dyer and Cepko, 2000; Fischer and Reh, 2003]. When Muller
cells enter the cell cycle, they decrease the expression of cell cycle inhibitors, including the cy-
clin-dependent kinase inhibitor p27/Kip1 [Dyer and Cepko, 2000]. ID2 is known to negatively
regulate the transcription of cell cycle inhibitor genes, including p15, p16, and p21 [Yokota and
Mori, 2002]. ID2 downregulates expression of cell cycle inhibitors by preventing the interaction
of basic helix-loop-helix (bHLH) transcription factors that promote the transcription of cell cycle
inhibitor genes [Yokota and Mori, 2002]. Alternatively, ID2 may stimulate proliferation by
binding to the unphosphorylated Rb protein, allowing the release of the transcription factor E2F.
E2F in turn activates genes involved in G1-S transition and hence proliferation [Yokota and
Mori, 2002]. Re-entry into the cell cycle may also indicate apoptotic activity [Klein and Acker-
man, 2003]. ID2 is known to play a role in neuronal apoptosis [Gleichmann et al., 2002]. Cere-
bellar granule neurons upregulate transcript and protein levels of ID2 during the onset of apopto-
sis [Gleichmann et al., 2002]. The expression of Id2 antisense RNA in neurons protects from
apoptosis. Together these data suggest that the increase in ID2 may stimulate cells of the INL
into the G1-S transition of the cell cycle either for proliferation or apoptosis. We are currently
using the genetic background offered by the BXD RI mouse strains to determine the role of the
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chromosome 12 locus and ID2 in retinal wound healing. We have confirmed the variability of
ID2 at the transcript and protein level in retinas of BXD RI mouse strains [Vazquez-Chona per-
sonal observation]. We are using high and low Id2 expressers to see the effect of Id2 dose effect
on wound healing events following retinal trauma.
The novel combination of microarray analysis, expression genetics, and bioinformatics
provides a new and powerful approach to defining regulatory elements in the genome. Using this
approach, we were able to generate specific, testable hypotheses defining pathways that regulate
proliferative and reactive responses in the retina and elsewhere in the CNS. As more diverse gene
expression data sets become available, it is our belief that comparison of gene expression and
regulation in different biological contexts will help identify the regulatory elements controlling
the reactive response in the retina.
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Chapter 4
Genetic Influences on Gene Expression
and
Retinal Wound Healing
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Introduction
Discovering the mechanisms that control retinal wound healing from large-scale analysis of gene
expression is a promising and challenging task. Gene expression profiling of retinal wound heal-
ing revealed that changes in the transcriptome have specific spatial and temporal patterns
[Vazquez et al., 2004; Chen et al., 2004; Yoshimura et al., 204; Wilson et al., 2003; Ahmed, et
al., 2004; Gerhardinger et al., 2005; Rattner and Nathans, 2005]. The retinal response to trauma
involves changes that start at the stress site and then spread to include the entire retina [Vazquez
et al., 2004]. Transcriptome-wide changes are highly regulated into three temporal patterns of
expression—early acute, delayed subacute, and late chronic phases. Genes within each phase are
functionally related and reflect the known cellular changes. Transcriptome profiling of injured
retina also revealed that global changes are highly similar across different injury models, includ-
ing mechanical trauma, ischemia, and increased intraocular pressure [Vazquez et al., 2004;
Yoshimura et al., 204; Ahmed, et al., 2004]. Together the growing collection of retinal transcrip-
tome profiles is cataloging the genes that underlie the biochemical and cellular changes of wound
healing. The next level of analyses for gene expression data involves defining the networks and
regulators that control specific wound healing processes such as cell death and tissue remodeling.
Our approach to defining regulatory mechanisms from transcriptome data involves (1)
highlighting networks of genes sharing similar patterns of expression across injury models and
(2) defining the location of gene expression modulators using genetic analyses of genes expres-
sion (that is, expression genetics). Comparative analysis of gene expression and gene regulation
across different biological contexts and different tissues can help define key networks, as well as,
define tissue specific networks [Segal et al., 2005]. Using this approach, we previously defined a
group of acute phase transcripts that is commonly upregulated in injured retina, brain, spinal
cord. In this group we found transcription factors and transcription repressors as well as cell acti-
vating factors such as chemokines [Vazquez et al., 2005]. In contemporary transcriptome re-
search, observations of highly co-expressed genes are supplemented by higher-level analyses
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aiming at discovering the networks controlling gene expression. One approach combines tran-
scriptome profiling with genetic linkage analysis to reveal the location of the genetic determi-
nants that modulate gene expression variability. Expression genetics has been instrumental in
identifying genetic determinants and gene expression phenotypes underlying complex traits, in-
cluding disease and behavior [Aitman et al., 1999; Karp et al., 2000; Berge et al., 2000]. In an
example of gene expression genetics, Chesler and colleagues [2005] identified genome-wide loci
that modulate gene expression phenotypes in forebrains of a genetically variable population, the
BXD recombinant inbred (RI) mouse strains. BXD RI strains were derived from experimental
crosses between the D57BL/6 and DBA/2J strains. Using their database available at GeneNet-
work [www.genenetwork.org], we made the surprising finding that a group of genes upregulated
in the retina, brain, and spinal cord share co-regulation of their expression levels in forebrains of
BXD RI mouse strains. Expression of acute phase genes in BXD RI mouse forebrains was
modulated by genetic differences within the three loci on chromosomes 6, 12, and 14 [Vazquez et
al., 2005]. This finding raised the hypothesis that these loci modulate the acute phase response of
the CNS.
In this study, we specifically test the hypothesis that loci on chromosomes 6, 12, and 14
modulate retinal wound healing. We determine the specificity of the loci by comparing regulatory
loci across functional groups and tissues. We define candidate genes using an integrated bioin-
formatic approach that combines online databases, defining single nucleotide polymorphisms and
gene expression profiling in the injured and developing CNS. We test the hypothesis by examin-
ing the direction of flow and targets in wound healing models where predicted modulators are
expressed at different expression levels. This approach illustrates an integrated bioinformatic ap-
proach that generates specific, testable hypothesis from gene expression data.
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Methods
Meta-analyses of Microarray Data Sets
This study was designed to define networks and regulators from our gene expression data of in-
jured rat retina [Vazquez et al., 2004]. The data set is available online at Gene Expression Omni-
bus (GEO, www.ncbi.hlm.nih.gov/geo) as the group series GSE1001. This data set surveyed the
temporal gene expression profiles of rat retinal wound healing (4 h and 1, 3, 7, and 30 days) after
a mechanical tear. Our working group of wound-healing genes was defined by comparing injured
retinal time points versus normal retina and using three criteria: fold changes > |±2|, Student’s t-
test (P < 0.05), and genes with moderate-to-high expression levels (please see Chapter 2 for dis-
cussion on expression thresholds). To complement our analysis of wound-healing genes, we ob-
tained publicly available microarray analyses that examined the transcriptome response of devel-
oping mouse retina [Dorell et al., 2004]; the transcriptome of cultured mouse neurons [Kraft et
al., 2004], mouse astrocytes [Kraft et al., 2004] rat Muller cells [Gerhardinger et al., 2005], hu-
man optic nerve astrocytes [Yang et al., 2004], human U87 glioma cells [unpublished data, Eldon
Geisert], and rat RPE cells [unpublished data, Eldon Geisert]; and the genetics of gene expression
in forebrains from 35 BXD RI mouse strains (available at GeneNetwork, [Chesler et al., 2005]).
We made clear in Chapter 3 (Table 3.1) the details and availability of each microarray data set.
For these analysis, we obtained the raw data (CEL files), determined signal values using Microar-
ray Suite 5.0 (MAS 5.0; Affymetrix, Santa Clara, CA), transformed signals to a log scale (base
2), and normalized microarray mean intensity to 8 as described previously [Vazquez et al., 2004].
These transformations yielded signal intensities ranging from 1 to 18 relative units of fluores-
cence. Further analyses included only transcripts with medium to high abundance (that is, signals
greater than 8.64 [Vazquez et al., 2004]).
The use of microarray data sets involved three different meta-analyses. First, we used
GeneNetwork to define regulatory loci shared by wound-healing genes (details below). Second,
we examined temporal expression patterns of wound-healing genes in the developing mouse ret-
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ina [Dorell et al., 2004] and in the injured rat retina [Vazquez et al., 2004]. Third, we determined
the expression level of wound-healing genes in cultured astrocytes, cultured Muller cells, cul-
tured microglia, and cultured neurons. A wound-healing gene was considered expressed in a tis-
sue if it displayed medium to high abundance. Comparison of rat genes across species was as-
sayed by finding the corresponding ortholog’s probe set(s) using Affymetrix NetAffex (June
2005 Annotation) and Ensembl AffyProbe (v33) database. Since gene names may differ across
species and multiple probe sets may be available, we include the probe set identifier when neces-
sary.
Online Regulatory Locus Analyses
Regulatory loci modulating gene expression in forebrains of BXD RI mouse strains were defined
using GeneNetwork [www.genenetwork.org]. Details on the methods, data, and analyses are
available at GeneNetwork [Chesler et al., 2005; Bystrykh et al., 2005]. We described the BXD RI
mouse strains and GeneNetwork in Chapter 3. Briefly, GeneNetwork is a suite of databases and
analysis software that identifies genomic loci that control transcriptome differences in brain re-
gions in a panel of 32 BXD RI mouse strains derived from C57BL/6 (B) and DBA/2J (D) mice,
both parental strains, and the F1 hybrid (a total of 35 isogenic lines [Chesler et al., 2005; By-
strykh et al., 2005]). Using quantitative genetic analysis and a genetic map consisting of 779 fully
genotyped markers, GeneNetwork correlates expression variability to genotypes at locations
throughout the mouse genome. The average distance between adjacent markers is approximately
4 megabases (Mb). Variability across strains was measured using analysis of variance (ANOVA)
testing the between-strain variance compared with the total variance for 100 arrays from 35
mouse strains. The degrees of freedom for the between-group and total variance are 34 and 99.
Strain-specific variation is significant (p < 0.05) when F34,99 > 1.5.We used the published, expres-
sion genetics data of mouse forebrain [UTHSC Brain mRNA U74Av2 HWT1PM, December
2003] and of mouse hematopoietic stem cells [GNF Hematopoietic Cells U74Av2 RMA, March
2004] to identify common and unique regulatory loci for wound-healing genes. We also supple-
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ment the forebrain data with unpublished expression genetics data of mouse striatum
(HBP/Rosen Striatum M430V2 RMA. April 2005) and mouse cerebellum [SJUT Cerebellum
mRNA M430 RMA, March 2005]. We also relate gene expression phenotypes to mouse neuro-
logical phenotypes using the BXD Published Phenotypes Database also available at GeneNet-
work [database queried on November 5, 2005)]
Online Bioinformatic Resources
We used online databases and computational tools to identify candidate genes within a regulatory
locus, to determine functional themes within a network of genes, and to query literature abstract
databases for biological interactions. To identify candidate genes within a regulatory locus, we
located genes within the appropriate genomic interval using the Genome Browser
[http://genome.ucsc.edu, Mouse May 2004 assembly]. Single nucleotide polymorphisms (SNPs)
were identified by comparing mouse strain genome sequences in the Celera SNP [Celera Discov-
ery Systems, CA; July 2003 Assembly], Ensembl Mouse SNPView [v33], and Entrez SNP data-
bases. Biological significance of a SNP was determined if the SNP affected a biological motif
(for example, transcription factor binding sites and protein-protein interaction sites) using the
MOTIF database [http://motif.genome.jp/]. Several online databases provide gene expression
data or expression distribution in the developing and injured CNS. Gene Expression Omnibus
(GEO) is a high-throughput gene expression abundance data repository, as well as an online re-
source for gene ex-pression data browsing, query, and retrieval [www.ncbi.nlm.nih.gov/geo].
Retina Developmental Gene Expression describes the gene expression profile of thousands of
genes in the developing postnatal C57BL/6 mouse retina that were analyzed by hybridization to
Affymetrix Mu74 Av2 [www.scripps.edu/cb/friedlander/gene_expression; Dorrell et al., 2004].
Mouse Retina SAGE Library provides serial analysis of gene expression tags or in situ hybridi-
zation images for a limited number of transcripts expressed in the developing and adult mouse
retina [https://bricweb.partners.org/cepko/default.asp; Blackshaw et al., 2004]. Gene Expression
Nervous System Atlas (GENSAT) maps the transcript distribution in the mouse CNS using in
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situ hybridiza-tion [www.ncbi.nlm.nih.gov/gensat]. To determine functional themes within a
network of genes, we retrieved the Gene Ontology annotation data using WebGestalt (WEB-
based GEne SeT AnaLysis Toolkit; [http://genereg.ornl.gov/webgestalt]). To mine literature ab-
stracts for biological interactions such activation and inhibition, and directionality, we used an
online tool Chilibot [http://www.chilibot.net, Chen and Sharp, 2004].
Animals, Anesthesia, and Surgery
Four strains of mice were used for this study (n = 48 mice). These included the DBA/2J strain (n
= 20), BXD38 strain (n = 20), C57BL/6 strain (n = 4), and F1 progeny from a DBA/2J and
C57BL/6 cross (n = 4). Strains were purchased from The Jackson Laboratory (Bar Harbor, ME)
and colonies were maintained. The BXD38 strain is an inbred line derived from brother-sister
matings starting from an F2 intercross [Taylor et al., 1999]. For all experiments we used adult,
male mice (10 weeks old, 22-25 g). All protocols used in this study were approved by the Animal
Care and Use Committee of the University of Tennessee Health Science Center and were in ac-
cordance with the Institute for Laboratory Animal Research and with the ARVO Statement for
the Use of Animals in Ophthalmic and Vision Research. Prior to any retinal injuries, mice were
deeply anesthetized with avertin (1.25% 2,2,2-tribromoethanol and 0.8% tert-pentyl alcohol in
water; 0.8-1.0 ml, intraperitoneal injection). Injured animals and non-injured animals used for
gene and protein expression were deeply anesthetized with CO2. Animals used for immunohisto-
chemistry were deeply anesthetized with avertin (1.0-1.2 ml, intraperitoneal injection) prior to
perfusion. Retinal wound healing was induced via a mechanical tear, toxic injury, and optic nerve
crushes. A tear was induced by penetrating the pars plana with a 27-gauge needle and scraping
the superior nasal retina, as previously described [Vazquez et al., 2004]. A toxic injury was in-
duced by injecting kanaic acid into the vitreous (2 ng diluted in sterilized saline). An optic nerve
crush was performed using a binocular operating microscope, incising the conjunctiva of eye,
exposing the optic nerve, and pressing on the nerve with a cross-action forceps for 15 seconds.
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Cell Culture Studies
Mouse astrocytic C8-D1A cells (ATCC, American Tissue Culture collection; CRL-2541) were
routinely maintained in Basal Medium Eagle (GIBCO, Carlsbad, California) supplemented with
5% Fetal Bovine Serum (Intergen, Logan, Utah), D-Glucose (Sigma-Aldrich, St Louis, MO),
Penstrep Antibiotic-Antimycotic (GIBCO), Gentamicin Sulfate (Sigma-Aldrich), and Sodium
Bicarbonate (Sigma-Aldrich). Cells were maintained in an incubator at 370C in 5% CO2. Wound
healing was modeled in culture by growing cell monolayers on 24-well plates and then scratching
the monolayer with a sterile plastic 10-ml pipette (Fisher Scientific, Hampton, NH). Morphologic
response of astrocytes along the margin of the wound was followed by taking phase contrast mi-
crographs at different time intervals following the wound. The rate of migration was measured by
the distance that cells migrate into the wound at different time points. Cell cycle dynamics were
analyzed with flow cytometry. Cells in single cell suspension were fixed with ice cold 70% etha-
nol. After the ethanol was washed off, cells were treated with 1% BSA in PBS to block nonspe-
cific binding. To stain DNA, cells were incubated with propidium iodine (10 ug/mL; Sigma-
Aldrich) and RNAse A (1 mg/mL; Sigma-Aldrich) in PBS at 37oC for 30 min. Samples were then
analyzed with a cytometer (Becton Dickinson FACSCalibur, BD Biosciences). Cell viability was
assayed with 0.4% trypan blue and examined by low-power microscopy.
RNA Interference
Using conventional criteria, we designed 21-base short interfering RNAs (siRNAs) that (1) avoid
the 75 bases downstream of the start codon, (2) form a 19-base core duplex with 3’TT overhangs,
(3) contain approximately 50% G/C content, and (4) display target specificity. siRNAs targeted
three sites of the Id2 mRNA (NM_010496, at 568, 898, and 1131; Table 4.1). Sense and anti-
sense strands were annealed as recommended by manufacturer (Integrated DNA Technologies,
Coralville, IA). Control siRNA sequences included a scrambled siRNA duplex and a Cy3-labeled
scrambled siRNA duplex (Dharmacon, Lafayette, CO). siRNA duplexes were transfected using
Oligofectamine (Invitrogen, Carlsbad, CA) as recommended by the manufacturer. Briefly, 2x105
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Table 4.1. Oligonucleotides used for RNA interference and real-time RT-PCR.
Targets Accession No. Sequence (5¢Æ3¢)
Id2_siRNA_1 NM_010496 AUUCAACGUGUUCUCCUGGdTdT
CCAGGAGAACACGUUGAAUdTdT
Id2_siRNA_2 NM_010496 ACAGCAUUCAGUAGGCUCGdTdT
CGAGCCUACUGAAUGCUGTdTdT
Id2_siRNA_3 NM_010496 CAAAGCACUGGUUGUCUGAdTdT
UCAGACAACCAGUGCUUUGdTdT
Id2 NM_010496 GTCCTTGCAGGCATCTGAAT
CTTAGTTTTCCTTCCGCTTTCTT
Lpin1 NM_015763 CCCCATTCCTCATAGCTCAA
CACTAGTGGCTCCTCCTTGC
Fos NM_010234 AGAATCCGAAGGGAACGGAA
GGTCGTTGAGAAGGGGCAG
Stat3 NM_21365 TGTTGGAGCAGCATCTTCAG
CTTGGCTCTTGAGGGTTTTG
Casp3 NM_00981 CCTCAGAGAGACATTCATGGC
TCGGCTTTCCAGTCAGACTC
Crygd NM_007776 AGCAGTGGATGGGTTTCAG
GTGGAATCGGTCCTGGAG
Cd81 NM_133655 CTGTTTGCCTGTGAGGTGG
TCAGTGTGGTCAGTGCGTT
Gfap NM_010277 AGGGACAATCTCACACAGGAC
CTCCAGCGACTCAACCTTC
Gapdh NM_001001303 TCCCACTCTTCCACCTTCGATG
GTCCACCACCCTGTTGCTGTA
Rps18 XM_215328 CTCGCTCCTCTCCTACTTGG
ACCGGGTTGGTTTTGATCT
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cells and 1x105 cells were seeded in 12-well and 24-well plates. Transfection was optimized us-
ing 50% confluent cells and 50 nM siRNA duplex concentration. For functional studies, we used
a second siRNA transfection 24hrs after the first transfection.
Real Time RT-PCR
Total RNA from was isolated and treated with DNase using the SV Total RNA Isolation kit
(Promega, Madison, WI). Transcript levels were measured using quantitative real-time reverse
transcription-polymerase chain reaction (qRT-PCR). We performed primer design, qRT-PCR re-
action, and RT-PCR analysis as described in Chapter 2. Nucleotide sequences are shown in Table
4.1. We performed qRT-PCR reactions in the iCycler (BioRad, Richmond, CA) using the rea-
gents in the SYBR Green RT-PCR kit (Applied BioSystems, Warrington, UK). To determine the
relative change in gene expression, we compared the number of cycles (Ct) needed to reach the
midpoint of the linear phase using the iCycler analysis software. All observations were normal-
ized either to the housekeeping genes Gapdh or Rps18.
Protein Expression and Localization
To quantify expression levels, we used standard immunoblot methods [Vazquez and Geisert,
2000]. Proteins were extracted from cells and tissue by homogenization in 2% Sodium Dodecyl
Sulfate (SDS) in 50nM TRIS buffer (pH=7.5). Equal quantities of proteins were separated on 4-
15% SDS-polyacrylamide gel electrophoresis (SDS-PAGE) and transferred to nitrocellulose
membranes. Primary antibodies included hamster anti-CD81 (Eat2; Becton Dichinson, San Jose,
CA), rabbit anti-GFAP (Company), rabbit-anti ID2 (Santa Cruz Biotechnology, Santa Cruz, CA),
rabbit anti-ezrin (Santa Cruz Biotechnology), rabbit anti-STAT3 (Santa Cruz Biotechnology),
and rabbit anti-PCNA (Santa Cruz Biotechnology). Primary antibodies were detected with per-
oxidase-labeled secondary anti-rabbit, anti-mouse, and anti-hamster antibodies (Jackson Im-
munoResearch, West Grove, PA).
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Indirect immunohistochemical methods were used to define the cellular localization of
GFAP [Vazquez and Geisert, 2000]. For the purpose of immunohistochemistry, deeply anesthe-
tized animals were perfused through the heart with saline and 4% paraformaldehyde in 0.1 M
phosphate buffer. Eyes were removed and fixed in 4% paraformaldehyde, stored in 30% sucrose,
and sectioned to obtain 16-µm frozen sections. To retrieve cross-linked cytoplasmic antigens, we
treated retinal sections with either a solution of 1 mmol/L ethylene glycol-bis (2-
aminoethylether)-N,N,N’,N’- tetraacetic acid (EGTA, pH 8.4; Sigma-Aldrich, St. Louis, MO)
and 0.3 M sucrose for 20 min at 80oC. For immunohistochemistry of cells, cells were grown and
transfected on 8-well Poly-D-Lysine Coated Culture Slide (BD Biosciences, Bedford, MA). Cells
were fixed with 4% paraformaldehyde and permeabilized with 5% acetic acid in ethanol. Sec-
tions and cells were washed in borate-buffered saline (BBS, pH 8.0; Sigma-Aldrich) and blocked
in 4% bovine serum albumin (BSA; Sigma-Aldrich) and 0.1% Triton X-100 (Sigma-Aldrich).
Rabbit polyclonal anti-GFAP (1:100 dilutions; Company) and FITC donkey anti-rabbit IgG
(1:200 dilutions; Jackson ImmunoResearch, West Grove, CA) were dissolved in BBS, 0.4%
BSA, and 0.1% Triton X-100. DNA was stained with 4,6-diamino -2-phenylindole (DAPI;
Sigma-Aldrich), and TOPRO-3 (Invitrogen). For fluorescence microscopy, sections were exam-
ined with a confocal laser-scanning microscope (MRC-1024; Bio-Rad, Hercules, CA). No im-
munoreactivity was observed in normal or injured retina when primary antibodies were omitted.
Results
Specificity and Targets of Chromosome 12 Locus
We examined regulation genes occurring during the process of CNS wound-healing (acute, suba-
cute, and chronic phase genes) using gene expression genetics of forebrains in 35 BXD RI
strains. Our meta-analyses revealed that a group of wound-healing genes (Appendix C, Table
C.1) shared genetic linkages to loci on chromosomes 6, 12, and 14 (Figure 4.1A). The linkage
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Figure 4.1. Chromosome 12 locus modulates wound-healing mechanisms in the CNS. Genetic
linkage maps show the regulation of gene expression in BXD recombinant inbred (RI) strains.
This regulation is based on the genetic correlation of gene expression (individual rows on the y-
axis) to genomic markers across the mouse genome (x-axis) as described in Chapter 3. Blue hues
represent correlations for elevated gene expression in mice with C57BL/6 allele at a given locus,
and orange hues represent correlation for elevated gene expression in mice with DBA/2J allele.
A: Expression of wound healing genes in mouse forebrains is controlled by three regulatory loci
on chromosomes 6, 12, and 14. B: Synaptic-related genes in mouse forebrains are also controlled
by regulatory loci on chromosomes 6 and 14. C: Wound-healing genes shared no regulatory loci
in hematopoietic stem cells. D: Published data from phenotypes in BXD RI strains further sup-
port that chromosome 12 locus also associates with neurological phenotypes. The C57BL/6 allele
for the locus is one of the loci associated with resistance to noised-induced cell death of spiral
ganglion cells, the cells innervating auditory receptors cells [GeneNetwork ID 10652 and 10655;
Willott and Erway, 1998]. The DBA/2J allele of this locus also predisposes susceptibility to gen-
eralized convulsions when exposed to intense auditory stimulation [GeneNetwork ID 10434-5,
10437-8, and 10504; Neumann and Collins, 1991]. In contrast, the C57BL/6 allele is one of the
loci that confers enhanced neurogenesis and survival of new neurons and astrocytes in adult hip-
pocampus [GeneNetwork ID 10338, 10340-1, and 10378; Kempermann and Gage, 2002]. Link-
age maps were generated using the Interval Mapping and Cluster Tree tools at GeneNetwork
[UTHSC Brain mRNA U74Av2 HWT1PM, December 2003; GNF Hematopoietic Cells U74Av2
RMA, March 2004; HBP/Rosen Striatum M430V2 RMA, April 2005; SJUT Cerebellum mRNA
M430 RMA, March 2005; BXD Published Phenotypes, queried November 2005].
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mapping of these genes suggest that gene expression is a complex trait with multiple loci affect-
ing gene expression phenotype. To define the specificity of regulatory loci, we compared the loci
controlling the expression of wound-healing genes to the loci controlling synaptic-related genes.
Wound-healing and synaptic-related genes shared regulatory loci on chromosomes 6 and 14
(Figure 4.1A and 4.1B). The only locus unique to wound-healing genes was chromosome 12 lo-
cus. The uniqueness of this locus was further tested by comparing the loci controlling wound-
healing genes in mouse forebrains and in hematopoietic stem cells. Wound-healing genes shared
no regulatory loci in hematopoietic stem cells (Figure 4.1C). We also observed that chromosome
12 locus modulates three neurological phenotypes in BXD RI strains: audiogenic seizures, hear-
ing loss based on spiral ganglion cell number, and neurogenesis of the adult hippocampus (Figure
4.1D). The comparison of regulatory loci across functional groups and across tissues reveals that
the chromosome 12 locus specifically regulates the transcript expression of reactive transcripts in
mouse forebrains.
The majority of the transcripts modulated by the chromosome 12 locus have their gene
location outside this locus. Regulation of gene expression by an element outside the gene location
is known as trans-regulation.  Some of these trans-regulated genes are associated with the CNS
response to injury: Fos, Nr4a1, and Gfap. Regulation of gene expression by a genomic element
within or adjacent to the gene location is termed cis-regulation. For example Id2 and Lpin1 lie
within the locus (Figure 4.1A). Despite their diverse genomic locations, the expression of these
genes is controlled by the segregating pattern of the C57BL/6 and DBA/2J alleles corresponding
to chromosome 12, 10 to 30 Mb (Figure 4.1A). On average when the C57BL/6 alleles are pre-
sent, Fos, Nr4a1, and Id2 are expressed at higher levels than when the DBA/2J alleles are pre-
sent. The converse is true for Gfap: when the DBA/2J alleles are present Gfap is expressed at
higher levels than when the C57BL/6 alleles are present. Since the pattern of expression of these
transcripts in forebrains is correlated to the chromosome 12 locus, it follows that their expression
patterns are correlated to each other. Indeed transcripts positively correlated to the same parental
allele are positively correlated. For example, Fos, Nr4a1, and Id2 are positively co-regulated by
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C57BL/6 alleles and are also positively correlated with each other, whereas they are negatively
correlated with Gfap, a transcript positively correlated to the DBA/2J allele (Appendix C, Table
C.2). Gene expression associations such as co-regulation by the same genomic loci and signifi-
cant expression correlation define genetic networks [Chesler et al., 2005]. Therefore, the wound-
healing genes that are linked to chromosome 12 locus are part of a genetic network that controls
their expression due to genetic differences between the parental strains (Figure 4.2A). Since these
transcripts are also differentially expressed in injured retina, this network may also control
wound-healing events in the retina and elsewhere in the CNS.
Biological Processes Controlled by Chromosome 12 Network
The most obvious approach to understanding the functional role of a genetic network is to ex-
amine the functions of gene products associated with the network. For the chromosome 12 net-
work four functional themes emerged: regulation of transcription, cell death, cell proliferation,
and neural development and differentiation (Figure 4.2B). A non-biased, statistical approach to
defining the function of the network (n = 41 genes) is to compare the observed number of regu-
lated genes as compared to the expected number in a population belonging to a particular func-
tional category. For the network we observed 27% (11 out of 41 genes) of genes to be related to
the regulation of neural development and differentiation. This percentage is higher than the per-
centage (7%) observed among the total population of retinal reactive transcripts, and much higher
than the percentage of expected genes in the entire genome. These bioinformatic-based results
document that genes in chromosome 12 network participate in the regulation of transcription, cell
death, cell proliferation, and neural development and differentiation. The functional significance
of the network is further validated by defining known molecular associations among these gene
products in each of these molecular processes. We queried the biological literature using text-
mining tools to illustrate networks of known biological interactions. Within the transcripts
grouped into the neural development and differentiation category, the literature documents
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Figure 4.2. Chromosome 12 locus modulates transcription, differentiation, proliferation, and
apoptotic mechanisms. A: Genetic networks were derived from transcripts sharing regulatory loci
as shown in Figure 4.1. Blue lines connecting specific genes to loci represent correlations for ele-
vated gene expression in mice with C57BL/6 allele, and orange lines represent correlation for
elevated gene expression in mice with DBA/2J allele. Genes located within the regulatory loci
(cis-regulated) are indicated with a two-arrow line. B: The major functional themes described by
the network’s gene functions are the regulation of transcription, differentiation, proliferation, and
cell death. A non-biased, statistical approach to defining the function of the network (n = 41
genes) is to compare the observed number of regulated genes as compared to the expected num-
ber in a population belonging to a particular functional category. For the network we observed
27% (11 out of 41 genes) of genes to be related to the regulation of neural development and dif-
ferentiation. This percentage is higher than the percentage (7%) observed among the total popu-
lation of retinal reactive transcripts, and much higher than the percentage of expected genes in the
entire genome. To determine functional themes within a network of genes, we retrieved the Gene
Ontology annotation data using WebGestalt (WEB-based GEne SeT AnaLysis Toolkit;
http://genereg.ornl.gov/webgestalt). C: We queried the biological literature using text-mining
tools to illustrate networks within the transcripts grouped into the neurogenesis category (Pax6,
Neurod1, Id2, Nfib, Egr1, Hes3, Stat3, Ets1, Sox11, Casp3, Itgb1, and Sdc1). The literature
documents known molecular interactions these genes, including activation and inhibition that oc-
cur during neurogenesis. To mine literature abstracts we used the online tool Chilibot
[www.chilibot.net].
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known molecular interactions such as activation and inhibition that occur during neurogenesis
(Figure 4.2A). These literature-based associations illustrate that transcription factor NeuroD1 ac-
tivates pro-neural transcription factor Pax6. The network also shows that transcription repressor
ID2 modulates NeuroD1. All these relationship are well established during neurogenesis. Addi-
tional content-rich networks can be derived for transcripts involved in the regulation of transcrip-
tion, cell cycle, and cell death. Text-mining approaches support our hypothesis and provide di-
rection of potential molecular interactions. Data mining of biological concepts, gene function,
and protein interactions suggests that the chromosome 12 network may regulate transcription,
proliferation, apoptosis, and changes in phenotype (that is, de-differentiation) during retinal
wound healing.
Candidate Upstream Modulators
Having determined the network’s targets and biological significance, the next level of analysis
defines the upstream modulator responsible for the chromosome 12 locus. The correlation of re-
active genes to the interval on chromosome 12 (10 to 30 Mb) suggests that within the locus there
are one or more polymorphic genes controlling the expression of genes in this network. This
chromosomal interval has a high degree of homology (that is, synteny) with intervals on the hu-
man chromosome 2 (1 to 18 Mb or p25 to p24.3) and on the rat chromosome 6 (34 to 48 Mb or
q14 to q16) [NCBI MapViewer, http://www.ncbi.nlm.nih.gov/mapview]. In these syntenic re-
gions, the gene order and gene homology is highly conserved. Within the locus there are over
sixty known genes (Figure 4.3A). A review of how this network was derived is helpful in deter-
mining the search criteria for candidate genes. The network was derived from transcripts that are
differentially expressed in the retina after trauma and from transcripts that are co-regulated in
mouse forebrains due to genetic differences between the C57BL/6 and DBA/2J mouse strains.
Consequently, a candidate gene must have genetic polymorphisms that result in the expression
variability of its own transcript (self-regulation). In addition, the candidate gene’s function must
be consistent with molecular events that occur during retinal wound healing. Our analyses to
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Figure 4.3. Candidate genes for chromosome 12 network. A candidate gene must have genetic
polymorphisms that result in the expression variability of its own transcript (cis-regulation). In
addition, the candidate gene’s function must be consistent with molecular events that occur dur-
ing retinal wound healing. A: Within the locus there are over sixty positional genes. This diagram
summarizes our computational work to examine each gene’s single nucleotide polymorphism
density; self-regulation in CNS tissues; gene expression pattern during the developing retina and
injured retina; and known function in CNS pathology and development. Within the zoomed in-
terval, bars represent genes and their spacing represents approximate location. Red bars represent
genes that meet criteria. Genes location was determined using Genome Browser
[http://genome.ucsc.edu, Mouse May 2004 assembly]. B: Polymorphisms for Id2 and Lpin1. The
C57BL/6 and DBA/2J sequences for Id2 display four genetic variants and for Lpin1 over140
variants. As a complementing guide to defining gene variants that are responsible for susceptibil-
ity to CNS injury, we compared the gene sequences of the DBA/2J to sequences from two resis-
tant strains, the C57BL/6 and 129/svj [Schauwecker and Steward, 1997; Inman et al., 2002]. This
approach identified three nucleotides in the Lpin1 sequence of the DBA/2J that are different from
sequences of both the C57BL/6 and 129/svj (Celera SNP IDs mCV22346966, mCV22347703,
and mCV22347384). Single nucleotide polymorphisms (SNPs) were identified using the Celera
SNP database available through the SNP Browser tool in GeneNetwork. C: We identified genes
whose expression patterns in forebrain, cerebellum, and striatum of BXD mouse strains map to
their gene locations. Within the interval we identified in red genes that appear to self-regulate
their own expression in at least two brain regions. Linkage maps were generated using the Inter-
val Mapping and Cluster Tree tools at GeneNetwork (UTHSC Brain mRNA U74Av2 HWT1PM,
December 2003; GNF Hematopoietic Cells U74Av2 RMA, March 2004; HBP/Rosen Striatum
M430V2 RMA, April 2005; SJUT Cerebellum mRNA M430 RMA, March 2005). D. We deter-
mined genes that are differentially expressed during the developing retina and injured retina (in
red). Gene expression patterns in the developing mouse retina were obtained using Retina Devel-
opmental Gene Expression [www.scripps.edu/cb/friedlander/gene_expression/]. Gene expression
patterns in the injured rat retina were obtained using our data available online at Gene Expression
Omnibus (GEO, www.ncbi.hlm.nih.gov) as the group series GSE1001. Gene expression levels
from cultured mouse neurons [Kraft et al., 2004], mouse astrocytes [Kraft et al., 2004], rat Muller
cells [Gerhardinger et al., 2005], human optic nerve astrocytes [Yang et al., 2004], human U87
glioma cells [unpublished data, Eldon Geisert], and rat RPE cells [unpublished data, Eldon Geis-
ert] were obtained from published and unpublished data. Asterisk represent genes with no probe
set available. We also examined if any of the genes in the locus were involved in gliosis, neu-
rodegeneration, neurogenesis in the CNS using the text-mining tool Chilibot [www.chilibot.net/].
We used the following Affymetrix probe sets: for Id2 were U74v2 93103_at, M430
1435176_a_at_A, and U34A rc_AI230256_at; for Lpin1 U74v2 98892_at, and M430
1426516_a_at_A; for Sox11 U74v2 101631_at and M430 1431225_at_B, and M430
1453002_at_B; and for AL024210 M430 1438758_at_A and M430 1449076_x_at_A. AL024210
is highly homologous to human MTCBP1 (NP_060739) and rat Alp1 (NP_954528).
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identify the upstream regulator for the network includes expression profiles from injured retina,
brain, and spinal cord; gene expression genetics of mouse forebrain, cerebellum, and striatum; as
well as, gene expression atlases and text-mining of biological literature.
We identified genes whose expression patterns in forebrain, cerebellum, and striatum of
BXD mouse strains map to their gene locations. Using this criterion, we identified the known
genes Lpin1, E2f6, Cys1, Oact2, Id2, and Sox11, as well as the predicted genes AL024210 and
Tct15 as polymorphic genes that display significant self-regulation of their transcript expression
in at least two CNS tissues. For example, Lpin1, Sox11, AL024210, and Id2 have their gene loca-
tion on chromosome 12 at 15.9, 23.9, 25.2, and 21.6, respectively. Their DNA sequences be-
tween the C57BL/6 and DBA/2J genomes display single-nucleotide polymorphisms (SNPs) in
their coding and regulatory regions (Figure 4.3B, Lpin1 and Id2 SNPs only shown). Lpin1 has
over140 SNPs within the transcribed regions most of them located within introns. Within the ex-
ons there are missense mutations (Celera SNP ID mCV22640829) and several silent point muta-
tions (Celera SNP IDs mCV22640556-7). Sox11 has a missense mutation (Celera SNP ID
mCV22347029) and several silent point mutations (Celera SNP IDs mCV22345285-7030).
AL024210 has SNPs in the first intron (Celera SNP ID mCV23344577) and in the 5’ untranslated
region (Celera SNP IDs mCV23344575-6). Id2 also has SNPs on its promoter (Celera SNP ID
mC22302957), introns (Celera SNP IDs mCV22302969, 77-79, 89), and third exon
(mCV22302990, 2991, 3002, 3003). These polymorphisms might explain the strong linkage of
expression patterns of Lpin1, Sox11, AL024210, and Id2 to their gene locations (cis-regulation).
The self-regulatory role of these genes extends across brain tissues including forebrain, cerebel-
lum, and striatum (Figure 4.3C). To further explain this self-regulatory function, we examined if
the polymorphisms can alter functional motifs or splice sites. For example, Id2 has a SNP on the
promoter (Celera SNP ID mC22302957) that is adjacent to a putative nuclear factor Y (NF-Y)
transcription factor-binding site [Vazquez et al., 2005]. Lpin1 has exonic SNPs near the 5’splice
site of intron 11 (Celera SNP ID mCV22346966) and near two spliced mouse expressed se-
quenced tags on exon 1 (Celera SNP IDs mCV22347703 and mCV22347384). Genetic variants
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in a transcription factor binding site and at splice locations can lead to difference in mRNA lev-
els. These differences make the genetic mapping possible. Of interest to CNS wound healing are
three Lpin1 SNPs in DBA/2J sequence. They are different to the nucleotides in C57BL/6 and
129/svj sequences. These two latter strains are known to be resistant to trauma-induced cell death
in brain and spinal cord [Schauwecker and Steward, 1997; Inman et al., 2002]. In silico analysis
of SNPs is valuable in defining candidate genes and predicting potential mechanism by which the
SNPs interfere with the expression of candidate genes.
The role of a gene as candidate regulator of chromosome 12 network, and potentially of
retinal wound healing, is bolstered by determining if its gene product is known to play a role
CNS development and disease. Using the publicly available data on mouse retinal development
[Dorell et al., 2004], we determined that Lpin1, Id2, and Sox11 are expressed by the developing
retina and have well defined patterns of expression (Figure 4.3C; note that AL024210 levels were
below detectable thresholds). Using our microarray and RT-PCR data on rat retinal injury
[Vazquez, et al., 2004], we found that Lpin1 and Id2 are acute phase genes during retinal injury
(Figure 4.3C; the Sox11 U34 probe set displayed signals below noise thresholds and there is no
probe set for AL024210). Lpin1, Id2, and Sox11 can be expressed by cultured neural cells in-
cluding quiescent cortical neurons and astrocytes, quiescent retinal pigment epithelium. Glial
cells cultured from reactive optic nerve head and diabetic retinas also expressed Id2 and Lpin1 at
high levels of expression, and Sox11 at low to moderate levels of expression. Together these re-
sults document that Lpin1, Id2, and Sox11 are candidate genes because they display (1) self-
regulation in the brain, cerebellum, and striatum; (2) polymorphisms between parental strains; (3)
differential expression during the developing retina and/or injured retina; and (4) moderate to
high levels of expression in normal and reactive neural cells. However, we cannot exclude the
role of predicted genes (AL024210 and Tct15), or an unknown gene within the locus as potential
regulators of chromosome 12 network. As a first step toward documented the effect of the chro-
mosome 12 locus on wound healing events, we focus on the candidate genes Id2 and Lpin1.
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Chromosome 12 Network Modulates Retinal Wound Healing
Our work has led to the hypothesis that the10-30 Mb locus on chromosome 12 modulates wound
healing in the CNS. The segregating pattern of the C57BL/6 and DBA/2J alleles for the chromo-
some 12 locus in BXD RI strain background generate a natural range of transcript expression
(low to high) for candidate genes. We utilize this system of gene expression dosage to test hy-
potheses and to further define expression relationships within the network.  We specifically focus
on gene dosage effects of candidate genes Id2 and Lpin1 on the expression of acute phase genes
Fos and Stat3, apoptosis gene Casp3, gliosis genes Gfap and Cd81, and survival gene Crygd.
We confirmed dose levels for candidate genes Id2 and Lpin1 in retinas from BXD RI
strains at the transcript and protein level. In forebrains of BXD RI mouse strains, normal Id2 and
Lpin1 transcript levels are highly variable (F34,99 = 5.2 and F34,99 = 5.1, p < 10-9; Figure 4.4A, ex-
pression pattern for Id2 shown). C57BL/6 forebrains expressed higher levels of Id2 and Lpin1
than DBA/2J forebrains, whereas, the F1cross displayed Id2 and Lpin1 levels between those of
the parental strains. In BXD RI strain forebrains, high Id2 and Lpin1 levels correlate with the seg-
regating pattern of the C57BL/6 allele, whereas, low Id2 and Lpin1 levels correlate with the
DBA/2J allele. Similar patterns of Id2 and Lpin1 variability was observed in the striatum and
cerebellum of BXD RI mouse strains [GeneNetwork, probe sets 1435176_a_at_A and
1426516_a_at_A]. To test this relationship in the retina, we measured transcript levels at both
ends of the Id2/Lpin1 expression spectrum. For a high Id2/Lpin1 expresser we used the BXD38
strain. For the low Id2/Lpin1 expresser we used the DBA/2J mouse strain. Qualitative RT-PCR
confirmed that the BXD38 retina expressed higher transcript levels of Id2 and Lpin1 than
DBA/2J retina (p < 0.05; Figure 4.4B). We also confirmed the protein levels for ID2 in selected
BXD RI mouse strains. Protein levels documented that ID2 protein levels in BXD38 and
C57BL/6 retinal samples were higher than in DBA/2J retinal samples, and the protein levels for
F1 cross were in between those of the parental stains (Figure 4.4B). In protein samples we also
noted low variability within strain samples; but in general the samples confirmed the ID2 dosage
predicted by the microarray analysis of BXD RI strain forebrains. Protein levels were not
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Figure 4.4. Id2 and Lpin1 are differentially expressed in response to genetic differences and
trauma. A: Gene expression pattern for Id2 across forebrains from BXD recombinant mouse
strains. Id2 expression is highly heritable (F34,99 = 5.2, p < 10-9). High Id2 expression levels cor-
related with the C57BL/6 allele of the chromosome 12 locus (at 10-30 Mb); whereas, low Id2
expression levels correlated with the DBA/2J allele. Similar results were also obtained for Lpin1
(F34,99 = 5.1, p < 10-9; data not shown). Data obtained from GeneNetwork [UTHSC Brain mRNA
U74Av2 HWT1PM, December 2003]. B: Transcripts levels for Id2 and Lpin1 in the retina of
BXD RI strains were measured with real time RT-PC. For a high Id2/Lpin1 expresser we used
the BXD38 strain. For the low Id2/Lpin1 expresser we used the DBA/2J mouse strain. We also
confirmed the protein levels for ID2 in selected BXD RI mouse strains. Protein levels were not
measured for Lpin1. C: Transcripts levels for Id2 and Lpin1 after retinal trauma. Transcripts were
measured in DBA/2J retina four hours after a mechanical tear or vitreal injections of kanaic acid.
D: Protein levels from injured retina also confirmed the upregulation of ID2. The upregulation of
ID2 in injured retina is consistent with the upregulation of classic wound healing factors such as
the acute phase factor STAT3, the reactive gliosis marker GFAP, and the proliferative maker
PCNA. Ezrin (villin 2) is a house-keeping gene product. For each protein and RNA sample, reti-
nas from two normal or injured animals were pooled (n = 4 retinas per sample).
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measured for Lpin1. These results suggest BXD38 retina expresses higher levels of Id2 and
Lpin1 than DBA/2J retina.
We also confirmed the response of Id2 and Lpin1 to retinal trauma. Microarray analyses
revealed that rat retina, brain, and spinal cord upregulate Id2 after a mechanical injury [Vazquez
et al., 2005]. In the rat retina, Id2 is upregulated during the acute phase (6 fold change, p < 0.03;
4 hours after injury). During the delayed acute and late chronic phase Id2 is also upregulated but
at lower levels (3 fold change, p < 0.05; 7 hours after injury). The rat U34 Affymetrix array does
not have a Lpin1 probe set. Here we measured Id2 and Lpin1 upregulation in mouse retina after
different models of retinal trauma. Id2 is upregulated as an acute phase gene in response to a reti-
nal tear and toxic injury in DBA/2J retina (2.8 ± 0.2 and 3.9 ± 0.3 fold changes, p < 0.05; Figure
4.4C). Similar changes were observed in the injured BXD38 retina (data not shown). Lpin1 is
also upregulated as an acute phase transcript in response to a toxic injury in DBA/2J retina (2.9±
0.25 fold changes, p < 0.05; Figure 4.4C). No significant changes were observed for Lpin1 in the
injured BXD38 retina (data not shown). Protein levels from injured retina also confirmed the
upregulation of ID2 (Figure 4.4D). The upregulation of ID2 in injured retina is consistent with
the upregulation of classic wound healing factors such as the acute phase factor STAT3, the re-
active gliosis marker GFAP, and the proliferative maker PCNA (Figure 4.4D). These results con-
firm that Id2 and Lpin1 are acute phase genes of the injured mouse retina.
To investigate the role of chromosome 12 locus during retinal injury, we examined the
wound-healing response of retinas that expresses high levels of Id2/Lpin1 (strains with the
C57BL/6 allele) and compared this to low levels of Id2/Lpin1 (strains with the DBA/2J allele).
We induced retinal wound healing by exposing the retina with kanaic acid, which results in glu-
tamate-induced neurotoxicity. The neurotoxin induced significant upregulation of candidate
genes and of retinal markers of acute phase, gliosis, apoptosis, and survival in BXD38 and
DBA/2J retina (Figure 4.5A). Expression differences between strains were measured by a ratio
with the injured BXD38 retina as the numerator and injured DBA/2J retina as the denominator.
We observed distinct expression differentials for candidate genes, wound-healing genes, and
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Figure 4.5. Higher levels of Id2 and Lpin1 correlated with lower retinal stress markers. To in-
vestigate the role of chromosome 12 locus during retinal injury, we examined the wound-healing
response of retinas that expresses high levels of Id2/Lpin1 (BXD38 strain with the C57BL/6 al-
lele) and compared this to low levels of Id2/Lpin1 (strains with the DBA/2J allele). A: Acute-
phase levels for markers of acute phase (Fos and Stat3), gliosis (Stat3, Gfap, and Cd81), apopto-
sis (Casp3), and survival (Crygd) were measured in BXD38 and DBA/2J retinas of fours after a
vitreal injection of kanaic acid. Data for DBA/2J retina shown. B: Expression differences be-
tween strains were measured by a ratio with the injured BXD38 retina as the numerator and in-
jured DBA/2J retina as the denominator. For each RNA sample, retinas from two injured animals
were pooled (n = 4 retinas per sample). C: We extended these findings by using an optic nerve
crush model, a retinal injury that produces a slow progressing wound-healing response. Six days
after an optic nerve crush, we measured stress levels using the classic stress marker GFAP, a cy-
toskeletal protein normally expressed by astrocytes and the end-feet of Muller cells (2 animals
per strain).
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survival genes (Figure 4.5B). Candidate genes Id2 and Lpin1 were expressed more highly in the
injured BXD38 retina than in the injured DBA/2J retina (2.1 ± 0.5 and 144 ± 2.1 fold differences,
p < 0.05). Expression of acute phase genes Fos and Stat3, apoptosis gene Casp3, gliosis genes
Gfap and Cd81 were lower in the injured BXD38 retina than in the injured DBA/2J retina (Figure
4.5B). As a measure of neuroprotection, we surveyed the transcript levels of the chaperone crys-
tallin gamma (Crygd). The high Id2/Lpin1 expresser strain (strains with the C57BL/6 allele) dis-
played higher transcript levels of the survival gene Crygd (Figure 4.5B). Our comparison of
wound-healing gene expression in the high and low Id2/Lpin1 expressers, suggest that higher
levels of Id2/Lpin1 expression and the C57BL/6 allele correlate with lower levels of acute phase,
gliosis, and apoptosis markers. Higher levels of Id2/Lpin1 expression and the C57BL/6 allele also
correlated with increased expression of survival gene Crygd.
We extended these findings by using an optic nerve crush model, a retinal injury that pro-
duces a slow progressing wound-healing response. An optic nerve crush results in a wound-
healing process that involves the death of retinal ganglion cells and activation of Muller cells
[Wax and Tezel, 2002]. We measured levels of stress using the classic stress marker GFAP, a
cytoskeletal protein normally expressed by astrocytes and the end-feet of Muller cells (2 animals
per strain). Six days after an optic nerve crush, the central and the peripheral retina of the low
Id2/Lpin1 expresser (DBA/2J strain) displayed increased GFAP immunoreactivity: Muller cells
increased the expression of GFAP, as seen by the increased immunoreactivity along the radial
branches of Muller cells (Figure 4.5C). In contrast the high Id2/Lpin1 expresser (the BXD38
strain) at six days after injury displayed GFAP labeling of Muller cells only at the peripheral ret-
ina and a delayed upregulation of GFAP in the central retina. The differences in GFAP im-
munoreactivity between the high and low Id2/Lpin1 expressers (Figure 4.5C) were consistent
with the mRNA results (Figure 4.5B): higher levels of Id2/Lpin1 (the C57BL/6 allele) confer a
decrease reactive response by Muller cells. These results suggest that the C57BL/6 allele may
confer resistance to retinal injury whereas the DBA/2J allele may confer susceptibility.
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Id2 Silencing Decreases Wound Healing Response of Cultured Astrocytes
Candidate upstream modulator ID2 is known to be involved in proliferation and differentiation of
neural precursor cells [Yokota and Mori, 2002]. In CNS pathology, ID2 also has been described
in reactive glia [Tzeng et al., 1999; Tzeng et al., 2001; Aronica et al., 2001; Hernandez et al.,
2002]. We investigated the function of ID2 in glial cells by silencing the Id2 transcript in a mouse
astrocyte cell line, the C8D1A astrocytes. C8D1A astrocytes efficiently uptake short inhibitor
RNAs (siRNAs) and transport them near the nucleus (Figure 4.6A, red channel). We designed
three siRNAs to target the Id2 mRNA (Figure 4.6B) and compared their silencing efficiency
against a scrambled siRNA. Off-target silencing was determined by measuring the transcript and
protein changes of the reactive gliosis molecule, CD81. After a 24 h transfection, the siRNAs
successfully reduced Id2 transcript to levels below 30%. The siRNA with the best silencing effi-
ciency was used for all experiments (93% silencing, p < 0.001; Figure 4.6B). This siRNA targets
the 3’ untranslated region of Id2 at about 568 nucleotides from the starting site. Id2 siRNAs pro-
duced minimal off-target effects, as shown by the non-significant changes in Cd81 transcript lev-
els (Figure 4.6B). Reductions in Id2 expression also resulted in a 33% decrease in ID2 protein
levels to (p < 0.02, Figure 4.6C). Protein change for off-target genes was minimal. CD81 protein
levels were virtually unchanged (Figure 4.6C). Therefore, our RNA interference technique suc-
cessfully decreased the expression of Id2 with minimal off-target effects.
To determine functional changes due to lower ID2 levels, we used a cell culture model of
wound healing induced by the loss of contact inhibition. In this model, astrocytes at the leading
edge upregulate GFAP, migrate, and proliferate to repair the wound. Twenty-four hours after
transfection, we induced the loss of contact inhibition by scrapping cells off at the center of the
monolayer. We followed morphological changes of the reactive astrocytes entering the wound
using time-lapse photography. At 24 and 48 h there was a significant decrease in the rate of
wound-healing closure (Figure 4.6D). For example, migration distance of the Id2-siRNA treated
cells was 54.8% (p < 10-6) of control-siRNA treated cells at 24 h after scratch (Figure 4.6D). To
determine if the decrease in wound healing was due changes in cell cycle dynamics, we measured
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Figure 4.6. Id2 silencing decreases the mitotic activity and healing response of cultured astro-
cytes.
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changes in mitotic rate using DNA cell cycle analysis. DNA content measurements with flow
cytometry revealed that there was a 32.5% decrease in the number of cells in the S-phase (from
32.6 to 24.7%). Together these data suggest that ID2 controls the progression of astrocytes
through the cell cycle.
Discussion
The present study defined a genetic network and the location of its upstream modulator using
gene expression profiling and bioinformatic tools. Our approach to defining networks controlling
retinal wound healing involves (1) highlighting networks of highly co-expressed genes in differ-
ent models of injury and different CNS tissues; (2) defining the location of an upstream regulator
to a specific genomic locus using expression genetics; (3) predicting upstream modulators and
targets using bioinformatic tools; and (4) testing the effect of candidate gene dosage on wound
healing using animal and cell culture systems. Here we predict, refine, and test a genetic network
that modulates the expression of genes involved in the early CNS wound-healing response. Up-
stream regulators for this network are located within the regulatory locus on chromosome 12, 10-
30 Mb away from centromere. Dosage levels for candidate genes within the locus  (Id2 and
Lpin1) correlated positively with lower expression levels for markers of acute phase response,
gliosis, and apoptosis. Our results support the convergence of gene expression profiling, expres-
sion genetics, and bioinformatics as a rational approach to discover molecular pathways control-
ling retinal wound healing.
Previous studies identified three genetic networks that modulate the gene expression of
wound healing genes [Vazquez et al., 2005]. Only one of these networks, chromosome 12 net-
work, appears specific to the response of the CNS to injury. Our comparison of regulatory loci
across tissues and functional groups documents that chromosome 12 locus specifically regulates
the expression of wound healing genes in mouse brains. Our data documents that this network
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modulates genes known to regulate of transcription, differentiation, proliferation, and apoptosis
of neural cells. Expression patterns of chromosome-12-modulated genes in the injured retina re-
veal that most of these genes are differentially expressed during the early acute and delayed suba-
cute phases (Appendix C, Figure C.1). The function and temporal expression of the network’s
genes are consistent with early wound healing events in the injured retina. The early wound
healing phases are characterized by neuronal cell death and glial proliferation at the site injury, as
well as by the early activation of neuronal and glial cells leading to phenotypic changes (that is,
de-differentiation). Published data also support the hypothesis that chromosome 12 network
modulates the CNS response to trauma. In BXD RI mouse strains, the DBA2/J allele for the
chromosome 12 locus is one of the loci associated with susceptibility to noised-induced cell death
of spiral ganglion cells, the cells innervating auditory receptors cells [Willott and Erway, 1998].
The DBA/2J allele also predisposes susceptibility to generalized convulsions when exposed to
intense auditory stimulation [Neumann and Collins, 1991]. In contrast, the C57BL/6 allele is one
of the loci that confers enhanced neurogenesis and survival of new neurons and astrocytes in
adult hippocampus [Kempermann and Gage, 2002]. Together these data suggest that the chromo-
some 12 network displays a prominent role in CNS wound healing.
To test the hypothesis that chromosome 12 network modulates the wound healing re-
sponse in the retina, we examined the acute phase expression of classic immediate early genes
Fos and Stat3, apoptotic gene Casp3, and reactive gliosis genes Stat3, Gfap, and Cd81 in one
BXD RI strain segregating the C57BL/6 allele (BXD38 strain) and another segregating the
DBA/2J allele (DBA/2J strain). The C57BL/6 allele correlated with low expression levels of
genes involved in the immediate-early response, cell death, and reactive gliosis. The C57BL/6
allele also correlated with increased levels of the survival gene Crygd. In contrast, the DBA/2J
allele correlated with higher levels of immediate-early response, cell death, and reactive gliosis
genes, as well as, with lower levels of the survival genes. Our immunohistochemistry of injured
retina confirmed that the C57BL/6 allele and DBA/2J allele correlated with lower and greater
levels of the classic marker of retinal stress, glial fibrillary acidic protein (GFAP). These data
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suggest that C57BL/6 allele confers protection and DBA/2J allele confers susceptibility to retinal
damage. Our results are consistent with published data. The C57BL/6 background confers resis-
tance to apoptosis and seizures in the auditory system; resistance to glutamate-induced neurotox-
icity in brain and spinal cord; enhanced neurogenesis and survival of new neurons and astrocytes
in hippocampus [Willott and Erway, 1998; Neumann and Collins, 1991; Kempermann and Gage,
2002; Schauwecker and Steward, 1997; Inman et al., 2002]. These data document that chromo-
some 12 locus can modulate the acute-phase expression of apoptotic, gliosis-related, and survival
genes; and that within this locus there is a master regulator of the CNS response to injury.
A genetic variant located on chromosome 12 locus is responsible for the phenotypic dif-
ferences in the wound healing response of BXD RI mouse strains. Using an integrated bioinfor-
matic approach, we examined each polymorphic gene within the locus to determine the best can-
didate genes that can self-regulate its expression (that is, cis-acting) and regulate the expression
of wound healing genes. Id2, Lpin1, Sox11, and AL024210 displayed cis-acting regulation in
brain, cerebellum, and striatum of BXD RI mouse strains. This means that a genetic variant (or
variants) within or near the loci of these genes affect their own expression. Id2, Lpin1, Sox11, and
AL024210 are candidate genes because they display highly conserved self-regulation across CNS
tissues. Of these candidate genes, Id2 is expressed by reactive glia in brain, spinal cord, and optic
nerve head [Tzeng et al., 1999; Tzeng et al., 2001; Aronica et al., 2001; Hernandez et al., 2002].
Id2 is also upregulated as an immediate early gene in injured retina, brain, and spinal cord
[Vazquez-Chona et al., 2005]. Such strong circumstantial evidence is not available for Lpin1,
Sox11, and AL024210. As a complementing guide to defining gene variants that are responsible
for susceptibility to CNS injury, we compared the gene sequences of the DBA/2J to sequences
from two resistant strains, the C57BL/6 and 129/svj [Schauwecker and Steward, 1997; Inman et
al., 2002]. This approach identified three nucleotides in the Lpin1 sequence of the DBA/2J that
are different from sequences of both the C57BL/6 and 129/svj (Celera SNP IDs mCV22346966,
mCV22347703, and mCV22347384). Our computational analyses of SNPs show that SNPs in
Id2 and Lpin1 may affect DNA binding sites or splice variants. Using these approaches we fo-
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cused on transcription regulator Id2 and the nuclear protein Lpin1 as the best, current candidate
genes. Additional studies are required to determine if transcription factor Sox11 and expressed
sequence AL024210 participate in early signaling of retinal wound healing. In normal and injured
retinas, Id2 and Lpin1 were more highly expressed in strains carrying the C57BL6 allele than
strains carrying the DBA/2J allele. Higher levels of Id2 and Lpin1 correlated with higher levels of
survival gene Crygd and lower levels of acute-phase genes Fos and Stat3, apoptotic genes Casp3,
and gliosis-related genes Gfap and Cd81. These results document that DNA variants on Id2 and
Lpin1 of DBA/2J allele may result in lower expression of Id2 and Lpin1 and in higher levels of
apoptotic genes and gliosis-related genes.
The known functions of ID2 are consistent with the potential roles of chromosome 12
during the early CNS response to injury: regulation of transcription, differentiation, proliferation,
and apoptosis. In its classical function, ID2 modulates neural and glial differentiation via the
negative regulation of basic helix-loop-helix (bHLH) transcription factors (for example, NeuroD
and Olig) [Ross et al., 2003; Liu and Harlan, 2003; Wang et al., 2001]. ID2 binds to bHLH tran-
scription factors to inhibit their binding to E-box sequences, defined by the CANNTG motif [Yo-
kota and Mori, 2002]. E-boxes are present in promoters of many pro-neural differentiation genes
(for example, Pax6) [Ross et al., 2003]. These data suggest that ID2 can modulate activation of
retinal cells by regulating E-box mediated transcription. Several of the network genes have E-
boxes in their promoters including Fos [Chaudhary and Skinner, 1999], Gfap [Tzeng, 2003],
Sdc1 [Vihinen et al., 1996], Pax6 [Marsich et al., 2003], and Cp [Vazquez-Chona, personal in
silico promoter observations]. For example, ID2 modulates the gene expression of Fos during
Sertoli cell differentiation [Chaudhary and Skinner, 1999]. ID2 can also promote proliferation by
inhibiting the E-box mediated transcription of cell cycle inhibitors (for example,
p21CIP1/WAF1, p15INK4B, and p16INK4B) [Pagliuca et al., 2000]. Alternatively, ID2 may
stimulate proliferation by binding to the unphosphorylated Rb protein, allowing the release of the
transcription factor E2F. E2F in turn activates genes involved in G1-S phase transition and hence
proliferation [Yokota and Mori, 2002]. In our studies, Id2 silencing in cultured astrocytes de-
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creased the number of cells entering the S phase. ID2 can also negatively modulate apoptosis. In
animals with Id2 null mutation, Sertoli cells and mammary epithelial cells display increased lev-
els of apoptosis relative to wild-type animals [Yokota and Mori, 2002]. The increased apoptosis
in Id2-/- animals suggest that ID2 may be required as a survival factor for some cell types [Yo-
kota and Mori, 2002]. In our studies, higher levels of Id2 correlated with higher levels of survival
gene Crygd and lower levels of acute-phase genes Fos and Stat3, apoptotic gene Casp3, and glio-
sis-associated genes Gfap and Cd81. Together the functions of ID2 and these data suggest that
ID2 is an ideal candidate upstream modulator of the chromosome 12 network.
The role of Lipin 1 during retinal wound healing is not clear. Lipin 1 belongs to a novel
family of nuclear proteins that are involved in adipose tissue development and insulin resistance.
Lipin proteins share three conserved domains: a lipin, N-terminal conserved region, a nuclear lo-
calization sequence, and a LNS (Lipin/Ned1/SMP2) conserved region. Mutations in the Lpin1
gene lead to fatty liver dystrophy (fld) in fld mice, characterized by loss of body fat, fatty liver,
hypertriglyceridemia, and insulin resistance [Peterfy et al., 2001]. Lpin1 null mutations also lead
to peripheral neuropathy due to the dysregulation of a battery of genes required for the regulation
of storage lipid metabolism in both the endoneurium and peri/epineurium [Verheijen et al., 2003].
The mechanisms of action by lipin proteins are unknown. A study of yeast lipin protein, Ned1,
revealed that lipin proteins can associate with factors involved in nuclear transport and chromo-
some segregation [Tange et al., 2002]. Gene expression patterns in the developing retina suggest
that Lpin1 is expressed during the time of Muller cell birth and differentiation (P8-P14) [Retina
Developmental Gene Expression, probe set 98892_at; Mouse Retina SAGE Library,
Mm.153625]. We will use in situ hybridization to determine the cellular source of Lpin1 mRNA.
We will also use fld mice to determine the role Lipin 1 has during wound healing.
Our work makes two clear contributions to the field of CNS wound healing research. At
one level, our work describes an integrated approach of gene expression profiling and higher-
level bioinformatic analyses to define networks and their regulators. This approach is valuable
because it suggests how researchers might develop a package of capabilities to enable a system-
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atic reconstruction of pathways related to their field. Our second contribution is the finding of a
regulatory locus that modulates the early response of the retina to injury. Computational analyses
and molecular manipulation of this locus will help define the regulatory gene(s) modulating the
response of mammalian CNS to trauma and chronic stress.
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Chapter 5
Discussion
104
This dissertation focused on understanding the response of the retina to injury. The response of
the retina to injury is controlled by changes in gene expression and the series of studies presented
in this dissertation are one of the first to use a unique combination of microarray studies to define
loci controlling the initial events controlling the injury response.  By implementing integrated
gene expression profiling, expression genetics, and bioinformatics, we revealed three novel as-
pects of this wound healing process. First, groups of functionally related genes underlie the early,
delayed, and sustained responses of wound healing (Chapter 2). Second, three specific genomic
loci modulate coordinated changes in gene expression in mouse brains: regulatory loci on chro-
mosomes 6, 12, and 14 (Chapter 3). Third, the chromosome 12 locus specifically modulates the
expression of a group of genes involved in early wound-healing events. As a result of these stud-
ies we have identified two very good candidate genes Id2 and Lpin1 as potential modulators for
the chromosome 12 network (Chapter 4). The chromosome 12 network represents one of the first
regulatory mechanism derived from gene expression data of injured retina. Previous chapters dis-
cussed the biological significance of each of theses findings. In this chapter, I provide a retro-
spective discussion of the biological significance and scope of my experimental design to catalog
global changes (microarrays), to define regulatory loci of gene expression (expression genetics),
and to identify candidate genes (bioinformatics).
Cataloging Global Changes During Wound Healing Using Microarrays
Global View of Gene Activity and Protein Expression
At the most basic level, microarray analysis measures mRNA abundance. Traditionally, microar-
rays target the 3’ regions of mRNA transcripts [Lipshutz et al., 1999]. Levels of hybridization to
3’regions are used to predict transcript expression levels and differences. We used real-time RT-
PCR as an independent means to confirm expression changes. Our results describe a strong
agreement in direction of change between the Affymetrix microarray platform and the real-time
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RT-PCR method: 100% agreement for probes with high signals and 85% agreement for probes of
all signal levels (n = 22 genes) [Rogojina et al., 2003; Vazquez et al., 2004]. There is also a mod-
erate correlation (r = 0.76) when comparing the magnitude of changes [Vazquez et al., 2004].
Our results and other studies confirm the power of microarray to describe global gene expression
changes in the injured retina [Vazquez et al., 2004; Chen et al., 2004; Yoshimura et al., 204; Wil-
son et al., 2003; Ahmed, et al., 2004; Gerhardinger et al., 2005; Rattner and Nathans, 2005].
We also confirmed the upregulation of protein changes predicted by our microarray study
including GFAP, CD81, ID2, STAT3, as well as crystallins alpha, beta, and gamma (Figures 2.4
and 4.4). The literature provides additional support for protein expression changes for NFKB,
CP, CLU, ANXA5, SPARC, and HSP27 [Wu et al., 2002; Wong et al., 2001; Strunnikova et al.
2001; Chen et al., 2003; Gilbert et al., 1999]. Our results demonstrate that changes in transcript
levels correlate with immediate changes in protein levels. The silencing of Id2 using RNA inter-
ference decreased ID2 protein expression (Figure 4.6). Several studies integrated dynamic ex-
pression profiles of transcript and protein and found that the trends of differential expression are
maintained across broad transcriptome and proteomic data [Hack, 2004; Beyer et al., 2004; Mi-
jalski et al., 2005; Lin et al., 2004]. Lin and colleagues [2004] further demonstrated that changes
in protein levels depend on gene expression changes. They showed that changes in protein levels
that occur during the stress response are blocked if gene transcription is inhibited. However, we
also found that the correlation between transcript and protein expression is weak to moderate
[Rogojina et al., 2003]. When we decreased the Id2 transcript by over 90%, protein changes for
ID2 decreased only by 33%. These discrepancies in our study suggest that hybridization to
3’regions provide a limited picture of gene expression control after transcription and translation.
Post-transcriptional control of gene expression includes the processing (for example, mRNA
splicing), export, localization, turnover, and translation of mRNAs [Mata et al., 2005]. Studies
that investigated alternative splicing of mRNA revealed that nearly 80% of the human genes have
alternative isoforms [Johnson et al., 2003]. We conclude that differential splicing might explain
the moderate correlation between our microarray and RT-PCR results. Post-translational events
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that could account for differences between our microarray and protein results include modifica-
tion and degradation. Despite these limitations, microarray analysis was, and continues to be, our
method of choice as it has a major advantage over current proteomic approaches. Proteomic ap-
proaches (two-dimensional gel and mass spectrometry) survey hundreds of gene products while
microarrays can survey thousands of genes in a single experiment. In summary, commercial ar-
rays provided a comprehensive, reliable assessment of global changes in the injured retina; how-
ever, the global microarray approach provided a qualitatively incomplete assessment of post-
transcriptional and post-translational regulation of specific proteins of interest.
The Challenge of Tissue Heterogeneity
Transcriptome-wide analyses of injured retina are bulk characterizations of gene expression from
diverse cell populations including photoreceptors, interneurons, ganglion cells, glial cells, periph-
eral blood cells, as well as their sub-populations. This type of cellular heterogeneity posses two
major difficulties. First, cellular heterogeneity challenges the technical sensitivity of the system
to detect transcripts expressed at low levels in unique cell populations. To enhance the detection
and confidence level, we used comparative analyses of expression signatures across species and
CNS tissues [Vazquez et al., 2005]. In our initial microarray study, Id2 was overlooked as a
wound-healing gene due to the strict statistical criterion of a 98% confidence level. By high-
lighting common reactive transcripts in retina, brain, and spinal cord, we decreased technical and
tissue specific noise and found that Id2 is a common acute phase gene in CNS injury using a 95%
confidence level.
The second issue raised by tissue heterogeneity is our ability to determine cell sources for
specific changes. We determined a potential source by examining the expression of a transcript in
profiles from cultured and dissociated CNS cells, including neurons, astrocytes, microglia, Mul-
ler glia, and RPE cells [Vazquez et al., 2005]. We found that often transcript expression and cel-
lular source is maintained across tissues. For example, Gfap and Cd81 are expressed by astro-
cytes in the brain and in Muller glial cells in the retina [Clarke and Geisert, 1998; Gerhardinger et
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al., 2005]. However, making inferences about in vivo expression from cultured cell expression
profiles must be made judiciously. Transcript expression is dynamic and certainly some transcript
levels measured in these cells are in response to the trauma of dissociation and sorting. The iden-
tification of cell-specific genes is possible through the application of computational and genome-
wide analyses. Bryant Jones [2005] documented that genes involved in the regulation of glial cell
development in Drosophila share a binding site for the glial cell missing (GCM) transcription
factor. We predict that computational analyses of non-coding regions will predict the cellular
source of gene expression. By combining our retinal transcriptome profiles with profiles of in-
jured CNS tissue and cultured neuronal cells we reduced the challenges of tissue heterogeneity.
Inferences About Changes in Function
Changes in retinal function and regulatory mechanisms can be inferred from the grouping of
genes with similar patterns of expression. We examined clustered genes based on their function
described by the Gene Ontology database (www.geneontology.org) and from the literature. From
these analyses, we determined that temporal clusters show significant enrichment in genes that
are known to mediate similar functions (Figure 5.1) [Vazquez et al., 2004]. Transcription factors
are expressed during the early response. Apoptosis and proliferation related genes are expressed
during the delayed phase. Tissue remodeling genes and reactive gliosis are expressed during the
chronic phase. Similar temporal patterns of functional groups were described in the wound-
healing response of spinal cord and brain [Di Giovanni et al., 2003; Velardo et al., 2004; Natale
et al., 2004]. The ultimate goal of gene expression profiling is to relate specific transcript changes
with specific changes in cell function. Our results document that the silencing of Id2 and Cd81
decreases astrocyte wound healing by different mechanisms: Id2 affects proliferation (Figure 4.6)
and Cd81 affects migration (X. Wang and E. Geisert, personal observations). However, microar-
ray analysis provided a limited view of the functional changes during retinal wound healing. We
found that our microarray analyses described cultured RPE cells as mitoticly active on the basis
of gene expression [Rogojina et al., 2003]. However, differences in proliferation rates between
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Figure 5.1. Gene expression after injury is temporally regulated and gene product functions are
consistent with known the biology of retinal wound healing.
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RPE cell lines are indistinguishable based on gene expression. These results show that post-
translational events (phosphorylation, localization, modification and degradation) modulate cell
function and that post-transcriptional regulation is not obvious from gene expression profiles. By
providing global views of functional changes, our analysis of expression data is a first step to-
ward the characterization of internal programs underlying retinal wound healing.
We predict that computational analyses will help define the molecular interactions de-
fined by genes that share similar pattern of expression. For example, computational analyses of
amino acid sequence analyses revealed that clustered genes share functional domains and display
sites of known protein-protein interaction [Novatchkova and Eisenhaber, 2001]. These data sug-
gest that gene clusters represent much more than abundance correlations. Indeed, Fraser and
Marcotte [2004] argued that the complete set of relations defined by amino acid and DNA se-
quences within a cluster provides the most complete and unbiased analysis of gene function and
regulation. By integrating gene expression data with additional levels of biological information
(for example, databases about gene function, functional motifs, and molecular pathways), we will
infer about specific biological processes underlying wound healing and catalog potential protein-
protein interactions.
Inferences About Regulatory Mechanisms
Similar patterns of expression by functionally related genes suggested the hypothesis that clus-
tered genes are regulated by common mechanisms. One approach defines modules of co-
regulated genes based on the sharing of cis-regulatory motifs (transcription factor binding sites,
enhancers, etc.). Livesey and colleagues [2000] documented that genes expressed during the ter-
minal differentiation of photoreceptors share promoter binding sites for the transcription factor
CRX. The regulatory relationships of genes and factors within a cluster have been built into mo-
tifs and networks, yielding clues about transcriptional networks modulating coordinated expres-
sion [Lee et al., 2002; Segal et al., 2005]. Gene expression however is modulated by more than
transcription factor activity (for example, heterochromatin remodeling and endogenous gene si-
110
lencing). Also, gene expression changes are modulated at the level of translation and post-
translation, as described earlier. Thus, transcriptional networks represent one level of gene ex-
pression that can be derived from combining expression clusters with computational analyses of
promoters. The next section describes an approach that can define transcriptional regulators as
well as post-transcriptional and post-translational regulators of co-regulated genes.
Defining Regulatory Loci That Modulate Gene Expression
Specificity of Regulation by Chromosome 12 locus
As a first step toward defining regulatory mechanisms from our retinal injury microarray data, we
used online expression genetics to define the genomic location for the upstream modulator(s)
controlling wound-healing gene expression [Vazquez et al., 2005]. Our meta-analyses revealed
that a locus on chromosome 12 (10-30 Mb locus from the centromere) modulates a group of in-
jury genes that are primarily expressed during the early phases of wound healing (Figure 5.2).
The discovery of regulatory networks using meta-analyses of brain expression genetics data
raises issues about meta-analysis reliability, wound-healing regulation specificity, and regulation
relevance to gene expression in the retina. We addressed the reliability of our observations by
testing whether genetic associations are replicated in independent cohorts. For example, chromo-
some 12 locus is a cis-regulatory locus for Id2, Lpin1, and Sox11 using two independent Gene-
Network databases: UTHSC Brain mRNA U74Av2 (Nov05) and the INIA M430 Brain (April05)
database (Figure 4.3). Both databases used independent samples and different array platforms
(U74Av2 and M430). We addressed specificity of regulatory loci by comparing regulation across
tissues (brain versus hematopoietic stem cells) and functional groups (wound healing versus syn-
aptic genes). From these analyses, we concluded that chromosome 12 locus specifically modu-
lates the expression of wound-healing genes in whole brains. We addressed the relevance of brain
data to gene regulation in the retina by examining gene regulation in multiple CNS tissues.
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For example, the chromosome 12 locus modulates the expression of Id2, Lpin1, and Sox11 and in
the forebrain, cerebellum, and striatum. The conserved gene regulation across CNS tissues was
our motivation for defining regulators for retinal injury genes using available data of genetic in-
teractions from mouse brains. Our RT-PCR data shows that the differential expression of specific
transcripts across the retinas of BXD RI strains was in agreement to those displayed in brain. Our
analyses of gene expression data injured retina, brain, and spinal cord supports the hypothesis
that there is a generalized response to CNS injury [Vazquez et al., 2005]. After injury for exam-
ple, a group of acute phase genes, mostly transcription factors, are upregulated in injured retina,
brain, and spinal cord. Regulation of transcript expression is also known to be maintained across
CNS tissues. The transcription factor STAT3 plays an important role in activating cortical astro-
cytes [Acarin et al., 2001] and retinal Muller glial cells [Wang et al., 2002]. Published neurologi-
cal phenotypes in BXD RI strains suggest that the chromosome 12 locus can modulate wound
healing events across CNS tissues: seizure response of the auditory system, cell death of spiral
ganglion cells, and proliferation of adult stem cells in the hippocampus [GeneNetwork IDs
10652, 10655,10434-5, 10437-8, 10504, 10338, 10340-1, and 10378; Willott and Erway, 1998;
Neumann and Collins, 1991; Kempermann and Gage, 2002]. These data documents the reliability
of our analysis, specificity of chromosome 12 regulation of wound-healing genes, and the rele-
vance of chromosome 12 across CNS tissues including the retina.
We have defined a genetic network that modulates wound-healing gene expression in the
CNS. The upstream modulator for this network is located within the 10-30 Mb locus from the
centromere of mouse chromosome 12 [Vazquez et al., 2005]. In injured BXD RI strains, the ex-
pression of reactive glial genes (Gfap, Fos, Stat3, and Cd81), cell death genes (Casp3), and sur-
vival gene (Crygd) correlate with the segregation of C57BL/6 and DBA/2J alleles for the chro-
mosome 12 locus. Reactive glial genes Gfap, Fos, Stat3, and Cd81 and cell death gene Casp3 are
expressed at lower levels in strains with the C57BL/6 allele than in strains with the DBA/2J al-
lele; whereas survival gene Crygd is expressed at higher levels in strains with the C57BL/6 allele
than in strains with the DBA/2J allele. Published data support the hypothesis that chromosome 12
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network modulates the CNS response to trauma. In BXD RI mouse strains, the DBA2/J allele for
the chromosome 12 locus is one of the loci associated with susceptibility to noised-induced cell
death of spiral ganglion cells, the cells innervating auditory receptors cells [Willott and Erway,
1998]. The DBA/2J allele also predisposes susceptibility to generalized convulsions when ex-
posed to intense auditory stimulation [Neumann and Collins, 1991]. In contrast, the C57BL/6 al-
lele is one of the loci that confers enhanced neurogenesis and survival of new neurons and astro-
cytes in adult hippocampus [Kempermann and Gage, 2002]. Moreover, the combined function of
genes in the network also suggests that the chromosome12 network can regulate transcription,
differentiation, proliferation, and cell death. These processes are characteristic of the early
wound-healing response [Vazquez et al., 2004]. Together these data suggest that the chromosome
12 network displays a prominent role in CNS wound healing.
Chromosome 12 Network Modulates Activation of Muller Glia
Preliminary results suggest that chromosome 12 network modulates transcript changes and phe-
notypic changes of retinal glial cells either through intrinsic or extrinsic mechanisms. The reac-
tive glial genes Gfap, Fos, Stat3, and Cd81 are expressed at lower levels in strains with the
C57BL/6 allele than in strains with the DBA/2J allele. Increased expression and nuclear translo-
cation of transcription factors FOS and STAT3 are characteristic of the early activation of Muller
cell signaling cascades [Geller et al., 2001]. Increased expression of cystoskeleton protein GFAP
and cell adhesion molecule CD81 are part of a series of phenotypic changes in the Muller cells
that include enlargement of cell body, extension of process into areas of retinal damage, and in
some cases proliferation [Bignami and Dahl, 1979; Clarke and Geisert, 1998]. Together, these
phenotypic changes in glial cells are known as reactive gliosis. The classic marker to measure
retinal stress and Muller cell reactivity is GFAP [Lewis and Fisher, 2003]. Immunohistochemis-
try of GFAP revealed a moderate reactive response by Muller cells in strains with the C57BL/6
allele relative to strains with the DBA/2J allele. The chromosome 12 locus also modulates the
gene expression of additional reactive gliosis markers, including Cp, Lcn2, Itgb1, and Col11a.
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Several of the chromosome 12 network genes are also differentially expressed in reactive Muller
cells including Egr1, Nr4a1, and Lcn2 [GEO data set GSE1979; Gerhardinger et al., 2005].
These data support a model where chromosome 12 locus intrinsically modulates the response of
Muller cells to retinal injury by repressing the expression of reactive gliosis genes.
Muller cell reactivity is also extrinsically modulated by the extent of neuronal survival.
Experimental models of glaucoma with no direct damage to retina, as in the case of the mechani-
cal crushing of retinal ganglion axons at the optic nerve head, suggest that survival and apoptotic
signals are relayed from the ganglion cells to the Muller cells. Indeed, Muller cell reactivity pre-
cedes ganglion cell death [Wax and Tezel, 2002]. Injured retina from BXD RI strains display
moderate Muller cell reactivity that correlates with lower apoptotic markers (Fos and Casp3) and
with higher survival markers (Crygd). Increased expression and activity of transcription factor
FOS and protease CASP3 are hallmarks of neuronal cell death in the retina [Hafezi et al., 1999].
Genetic and pharmacological inactivation of FOS and CASP3 protects retinal cells against apop-
tosis [Wenzel et al., 2000]. Both Fos and Casp3 are controlled by the chromosome 12 network.
Additional chromosome 12 network genes involved in the positive regulation of cell death in-
clude Nr4a1, Trib3, Vdac1, Lyzs, and Lamp2. Anti-apoptotic genes include Bcl2, Tcf4, and
Ptpn16/Dusp1. In addition to modulating the expression of apoptosis-related genes, chromosome
12 locus also participates in the regulation of cell death phenotypes in BXD RI mouse strains.
The DBA2/J allele is associated with susceptibility to noised-induced cell death of spiral gan-
glion cells [Willott and Erway, 1998]. Here we showed that the DBA/2J allele correlated with
higher levels of apoptotic genes Fos and Casp3 in injured retina. In our studies, the C57BL/6 al-
lele correlated with higher levels of survival gene crystallin gamma D. Crystallins are heat-shock
like proteins and their upregulation rescues retinal degenerations [Otani et al., 2004]. In injured
retina, ganglion cells, photoreceptors, and interneurons upregulate crystallins [Vazquez et al.,
2004; Otani et al., 2004]. These data suggest that chromosome 12 can modulate survival and cell
death signaling mechanisms of retinal neural cells. The extent of neuronal survival and cell death
extrinsically influences the extent of Muller cell reactivity.
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Significance of Chromosome 12 Network in Glaucoma
The chromosome 12 network represents a novel mechanism that explains differences in the re-
sponse to retinal injury in murine models. Specifically, our data shows that the DBA/2J allele of
the chromosome 12 locus confers susceptibility to neurodegeneration and glial reactivity induced
by different experimental models of retinal injury, including toxic injuries and optic nerve crush.
Our data and published data [Wax and Tezel, 2002] show that retinal ganglion cells are the most
susceptible retinal cells to neurodegeneration after toxic injuries and optic nerve crushes. The
work by Simon John’s group [2005] has shown that DBA/2J mice are highly susceptible to reti-
nal ganglion cell death due to elevated intraocular pressure, a hallmark of glaucoma. In humans,
family history and genetic factors are important in the susceptibility or resistance to glaucoma.
Understanding the genetic factors that control neuronal degeneration and glial reactivity in the
retinas of BXD RI mice can help elucidate the mechanisms that control susceptibility to glau-
coma in humans. The chromosome 12 locus may represent the location for genetic variants re-
sponsible for susceptibility to glaucoma. This chromosomal interval has a high degree of homol-
ogy (that is, synteny) with intervals on the human chromosome 2 (1 to 18 Mb or p25 to p24.3)
and on the rat chromosome 6 (34 to 48 Mb or q14 to q16) [NCBI MapViewer,
http://www.ncbi.nlm.nih.gov/mapview]. In these syntenic regions, the gene order and gene ho-
mology is highly conserved. The next section outlines our work to identify the polymorphic
genes responsible for differences in wound-healing response in BXD RI strains.
Finding Regulators of Retinal Wound Healing
We used gene expression genetics as a guide to identify the location of modulators of wound-
healing genes. Regulatory loci can span hundreds of genes (several megabase pairs [Mb]). In our
study the regulatory locus spans a region of approximately 20 Mb, containing nearly seventy
known genes (Figure 5.3). Our approach to define the candidate gene(s) was guided by the biol-
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ogy of the system: co-regulation of wound-healing genes in segregating populations. Therefore,
likely candidate modulators are positional, polymorphic genes with expression variability that
map to their own locus and with product functions relevant to wound healing. Our data support
Id2, Lpin1, and Sox11 as the best current candidate genes.
We searched for genetic variants because that is the variable that accounts for expression
phenotypes in the BXD RI strains. Identifying polymorphic genes is assayed by comparing the
sequenced genomes of the parental strains. DNA variants within the regulatory region of candi-
date genes can alter transcription rates by affecting the binding of transcription factors to the
promoter. We proposed that the strong self-regulation of Id2 in BXD RI strains is due to a SNP
that affects the binding to the CAAT consensus sequence in the promoter (Figure 5.3) [Vazquez
et al., 2004]. DNA variants in the transcribed regions also affect hybridization levels of the target
to the probes in the array. This is why probes for the same candidate gene but targeting different
mRNA regions may provide different hybridization levels. This was illustrated by Aitman and
colleagues [1999] who used linkage analysis and microarrays to identify a variant form of Cd36
as the fatty acid transporter gene causing insulin resistance in hypertensive rat. The gene in the
hypertensive rat has a DNA variant located in the 3’ untranslated region that affects its hybridi-
zation to the microarray probe derived from the 3’ region from wild-type animals. The examples
of Id2 and Cd36 illustrate that microarray hybridization signals are instructive in suggesting can-
didate genes. Unfortunately, most commercial microarrays fail to detect DNA variants toward the
5’ region due to the 3’ bias of probes. In these cases, candidate genes can be defined by deter-
mining their relevance to wound healing events and determining whether missense mutations al-
ter gene product functions.
A comprehensive and systematic way to determine whether a gene is relevant to wound
healing is to examine its expression pattern using the growing collection of gene expression pro-
filing of injured CNS. Transcript information can be complemented and supplemented by mining
the literature for a known function in CNS injury and development. One must be careful in
117
A
B
Positional genes
Lipin  E2f6  Odc1Nmyc1 Tyki   Sox11Cys1 Oact2 Id2 AL024210  Ttc15  Mytl1Vsnl1 Ddx1 Ywhaq Adam17 Sntg2  Lamb1 
0 50 100 (Mb)
Chr 12
Expression variability
Start Stop
exon1 exon2 exon3
+320
SNPs
Non-coding
Coding
C57BL/6  GCCAATG
DBA/2J   GCCAATA
Network’s functional themes:
 4 Transcription
 4 Neural development
 4 Proliferation
 4 Cell death
CNS injury:
 4 Brain
 4 Spinal cord
 4 Optic nerve
 4 Retina
Variability maps to its gene location
Polymorphic
Low Id2 expresser
Relevant SNP
Figure 5.3. Id2 is a candidate gene modulating the chromosome 12 network.
118
 ruling out candidate genes based on the absence of information. In our original screen for candi-
date genes we selected Id2 over Lpin1 based on preponderance of biological data suggesting that
the functions of Id2 were consistent with CNS wound healing (Figure 5.3). Post-hoc results with
real-time RT-PCR suggest that Lpin1 in the retina also displayed high expression differences due
to genetic variations and due to trauma (Figure 4.4). Differences in gene product activity in seg-
regating populations, however, can be independent of gene expression differences. A mutation
can affect functional domains such as sites for phosphorylation, protein-DNA interaction, and
protein-protein interaction that affect the expression of down stream targets without affecting the
expression of upstream modulators. Surveys of functional domains are possible by computational
analysis of libraries that catalog functional domains based on amino acid sequences. Based on
evidence of transcript self regulation, transcript differential expression during retinal develop-
ment and retinal injury, as well as relevant function of candidates, we have determined that Id2,
Lpin1, and Sox11 have strong biological data suggesting their participation in wound healing.
Bioinformatic tools have guided our approach to define hypotheses about modulators of
retinal wound healing. This approach is possible with the growing body of biological data that
map the global function of cells at different levels (for example, at the level of the genome, tran-
scriptome, proteome, phenome, etc.). High-through put data are, by nature, error prone. There-
fore, high-through put data supporting specific hypotheses need to be confirmed by independent
means or alternative methods. In this body of work, we illustrate the value of comparative analy-
ses of high-through put data to confirm hypotheses, as we did for our analyses of acute-phase
genes in the CNS and regulatory locus analyses [Vazquez et al., 2005]. Skepticism of any data,
even published data, is healthy. We initially ignored the use of mice with the Id2-null mutation
for studies of adult wound healing because the data by Wang and colleagues [2001] indicated that
the Id2-null were post-natal lethal. However, the data by others indicate that Id2-null mice show
growth retardation but are viable [Yokota and Mori, 2002]. In perspective, bioinformatic data are
reliable when they meet quality control criteria and statistical stringency. In this respect, hypothe-
ses derived from bioinformatic means are no different than those derived from classical means,
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and, should not be required to undergo more stringent, nor less stringent, testing and refinement.
Here, we described a method that utilizes a collection of bioinformatic tools to candidate genes
responsible for the regulatory locus on chromosome 12. We also proposed models for the intrin-
sic and extrinsic modulation of Muller cell reactivity.
Model of Intrinsic Regulation Muller Cell Reactivity
We integrated computational analyses of biological data (that is, bioinformatics) with the litera-
ture to generate potential models of regulation. The known functions of ID2 in the regulation of
transcription and neural differentiation are consistent with a model of intrinsic regulation of
Muller cell reactivity by the chromosome 12 network. Id2 is expressed by reactive glia in brain,
spinal cord, and optic nerve head [Tzeng et al., 1999; Tzeng et al., 2001; Aronica et al., 2001;
Hernandez et al., 2002]. Id2 is also upregulated as an immediate early gene in injured retina,
brain, and spinal cord [Vazquez et al., 2005]. The retina upregulates Id2 in response to different
models of injury including mechanical injury, toxic injury, optic nerve crush, increase intraocular
pressure. Expression profiles document that Id2 is highly expressed in reactive Muller cells [GEO
data set GSE1979, probe set rc_AI230256_at]. In its classical function, ID2 modulates neural and
glial differentiation via the negative regulation of basic helix-loop-helix (bHLH) transcription
factors (for example, NeuroD and Olig) [Ross et al., 2003; Liu and Harlan, 2003; Wang et al.,
2001]. ID2 binds to bHLH transcription factors to inhibit their binding to E-box sequences, de-
fined by the CANNTG motif [Yokota and Mori, 2002; Ross et al., 2003]. E-boxes are present in
promoters of many reactive gliosis markers modulated by chromosome 12 network including Fos
[Chaudhary and Skinner, 1999], Stat3 [Shi et al., 1996], Gfap [Tzeng, 2003], Sdc1 [Vihinen et
al., 1996], and Cp [F. Vazquez, personal in silico promoter observations]. There is evidence that
ID2 modulates the gene expression of Fos during Sertoli cell differentiation [Chaudhary and
Skinner, 1999]. Based on these data, we proposed a model of an intrinsic program, where ID2 is
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expressed in Muller cells and modulates reactive gliosis markers via E-box mediated transcrip-
tion (Figure 5.4).
Regulation of Muller cell reactivity by the chromosome 12 network via repression of E-
box mediated transcription is consistent with the known activating signaling pathways of reactive
glial markers. Two transcriptional activators of Gfap expression are downstream targets of chro-
mosome 12, Fos and Stat3. Both FOS and STAT3 mediate Gfap expression via activating protein
1 (AP1) binding sites and STAT binding sites (Figure 5.4) [Besnard et al., 1991]. ID2 in turn can
mediate control of Fos and Stat3 expression by preventing bHLH from binding to their E-boxes.
Thus, ID2 can modulate Gfap expression by negatively regulating Fos and Stat3 expression. Al-
ternatively, ID2 could negatively regulate Gfap expression. Gfap has an E-box in its promoter
[Tzeng, 2003]; however, there is no evidence to support that Gfap expression is regulated through
the E-box binding site. Repression of E-box mediated transcription of Fos, Stat3, and Gfap, can
all contribute to lower levels of Gfap. A similar paradigm might exist for additional chromosome
12 network genes that are expressed in reactive glia. For example, Cp has binding sites for FOS
and STAT3 as well as E-box binding sites [F. Vazquez, personal in silico promoter observations].
In this model, chromosome12 network modulation of Muller cell reactivity offers a new level of
regulation via ID2 that is consistent with current activating mechanisms of retinal glial cells.
Perspectives on Testing Candidate Genes
Cellular Localization
Whole genome-wide analyses are powerful approaches to defining regulatory mechanisms. The
next level of analyses requires the experimental confirmation of these regulatory mechanisms. A
first step toward evidence of causation and mechanism of action is determining cellular localiza-
tion of candidate modulators. When antibodies are available, immunohistochemistry is an effi-
cient, and cost effective technique to determine the cellular source of gene products. We
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however found that antibodies need appropriate controls to confidently determine the cellular
source. For example, we found that an ID2 polyclonal antibody (Santa Cruz Biotechnology, SC-
489) labels interneurons of the retina. However, when we tested against retina from animals with
a null-mutation for Id2 we found virtually no difference between wild-type and knock-out ani-
mals (Appendix D, Figure D.1). The non-specificity of the ID2 antibody was surprising as the
antibody in western blots recognizes an antigen that corresponds to the molecular weight of ID2,
and the intensity of immunoreaction is proportional to transcript levels (Figure 4.4). LPIN1 anti-
body (Alpha Diagnostic, LPN11-A) is also non-specific in tissue. In both cases, antibodies were
generated against small, synthetic peptides that may not reflect the protein conformation in tis-
sues. The limited availability and reliability of antibodies to assess gene function illustrates the
current limitation of protein and molecular methods to keep up with gene-discovery approaches.
Gene Dosage Effect Using BXD RI Strains
We tested the role of candidate genes during wound healing by testing the effect of gene expres-
sion dosage in BXD RI mouse strains. The natural range of gene expression in BXD RI mouse
strains offers a powerful tool to test and refine hypotheses. Candidate genes whose expression
dosage correlate with the degree of resistance or susceptibility of retinal wound healing provide
strong evidence of wound healing modulation. In this project, we showed that high levels of ex-
pression for Id2 and Lpin1 correlate with lower expression levels for markers of acute phase, re-
active gliosis, and cell death. Our results nicely complement published neurological studies
which showed that the chromosomal region around the Id2 and Lpin1 loci correlate with the ex-
tent of audiogenic seizure, neuronal hearing cell death, and hippocampal adult neurogenesis
[Willott and Erway, 1998; Neumann and Collins, 1991; Kempermann and Gage, 2002]. BXD RI
strains also offer a system to differentiate the contribution of candidate genes to wound healing
by increasing the resolution of the regulatory locus, currently at 10-30 Mb from centromere. The
new BXD RI strain set developed by Peirce and colleagues [2004] offer two chromosomal re-
combinations between genetic markers at 11 and 22 Mb (D12Mit182 and D12Mit84) and be-
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tween genetic markers at 22 and 30 Mb (D12Mit84 and D12Mit153). Additional strains
(BXDA24, BXDA35, BXDA7) could help refine the correlations between candidate genes Lpin1,
Id2, Sox11, and AL024210 (located at 15.9, 21.6, 23.9, and 25.2 Mb) and extent of retinal wound
healing. There is an important experimental design consideration: Since each BXD RI mouse
strain is a unique recombination of the parental genomes, the experiment needs to include suffi-
cient number of strains to significantly correlate gene dosage level effects on wound healing phe-
notype with the segregation of corresponding alleles. At a minimum, the parental strains, the F1
cross, and an additional strain from each end of the expression range need to be included in the
experiment. Our data support that BXD RI strains are valuable in increasing the resolution of
linkage mapping and correlating gene dosage with susceptibility or resistance to retinal injury.
In Vitro Testing
Cell culture systems can also provide evidence of modulation. Our results show that RNA inter-
ference in cultured cells is a practical way to decrease transcript levels. Short interfering oligonu-
cleotides that target Id2 and Cd81 mRNAs efficiently decreased Id2 and Cd81 transcript levels in
cultured astrocytes. The RNA interference culture system also facilitates the testing of specific
hypotheses. Decreases in the levels of Id2 and Cd81 lead to a decrease in wound-healing rates of
cultured astrocytes. We also determined that Id2 silencing leads to a decrease in wound-healing
rates by altering proliferation of cultured astrocytes. In contrast, the silencing of the cell mem-
brane gene Cd81 leads to a decrease of wound healing by altering the migration of cultured astro-
cytes [X. Wang and E. Geisert, personal observations]. Phenotypes from gene silencing experi-
ments often resembled phenotypes from cells obtained from mice with the null-mutation. Astro-
cytes from the Cd81-/- mice also display decreased wound-healing rates [X. Wang and E. Geis-
ert, personal observations]. Likewise, our observation that lower Id2 levels decrease proliferation
rates is consistent with data from neuronal precursor cells from the Id2-/- mice [Wang et al.,
2001]. These observations support the reliability of RNA interference to define the function of a
candidate gene in a specific cell type. The reductionist approach of RNA interference in cell cul-
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ture is valuable in identifying downstream and upstream targets [Berns et al., 2004]. Since ID2
can regulate proliferation and differentiation by regulating transcription, future experiments will
define the transcripts that are affected by Id2 silencing. As with any gain- or loss-of-function ex-
periments, the observations of cause and effect can be strengthen if the altered phenotype can be
reversed either by genetic means or pharmacological means. In the case of RNA interference, the
phenotype can be reversed by ectopic expression of the target gene. When testing of hypothesis
in cell culture, one must keep in mind that while cell culture systems offer direct cellular accessi-
bility and microenvironmental control, as well as efficient comparison between many experi-
mental conditions, they are in artificial environments that differ from the normal, complex tissue
environment. Nonetheless, in vitro systems are a reliable first line of testing that provides a feasi-
ble and cost-effective way to screen a list of candidate targets [Leveillard et al., 2004]. Moreover,
cell culture systems are also amenable to manipulation to determine the mechanisms of action.
In Vivo Testing
Powerful approaches to test candidate genes in animal models include the deletion or over ex-
pression of candidate genes, as well as, the rescue or introduction of candidate mutations. Re-
verse genetic approaches provide a powerful way to assess gene function, but interpretations
from transgenic models can be complicated by unintended complementation during development,
genetic background, and epigenetic influences. One clear example is the Rb gene. In humans a
mutation in this gene causes retinoblastoma. However in the mouse the Rb-null mutation fails to
produce retinoblastoma due to compensation by the other members of the RB family (p107 or
p130) [Dyer and Bremner, 2005]. Another concern with transgenic mice is the genetic back-
ground and flanking genes of the animals used for transgenics are important factors that can af-
fect the interpretation of the results [Wolfer et al., 2002]. Geisert and colleagues [2002] docu-
mented that when the null mutation of Cd81 is placed on different genetic backgrounds, there is a
remarkable range in the penetrance of the null allele phenotype, demonstrating that the mutation
can be affected by modifier loci. Reverse genetic approaches to determine the gene function dur-
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ing wound healing also need to consider that strains differ in their response to CNS injury. For
example, there are strains that display resistance to neurotoxic injury (C57BL/6, BALB/cJ,
129S1/SvImJ, C3H, ICR, SJL) and strains that are susceptible to neurotoxicity (DBA/2J, CD-1,
FVB/N, 129T2 Sv/EMS, and C57BL/10) [Inman et al., 2002]. Furthermore, functional conse-
quences of changes in gene activity are often asymmetric, meaning that the over expression and
the deletion of a gene may not yield opposite phenotypes. For example, the transgenic mice over-
expressing the antioxidant enzyme glutathione peroxidase 1 display increased tolerance to hyper-
oxia, whereas the mice lacking glutathione peroxidase 1 display no effects on animal survival
under hyperoxia [Ho et al., 1998]. These studies suggest the complexity of gene expression
regulation by genetic interactions and by mechanisms independent of nucleotide sequence (epi-
genetics).
Suggested Protocol
Based on our successes and failures we proposed the following protocol for determining and
testing candidate genes: (1) confirm transcript differential due to genetic background and injury;
(2) improve the power and resolution of genetic mapping by using new BXD RI strain set devel-
oped by Pierce and colleagues [2004]; (3) determine cellular co-localization of candidate gene
using in situ hybridization or immunohistochemistry, (4) examine the effect of gene silencing and
overexpression in the appropriate cell system and the appropriate functional assay; (5) determine
the candidate gene effect on wound healing using transgenics such as mice with gene knock-in
and null-mutations; and (6) if transgenics are not available or viable, the natural gene dosage of
the BXD RI strains can be used to supplement (and complement) the testing of candidate genes.
Of particular interest would be to compare perturbed transcriptional networks and wound-healing
response in segregating populations with those in single-gene perturbation experiments. This
method can address the weaknesses of forward and reverse genetic approaches [Mehrabian et al.,
2005]. Specifically, the segregating population (for example, the BXD RI strain set) is used to
define genetic networks associated with the complex regulation of wound healing. Single-gene
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perturbation experiments (for example, the Id2 or Lpin1 null mice) are used to define the effects
on specific transcriptional networks. The altered gene expression signature and wound-healing
response in transgenics is mapped back into the segregating population and interpreted in the
context where the complex trait had initially been observed. Additionally, cell culture systems
can help determine the direction of flow and the gene product interactions within the network.
Therefore, I propose that observations from different lines of experimental evidence are not mu-
tually exclusive but together can add to our understanding of gene expression regulation and their
relationship to the progression of wound healing.
Conclusion
The present series of studies defined global changes that occur after injury. They also defined a
genetic network that modulates the retinal wound healing response. Our data supports that the
chromosome 12 network intrinsically or extrinsically modulates early Muller cell activation.
The upstream regulator for this network is located on a locus of chromosome 12. Id2 and Lpin1
are current candidate modulators for the network as higher levels of Id2 and Lpin1 correlated
with higher levels of the survival genes, and with lower levels of reactive gliosis genes and
apoptotic genes. In this body of work, I have moved beyond cataloging changes in the transcrip-
tome to identifying candidate genes modulating the retinal response to injury. During this process
I developed an integrated approach of gene expression profiling and higher-level bioinformatic
analyses to define genetic networks. This work not only advances our understanding of the mo-
lecular networks controlling the CNS response to injury, but may also form the basis for inter-
ventions that can rescue injured neurons and re-establish lost CNS connections.
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Array design description
Array used: Affymetrix rat genome U34A (see details of this array at www.affymetrix.com)
Experimental design
1) Authors and contact information: Félix Vázquez-Chona, Bong K. Song, and Eldon E. Geisert,
Jr.
Eldon E. Geisert, Jr.
Department of Ophthalmology
University of Tennessee Health Science Center
855 Monroe Avenue
Memphis, Tennessee 38163, USA
Phone (901) 448-7740
Fax (901) 448-5028
Email: egeisert@utmem.edu
2) Type of experiment:
a. Expression of gene in normal retina vs. injured retina
b. Time course expression
3) Experimental factors:
a. Effect of injury on gene expression
b. Effect of survival time on gene expression
4) Number of hybridizations: 18
5) Quality controls:
a. The expression profiles (n = 18 arrays) met a strict set of quality-control parameters.
Housekeeping genes displayed consistent values and 5’ to 3’ ratios of less than 3.  The
average percentage of “Affymetrix present” calls across all arrays was 40.0 ± 1.1%.
The intensity profiles (log2 scale) for all the arrays showed a normal distribution with
a mean at 6.59 ± 0.04 and an average standard deviation (s2) of 2.32 ± 0.04.
Comparison of expression profiles among arrays from independent replicates of the
same experimental group (n = 3 arrays/group) showed a within-group average
correlation of 0.92 ± 0.01.
b. All arrays were done in triplicate with biological replicates (i.e., RNA from a separate
pool of animals).
c. Real-time PCR reactions validated results for the following genes: Fos, Fosl1 (Fra-1),
Il1b, Irf1, Cryab, Crygd, Cd81, and Gfap.
6) Description of experiments: We examined gene expression levels in the normal rat retina, and
injured rat retinas with 4 hours and 1, 3, 7, and 30 day survival time.
Sample description
1) Bio-source properties:
a. For gene expression studies, we used 36 adult male Sprague Dawley rats.
b. We anesthetized 36 experimental animals by intraperitoneal injection of a mixture of
xylazine (13 mg/kg) and ketamine (87 mg/kg), then induced a retinal tear in both eyes
of each rat.  For this purpose, we used a 27-gauge needle to penetrate the pars plana,
then scraped the superior temporal retina medially to laterally.  Care was taken to
prevent lens and sclera damage.
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c. Twelve control animals received no injury.
d. All animals were sacrificed by intraperitoneal injection of a mixture of xylazine (26
mg/kg) and ketamine (174 mg/kg).
2) Biomaterial manipulations:
a. We anesthetized 36 experimental animals by intraperitoneal injection of a mixture of
xylazine (13 mg/kg) and ketamine (87 mg/kg), then induced a retinal tear in both eyes
of each rat.  For this purpose, we used a 27-gauge needle to penetrate the pars plana,
then scraped the superior temporal retina medially to laterally.  Care was taken to
prevent lens and sclera damage.
b. Experimental animals were split in groups of 6 and had survival times of 4 hours and
1, 3, 7, and 30 days.
c. Twelve control animals received no injury.
d. Control and injured animals were sacrificed by intraperitoneal injection of a mixture
of xylazine (26 mg/kg) and ketamine (174 mg/kg).
e. Retinas used for expression studies were dissected and examined under a
stereomicroscope, SXZ12 (Olympus, Japan), and immediately processed.
3) Extract preparation: For total RNA extraction, we used the TRIzol method (Life
Technologies, Carlsbad, CA) and confirmed the integrity of RNA with the Agilent 2100
bioanalyzer (Agilent Technologies, Palo Alto, CA).
4) cDNA synthesis, labeling, and hybridization:
a. Using Genome Explorations (Memphis, TN), we synthesized, labeled, and hybridized
cRNA onto arrays according to standard Affymetrix (Santa Clara, CA) methods
previously described by Rogojina et al. in Mol Vis. (2003) 9:482-96.
b. For additional information on hybridization procedures and reagents please visit
www.affymetrix.com.
Data analysis
1) Measurements: We scanned arrays on the Agilent Gene Array scanner (Affymetrix).
2) Image analysis: We measured gene expression levels with Microarray Suite 5.0 (MAS 5.0;
Affymetrix) using a target signal of 250.  For details on the MAS 5.0 algorithms please see
www.affymetrix.com.  We also obtained Robust Multi-array Average (RMA) values using
RMAexpress (http://stat-www.berkeley.edu/~bolstad/RMAExpress/RMAExpress.html).  For
details on RMA algorithms please see Irizarry RA, et al. (2003) Nucleic Acids Res. 31:e15.
3) Transformation and Normalization:  The most widely used alternative transformation of the
signals and ratios is the logarithm base 2, which has the advantage of producing a continuous
and broad spectrum of values and treating up- and downregulated genes in a similar fashion
[Quackenbush J, (2001) Nat Rev Genet. 2:418].  For temporal analysis of the data and
comparison between data extraction methods, the mean intensity for each microarray was
normalized to 8 (log2 scale).  Total intensity normalization is a well-established method to
normalize microarrays [Quackenbush J, (2001) Nat Rev Genet. 2:418; Di Giovanni S et al.
(2003) Ann Neurol. 53:454].  These transformations yielded MAS 5.0 signal intensities
ranging from 1 to 18 relative units of fluorescence.
4) Data filtering:  To determine a “present” signal threshold in our system, we plotted the
coefficient of variation versus the averaged signal value and determined the threshold signal
yielding stable coefficients of variation.  From this analysis, the “present” signal threshold
was set at 8.64.  Below this threshold, signals displayed coefficients of variation greater than
10%, while their variance increased exponentially (Supplemental Fig. 2.1).  Using this
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criterion, 4,480 (50.9%) of the genes met the “present” criterion in at least one condition and
were considered for further analysis.
5) Normalized MAS 5.0 and RMA comparison: We compared the “present” and normalized
MAS 5.0 signals to RMA values and found an average correlation of 0.92 ± 0.01 (Table B.3).
This result is consistent with studies comparing the standard deviation of RMA and MAS 5.0
to absolute expression [Fig. 1 in Irizarry RA, et al. Nucleic Acids Res. 2003;31:e15].  We also
compared the MAS 5.0, RMA, and RT-PCR fold changes for Fos, Fosl1 (Fra-1), Il1b, Irf1,
Cryab, Crygd, Cd81, and Gfap at 4 hours, 3 days and 30 days after injury (Table 3 within
paper).  For these genes, fold changes measured with normalized MAS 5.0 and RMA values
were highly similar (r = 0.89).  Both MAS 5.0 and RMA fold changes were similar in
magnitude and direction to fold changes obtained with RT-PCR.  However, RT-PCR fold
changes had higher correlations with normalized MAS 5.0 (r = 0.76) than with RMA (r =
0.58).  Together, the high correlation between normalized MAS 5.0 values and RMA values,
and the similarity between microarray fold changes and RT-PCR fold changes, confirm the
reliability of our “present” signals, which eliminate genes with low expression signals.  Thus,
we have used the normalized MAS 5.0 values for our subsequent analysis.
6) Differentially expressed genes:  We used several statistical tools and stringent criteria to
identify differentially expressed genes.  First, we eliminated genes with low expression values
from our analysis.  Previous studies comparing MAS 5.0 results to serial analysis of gene
expression (SAGE) results have shown that MAS 5.0 and SAGE reliably detect medium- to
high-abundance transcripts in complex tissues like the brain [Evans SJ, et al. (2002) Eur J
Neurosci. 16:409].  Our criterion for selecting reliable (i.e., present) signals for further
analysis is described in the Results section under the heading Data extraction and
normalization.  Second, we considered a gene as differentially expressed if the fold change
was > 1.7 and if the change was significant at the P < 0.02 level using Student’s t-test (Table
2).  Third, we determined the expected proportion of significant changes by using the false
discovery rate (FDR) of Benjamini and Hochberg (Table 2).  The average FDR for our
injured vs. control comparisons was 21 ± 5.1%.  This FDR level is consistent with studies in
our lab comparing the reliability of MAS 5.0 signals to detect true biological changes
[Rogojina A, et al. (2003) Mol Vis. 9:482].  Fourth, to further eliminate false positives we
present only genes whose expression pattern have well-defined pattern across 5 survival times
(4 hours, and 1, 3, 7, and 30 days; Fig. 2.2; Tables B.4 and B.5).  Thus, looking at genes that
are clustered (i.e., cooexpressed) decreases further the potential for false positives [Heyer LJ,
et al. 1999 Genome Res. 9:1106].
Availability of microarray data
The raw MAS 5.0 data set is publicly available at Gene Expression Omnibus (GEO,
www.ncbi.nlm.nih.gov/geo/), a gene expression and hybridization array data repository.  A list of
experimental conditions, samples and GEO accession numbers is provided in Table B.1.
141
Appendix B
Supplemental Material For Chapter 2
142
Table B.1. Experimental conditions, samples, and GEO accession numbers.
Experimental
condition
Sample and
array code
Accession No.
Control EEG034 GSM15760
EEG036 GSM15761
EEG094 GSM15762
4h injury EEG078 GSM15763
EEG081 GSM15764
EEG082 GSM15765
1d injury EEG076 GSM15766
EEG079 GSM15768
EEG080 GSM15769
3d injury EEG069 GSM15770
EEG070 GSM15772
EEG075 GSM15773
7d injury EEG011 GSM15779
EEG012 GSM15780
EEG077 GSM15781
30d injury EEG018 GSM15782
EEG019 GSM15783
EEG093 GSM15784
The raw MAS 5.0 data set is publicly available at Gene Expression Omnibus (GEO,
www.ncbi.nlm.nih.gov/geo/) under the GEO accession numbers listed here and as the group
series GSE1001.  Each sample represents a biological replicate with eyes pooled from 2 animals.
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Table B.2. Oligonucleotides used for real-time RT-PCR.
Gene Accession No. Sequence (5¢Æ3¢) Product (bp)
Fos XM_234422 AGAATCCGAAGGGAAAGGAA 319
GGTCATTGAGAAGAGGCAGG
Fosl1 NM_012953 GGATGGTGCAGCCTCATTT 273
CATCCTCCAACTTGTCGGTC
Il1b NM_031512 ACCCAAGCACCTTCTTTTCC 149
AGACAGCACGAGGCATTTTT
Irf1 NM_012591 CAGGGCTGAGCTGGATCAAT 103
CGGAACAGACAGGCATCCTT
Cryab NM_012935 TCCTTTCCACTCCCCAAG 176
TGTCCTTCTCCATACGCATC
Crygd NM_033095 AGCAGTGGATGGGTTTCAG 152
GTGGAATCGGTCCTGGAG
Cd81 XM_346575 CTGTTTGCCTGTGAGGTAGC 196
TCAGTGTGGTCAGCGTATTG
Gfap NM_017009 AGGGACAATCTCACACAGGAC 162
CTCCAGCGACTCAACCTTC
Rps18 XM_215328 CTCGCTCCTCTCCTACTTGG 119
ACCGGGTTGGTTTTGATCT
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Figure B.1. Effect of expression level on coefficient of variation. To determine a “present” signal
threshold in our system, we plotted the coefficient of variation versus the averaged signal value
and determined the threshold signal yielding stable coefficients of variation.  From this analysis,
the “present” signal threshold was set at 8.64.  Below this threshold, signals displayed
coefficients of variation greater than 10%, while their variance increased exponentially.  Using
this criterion, 4,480 (50.9%) of the genes met the “present” criterion in at least one condition and
were considered for further analysis.
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Table B.3. Correlation between normalized MAS 5.0 and RMA signals.
Experiment Correlation
Ctrl 0.91
4h 0.91
1d 0.92
3d 0.93
7d 0.91
30d 0.93
Average 0.92 ± 0.01
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Table B.4. Gene clusters in the injured retina.
Fold Change
C
tr
l
4h 1d 3d 7d 30
d
Symbol Response Early Delayed Late ProbsetID
1 Pak3 Early 6.0 3.9 2.9 rc_AA997367_s_at
2 Pde4b Early 1.8 1.8 1.7 rc_AA799729_g_at
3 Plat Early 7.8 2.5 1.9 M23697_at
4 Cebpd Early 2.5 2.2 3.0 M65149_at
5 RT-BM1 Early 2.1 2.0 2.1 AF029240_g_at
6 Krt1-14* Early 2.4 2.0 2.5 rc_AI639415_at
7 Akap12 Early 2.3 1.1 1.6 U41453_at
8 Nfkb1 Early 3.8 1.7 2.0 L26267_at
9 Cxcl10 Early 5.5 1.0 2.9 U17035_s_at
10 Btg2 Early 2.6 1.2 1.6 M60921_g_at
11 Zfp36l1 Early 2.5 1.5 1.7 rc_AI136891_at
12 Ssecks322 Early 3.6 2.0 1.6 U75404UTR#1_s_at
13 Il6r Early 2.1 1.3 1.4 M58587_at
14 Kcnj1 Early 1.9 1.2 1.1 S78154_at
15 EST Early 1.8 1.3 (1.2) rc_H33084_at
16 Cbfb Early 2.0 1.5 1.2 AF087437UTR#1_s_at
17 Igfals Early 2.0 1.5 1.0 S46785_at
18 Nr4a1 Early 2.4 (1.6) (1.6) U17254_g_at
19 Mat2a Early 3.0 1.5 (1.0) J05571_s_at
20 Arhgap7 Early 2.4 1.3 1.2 D31962cds_at
21 PDP1 Early 1.9 1.5 1.0 AF062740_at
22 Egr1 Early 3.4 (2.9) (3.4) rc_AI176662_s_at
23 Fos Early 2.6 (1.1) (1.1) X06769cds_g_at
24 Ugt1a7 Early 1.9 1.7 1.2 AF039212mRNA_s_at
25 Ndufa6* Early 1.7 1.3 1.1 rc_AI229924_at
26 EST Early 1.7 1.7 1.2 U21721mRNA_at
27 Cd36l2 Early 1.7 1.4 1.2 D10587_at
28 Qpct Early 2.5 1.5 (1.0) AF039308_at
29 Mak Early 2.0 1.8 1.3 M35862_at
30 Egr1 Early 6.6 (1.3) (1.7) U75397UTR#1_s_at
31 Slc2a3 Early 2.6 1.4 1.2 D13962_g_at
32 Insig1 Early 2.5 1.4 1.2 L13619_g_at
33 EST Early 2.6 (1.9) (1.8) X03347cds_g_at
34 Cst4 Early 2.5 1.8 1.3 M75281_at
35 Crem Early 2.9 (1.2) (1.4) U04835_at
36 Nup153 Early 2.1 1.8 (1.2) rc_AI177052_at
37 Insig1 Early 2.0 1.2 1.1 L13619_at
38 Jag1 Early 2.9 1.4 1.0 L38483_at
39 Stc1 Early 5.0 1.6 1.1 U62667_at
40 AF-6 Early 2.0 1.2 1.3 rc_AA859702_at
41 Gnaq Early 2.1 1.3 1.3 Y17164UTR#1_at
42 Drd5 Early 1.8 1.4 1.1 M69118cds_at
43 Gucy2e Early 2.6 1.7 1.5 L36029_at
44 p65 Early 2.7 1.7 1.3 X52772cds_at
45 ESTs Early 2.2 1.8 1.5 rc_H31078_at
46 PLA2IR Early 2.3 1.4 1.2 D30781_at
47 Fosl1 Early 41.9 1.6 (1.0) M19651_at
48 Zfp36l1 Early 2.3 1.1 1.4 rc_AI112516_at
49 EST Early 2.0 1.3 1.6 rc_AI176491_at
50 Pex11a Early 2.1 1.8 1.6 AJ224120_at
51 Atf3 Early 3.3 1.3 1.7 M63282_at
52 Pde4b Early 2.2 1.8 1.5 M25350_s_at
53 Igf1 Early 2.1 1.6 1.4 M15481_g_at
54 Mt1a Early 2.0 (1.3) 1.1 rc_AI102562_at
55 Cish3 Early 5.7 3.0 1.9 AF075383_at
56 Ctsl Early 2.4 2.1 1.4 S85184_g_at
57 ESTs Early 1.8 1.6 1.3 rc_AA875633_at
58 Bax Early 1.9 1.4 1.7 S78284_s_at
59 Rnf4 Early 1.8 2.0 1.2 AF022081_at
60 Tpm3 Early 3.8 2.2 1.7 L24776_at
61 Camk2d Early 2.4 2.5 1.2 rc_AI009268_at
62 Prkacb Early 3.1 2.7 1.6 D10770_s_at
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Table B.4. (continued). Gene clusters in the injured retina.
Fold Change
C
tr
l
4h 1d 3d 7d 30
d
Symbol Response Early Delayed Late ProbsetID
63 Ttgn1 Delayed 1.7 2.2 1.3 X53565_at
64 Vcam1 Delayed† 5.1 14.0 7.6 M84488_at
65 EST Delayed 2.0 2.6 1.1 rc_AI236484_at
66 Il1b Delayed† 3.9 2.4 1.7 M98820_at
67 P2ry4 Delayed† 6.6 4.4 4.2 Y11433_s_at
68 Tubb1 Delayed 1.2 2.3 1.5 AB011679_at
69 EST Delayed 1.5 2.0 1.6 rc_AA893743_g_at
70 Agtpbp1* Delayed 1.3 3.7 2.2 rc_AA891864_at
71 Stat3 Delayed† 5.2 3.7 2.1 X91810_at
72 Dnajb9 Delayed 1.7 2.5 1.2 rc_AI011998_at
73 Pros1 Delayed 1.3 2.9 1.5 U06230_s_at
74 Irf1 Delayed 3.8 3.8 3.0 M34253_g_at
75 Ywhae Delayed 2.2 2.5 1.1 rc_AA965154_at
76 Lcn2 Delayed 9.8 35.5 28.0 rc_AA946503_at
77 Ptn Delayed 1.6 2.5 2.2 rc_AI102795_at
78 A2m Delayed 27.9 54.7 43.0 M22670cds_at
79 Itgb1 Delayed 2.1 3.9 2.4 rc_AI177366_at
80 D123 Delayed 1.8 2.1 1.5 U34843_g_at
81 Dlg1 Delayed 1.6 4.3 1.9 U14950_at
82 Arl5 Delayed 2.1 2.4 1.5 rc_AA875135_at
83 Crot Delayed 1.6 2.9 1.4 U26033_at
84 Cox7a Delayed 2.8 2.6 1.6 U75927UTR#1_at
85 Ywhaq Delayed 2.8 2.8 1.5 rc_AI229407_at
86 Ctsc Delayed 1.5 4.1 2.2 D90404_g_at
87 Akap11 Delayed 1.9 2.8 1.4 U48288_at
88 unr Delayed 2.7 3.0 1.6 rc_AA957961_at
89 Cntn1 Delayed 2.2 3.3 1.6 D38492_at
90 Eif5 Delayed 2.6 3.0 1.4 K01677_at
91 EST Delayed 1.8 2.4 1.6 rc_AI639367_at
92 Lman1 Delayed 2.0 3.1 1.5 U44129_at
93 Ania4 Delayed 8.4 7.8 2.7 AF030089UTR#1_at
94 Lamp2 Delayed 1.8 3.3 1.9 D90211_s_at
95 Litaf Delayed 3.7 5.5 4.1 U53184_at
96 Pik3r3 Delayed 3.1 3.4 2.5 D64047_at
97 Eef1a2 Delayed 3.4 4.9 1.9 rc_AI008852_at
98 EST Delayed 2.6 4.5 2.0 rc_AA892522_at
99 Casp3 Delayed 1.8 4.6 1.9 U49930_at
100 Gludins Delayed 3.1 4.6 1.8 D11439_s_at
101 Casp3 Delayed 3.2 6.9 3.0 U84410_s_at
102 IMPG2 Delayed 3.5 6.0 2.1 U76717_at
103 Gp38 Delayed 2.4 3.7 2.2 U92081mRNA_s_at
104 EST Delayed 1.3 1.8 1.5 rc_AA800016_at
105 Vhl Delayed 1.2 1.8 1.5 U14746_at
106 Arl1 Delayed 1.2 2.0 1.4 rc_AA875253_at
107 Sv2b Delayed 1.3 1.7 1.4 rc_AI639484_at
108 EST Delayed 1.3 1.8 1.6 rc_AA866369_at
109 EST Delayed 1.2 2.0 1.3 rc_AA891978_at
110 Impa1 Delayed 1.3 2.4 1.6 rc_AA801286_at
111 Plrg1 Delayed 1.4 2.2 1.5 rc_AI639353_at
112 Inpp4 Delayed 1.3 1.8 1.1 U96921_at
113 Gif Delayed 1.9 4.1 2.0 D45199cds_s_at
114 Fuca Delayed 1.4 2.3 1.9 X16145_at
115 Nap1l1 Delayed 1.4 2.6 1.8 rc_AA859920_at
116 Ap3m1 Delayed 1.5 2.2 1.3 L07073_at
117 EST Delayed 1.3 2.1 1.6 rc_AA800034_at
118 EST Delayed (1.2) 1.9 1.5 rc_AA859933_at
119 Abi2 Delayed 1.2 1.8 1.8 U94904_s_at
120 EST Delayed 1.8 2.1 1.4 rc_AA891220_at
121 EST Delayed (1.0) 1.7 1.5 rc_AA892270_g_at
122 Cd82 Delayed† 1.0 1.8 1.4 rc_AI231213_at
123 P4hb Delayed† 1.1 1.7 1.5 X02918_at
124 Ppp2rb Delayed 1.2 2.2 1.5 rc_AI103238_at
125 Lim2 Delayed† 1.1 2.5 2.0 S55224_s_at
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Table B.4. (continued). Gene clusters in the injured retina.
Fold Change
C
tr
l
4h 1d 3d 7d 30
d
Symbol Response Early Delayed Late ProbsetID
126 RT1Aw2 Late† (1.0) 2.0 1.9 M24026_f_at
127 Lhx2 Late† (1.7) 2.3 1.7 L06804_at
128 Lip1 Late† (1.1) 3.4 2.0 S81497_s_at
129 Lip1 Late (1.5) 2.4 1.9 S81497_i_at
130 Tpm3 Late 1.5 2.0 1.9 S82383_s_at
131 Hsd17b4 Late 1.1 2.0 1.9 rc_AI013834_s_at
132 Cp Late† 2.1 13.3 5.9 rc_AA817854_s_at
133 Gtpi* Late† 2.1 11.4 5.3 rc_AA891944_at
134 Mx3 Late† 2.7 4.8 8.7 X52713_at
135 Fcgr3 Late† 1.7 11.5 6.0 M32062_g_at
136 Anxa5 Late† 1.4 2.7 2.3 D42137exon_s_at
137 Cd82 Late† 1.3 3.1 2.2 rc_AI231213_g_at
138 Spin2c Late 2.8 32.9 8.7 D00753_at
139 EST Late 1.1 1.5 1.7 rc_AA800199_at
140 Cntf Late 1.5 3.0 2.6 rc_AA892559_at
141 Snn Late (1.1) 1.7 2.0 M81639_at
142 Aprt Late 1.7 3.2 3.1 rc_AI177096_at
143 Gsta1 Late 1.5 2.3 2.5 S72505_f_at
144 Prkr Late 1.3 3.7 2.6 L29281_at
145 Cd81 Late 1.1 1.8 1.8 rc_AI103957_g_at
146 Sparc Late 2.0 5.5 5.8 rc_AA891204_s_at
147 Sparc Late 1.6 3.3 3.3 Y13714_at
148 Mgp Late 1.3 3.0 5.5 rc_AI012030_at
149 Slc1a4 Late 1.1 2.8 3.1 S59158_at
150 Lyz Late 4.8 37.4 31.3 rc_AA892775_at
151 Idh2 Late 1.0 2.0 1.9 rc_AA891785_g_at
152 Arpc1b Late 1.4 4.1 3.2 AF083269_g_at
153 Slc25a20 Late (1.3) 2.0 1.8 rc_AA800120_at
154 Ctsh Late (1.0) 2.5 2.4 M38135_at
155 Fcgr3 Late 1.9 18.9 13.6 M32062_at
156 Cp Late 2.0 10.2 9.4 L33869_at
157 Apoe Late 1.1 1.8 2.7 X04979_at
158 RT1.Da u Late 3.2 14.0 13.9 M15562_g_at
159 Pmp22 Late (1.1) 1.8 2.0 S55427_s_at
160 Pap2b Late (1.3) 4.9 3.5 rc_AA924925_at
161 C1s Late (9.1) 3.8 3.9 D88250_at
162 Apobec1 Late (1.7) 11.8 5.7 L07114_at
163 Cd9 Late 1.1 2.7 2.5 X76489cds_g_at
164 RT1.Da u Late 1.3 6.1 4.7 M15562_at
165 Ctss Late (1.1) 2.6 5.8 L03201_at
166 Cryba1 Late 1.1 6.0 6.2 AF013248_at
167 Cd48 Late (1.3) 5.3 3.8 X13016_at
168 Snca Late 1.5 2.4 2.6 S73007_g_at
169 Cryab Late 1.6 6.3 7.4 X60351cds_s_at
170 C1r Late (1.1) 4.2 5.0 rc_AA799803_at
171 RT1.Mb Late (1.3) 6.4 5.7 rc_AI171966_at
172 Crygd Late (1.8) 5.0 15.1 X57169_f_at
173 Cryge Late (1.4) 3.6 9.0 M19357cds_f_at
174 A2m Late 2.0 5.4 6.1 M23566exon_s_at
175 Ppicap Late (1.1) 2.5 2.8 AF065438_at
176 A2m Late 1.4 5.7 5.9 rc_AA900582_at
177 Crygd Late (1.4) 7.9 29.6 X57169_i_at
178 Ptgfr Late 1.5 4.8 6.0 rc_AI170268_at
179 Gfap Late 1.4 7.8 16.8 AF028784cds#1_s_at
180 Crybb2 Late 1.3 7.4 14.7 X83671cds_i_at
181 Bfsp1 Late (1.1) 20.1 27.7 AB003104_at
182 Cryaa Late 1.0 6.5 8.3 U47921_s_at
183 Grifin Late 1.1 11.1 13.9 AF082160_at
184 C1qb Late 1.1 29.1 72.6 X71127_g_at
185 RT1.C/E Late 1.2 3.5 5.1 rc_AI235890_s_at
186 Gfap Late 1.3 10.4 19.1 AF028784mRNA#1_s_at
187 Cd74 Late (1.0) 18.5 37.2 X14254cds_g_at
188 mrf-1* Late (1.3) 13.3 33.7 U10894_s_at
189 C3 Late (5.8) 8.2 33.6 M29866_s_at
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Supplementary Table B.4. (continued).  Upregulated genes and their clusters
Fold Change
C
tr
l
4h 1d 3d 7d 30
d
Symbol Response Early Delayed Late ProbsetID
190 C3 Late (4.9) 5.4 17.0 X52477_at
191 Crybb2 Late (1.2) 6.7 13.3 X16072_at
192 Clu Late 1.4 3.0 3.9 M64733mRNA_s_at
193 Scyb13* Late 2.7 3.7 17.3 rc_AA892854_at
194 Dpysl4 Late 1.5 2.0 3.1 U52103_at
Upregulated genes (fold change > 1.7 and P < 0.02) were clustered with CLUSFAVOR 6.0
[Peterson, 2002] using principal component analysis.  Using the first 3 components (at least 98%
of the variability) and correlations ≥ ± 0.6, we identified 3 major responses: the early, delayed,
and late, sustained response.  The early fold change represents the expression change at 4 hours.
The delayed fold change corresponds to the average change at 1 and 3 days.  The late change is
the averaged fold change at 7 and 30 days.  Values in parentheses represent negative fold
changes.
* Expressed sequence tags (ESTs) whose identity was defined by gene homology.
† Clustered genes whose correlations were high on adjacent clusters.
Shades of color represent standardized levels of expression as follows:
-1.6 -1.4 -1.2 -1.00 -0.8 -0.6 -0.4 -0.2 -0 +0 0.20 0.40 0.6 0.8 1.0 1.2 1.4 1.6
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Table B.5. Gene functional clusters in injured retina
Fold Change
Symbol Name GenBank Cluster† Early Delayed Late
1 Transcription
Atf3 Activating transcription factor 3 M63282 E 3.3 1.3 1.7
Cbfb Core binding protein beta AF087437 E 2.0 1.5 1.2
Cebpd CCAAT/enhancer binding protein delta M65149 E 2.5 2.2 3.0
Crem CAMP responsive element modulator U04835 E 2.9 (1.2) (1.4)
Egr1 Early growth response 1 (Krox-24) AI176662 E 3.4 (2.9) (3.4)
Fos c-fos X06769 E 2.6 (1.1) (1.1)
Fosl1 Fos-like antigen 1 (Fra-1) M19651 E 41.9 1.6 (1.0)
Irf1 Interferon regulatory factor 1 M34253 D 3.8 3.8 3.0
Isl1 ISL1 transcription factor S69329 E 1.7 1.7 1.7
Lhx2 LIM homeobox protein 2 L06804 D, L (1.7) 2.3 1.7
Nfkb1 Nuclear factor kappa B p105 L26267 E 3.8 1.7 2.0
Nr4a1 Nuclear receptor subfamily 4a1 U17254 E 2.4 (1.6) (1.6)
Plrg1 Pleiotropic regulator 1 AI639353 D 1.4 2.1 1.5
Rnf4 Ring finger protein 4 AF022081 E 1.8 2.0 1.2
Stat3 Stat3 X91810 D 5.2 3.7 2.1
Zfp36l1 Zinc finger protein 36, C3H type-like 1 AI136891 E 2.5 1.5 1.7
2 Cell cycle and growth
Abi2 abl-interactor 2 U94904 D 1.2 1.8 1.8
Akap11 A kinase anchor protein 11 U48288 D 1.9 2.7 1.4
Akap12 A kinase anchor protein 12 U41453 E 2.3 1.1 1.6
Arhgap7 Rho GTPase activating protein 7 D31962 E 2.4 1.3 1.2
Btg2 B-cell translocation gene 2 M60921 E 2.6 1.2 1.6
Cd82 Cd82 (Kai1) AI231213 D, L 1.3 3.1 2.2
D123 Cell cycle related D123 U34843 D 1.8 2.1 1.5
Dlg1 Discs-large homolog 1 U14950 D 1.6 4.3 1.9
Igf1 Insulin-like growth factor 1 M15481 E 2.1 1.6 1.4
Igfals IGF binding protein complex acid-labile S46785 E 2.0 1.5 1.0
Insig1 Growth response protein CL-6 L13619 E 2.5 1.4 1.2
Itgb1 Integrin, beta 1 AI177366 D 2.1 3.8 2.4
Lcn2 Lipocalin 2 AA946503 D 9.8 35.5 28.0
Nap1l1 Nucleosome assembly protein 1-like 1 AA859920 D 1.4 2.6 1.8
Pak3 p21 CDKN1A activated kinase 3 AA997367 E 6.0 3.9 2.9
Ppap2b Phosphatidic acid phosphatase type 2B AA924925 L (1.3) 4.9 3.5
Prkr interferon-inducible Eif2ak2 L29281 L 1.3 3.7 2.6
Ptn Pleiotrophin (Hbnf) AI102795 D 1.6 2.5 2.2
Ssecks322 Src- and ras-suppressed gene, 322 U75404 E 3.6 2.0 1.5
Vhl Von Hippel-Lindau syndrome U14746 D 1.2 1.8 1.5
Ywhae 14-3-3E AA965154 D 2.2 2.5 1.1
Ywhaq 14-3-3Q AI229407 D 2.8 2.8 1.5
3 Apoptosis and cell death
Apobec1 Apolipoprotein B editing protein L07114 L (1.7) 11.8 5.7
Bax Bcl2-associated X protein S78284 E 1.9 1.4 1.7
Casp3 Caspase 3 U49930 D 1.8 4.6 1.8
Ctsl Cathepsin L S85184 E 2.4 2.1 1.4
Eef1a2 Euk. translation elongation factor 1a2 AI008852 D 3.4 4.9 1.9
Litaf LPS-induced TNF-alpha factor U53184 D 3.7 5.5 4.1
Mx3 Myxovirus resistance 3 X52713 D, L 2.7 4.8 8.7
Tnfrsf21* TNF receptor 21 * AA891842 D 1.2 1.6 2.0
Vdac1 Voltage-dependent anion channel 1 AF048828 E, L 1.7 1.2 1.8
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Table B.5. (continued). Gene functional clusters in injured retina
Fold Change
Symbol Name GenBank Cluster† Early Delayed Late
4 Immune/inflammation/Stress
C1qb Complement component 1qb X71127 L 1.1 29.1 72.6
C1r Complement component 1r* AA799803 L (1.1) 4.2 5.0
C1s Complement component 1s D88250 L (9.1) 3.8 3.9
C3 Complement component 3 X52477 L (4.9) 5.4 17.0
Cd48 Cd48 X13016 L (1.3) 5.3 3.8
Cd74 Cd74 X14254 L (1.0) 18.5 37.2
Cish3 Cytokine inducible SH2-containing 3 AF075383 E 5.7 3.0 1.8
Cst4 Cystatin S M75281 E 2.5 1.8 1.2
Ctsc Cathepsin C D90404 D 1.5 4.1 2.2
Cxcl10 Chemokine (C-X-C motif) ligand 10 U17035 E 5.5 1.0 2.9
Dnajb9 DnaJ (Hsp40) homolog, subfamily b9 AI011998 D 1.7 2.5 1.2
Edn2 Endothelin-2 U59510 L 2.1 2.9 5.1
Fcgr3 Fc receptor IgG, low affinity 3 M32062 D, L 1.9 18.9 13.6
Fcgr3 Fc receptor IgG, low affinity 3 M32062 D, L 1.7 11.5 6.0
Gsta1 Glutathione-S-transferase, alpha 1 S72505 L 1.5 2.3 2.5
Gtpi* Interferon-g induced GTPase* AA891944 D, L 2.1 11.4 5.3
Hspa1a Heat shock 70kD 1A AA818604 L 1.6 1.7 2.1
Ifitm3l Interferon induced transmembrane 3l X61381 D, L 2.4 4.3 3.9
Il1b Interleukin 1, beta M98820 D 3.9 2.4 1.7
Il2rb Interleukin 2 receptor beta (CD122) M55050 E 5.5 1.3 3.8
Il6r Interleukin 6 receptor M58587 E 2.1 1.2 1.4
Lman1 Lectin mannose-binding 1 U44129 D 2.0 3.1 1.5
Mt1a Metallothionein AI102562 E 2.0 (1.3) 1.1
Pros1 Protein S U06230 D, 1.3 2.9 1.5
Ptgs2 Prostaglandin synthase 2 (COX-2) S67722 E 2.1 (2.6) (3.2)
RT1.C/E MHC class Ib (RT1.C/E) AI235890 L 1.2 3.5 5.1
RT1.Da u MHC class IIa RT1.u-D-alpha M15562 L 3.2 14.0 13.9
RT1.Mb MHC class II DM beta AI171966 L (1.3) 6.4 5.7
RT1Aw2 MHC class Ib alpha M24026 D, L (1.0) 2.0 1.9
RT-BM1 MHC class Ib BM1k antigen AF029240 E 2.1 2.0 2.1
Scyb13 * Small inducible cytokine B13* AA892854 L 2.7 3.7 17.3
Snn Stannin M81639 L (1.1) 1.7 2.0
Sod2 Superoxide dimutase 2 mitochondrial Y00497 E 2.6 2.0 1.8
5 Neural development/degeneration & Gliosis
A2m Alpha-2-macroglobulin AA900582 D, L 1.4 5.7 5.8
Ania4 Activity & neurotransmitter-induced 4 AF030089 D 8.4 7.8 2.7
Anxa5 Annexin V D42137 L 1.4 2.7 2.3
Apoe Apolipoprotein E X04979 L 1.1 1.7 2.7
Cd81 Cd81 (TAPA) AI103957 L 1.1 1.8 1.8
Clu Clusterin M64733 L 1.4 3.0 3.9
Cntf Cntf AA892559 L 1.5 3.0 2.6
Cntn1 Contactin 1 D38492 D 2.2 3.3 1.6
Cp Ceruloplasmin (ferroxidase) L33869 L 2.0 10.2 9.4
Cryab Crystallin alpha B M55534 L 1.9 6.0 4.7
Cstb Cystatin beta AI008888 E 1.5 1.7 1.3
Dpysl4 Dihydropyrimidinase-like 4 (Crmp3) U52103 L 1.5 2.0 3.1
Drd5 Dopamine receptor D5 M69118 E 1.8 1.4 1.1
Gfap Gfap AF028784 L 1.4 7.8 16.8
Jag1 Jagged 1 L38483 E 2.9 1.4 1.0
mrf-1* Microglia response factor (Aif1)* U10894 L (1.3) 13.3 33.7
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Table B.5. (continued). Gene functional clusters in injured retina
Fold Change
Symbol Name GenBank Cluster† Early Delayed Late
Ninj1 Ninjurin U72660 D 1.3 1.5 1.4
Pea15 Phosphoprotein in astrocyte 15 AA894345 L 1.0 1.4 1.8
Pmp22 Peripheral myelin protein 22 (Gas-3) S55427 L (1.1) 1.8 2.0
S100a1 S100 A1 U26356 L 1.3 1.3 1.7
Snca Synuclein 1 S73007 L 1.5 2.4 2.5
Sparc Sparc (osteonectin) AA891204 L 2.0 5.5 5.8
Spin2c Serine protease inhibitor D00753 L 2.8 32.9 8.7
Vcam1 Vcam 1 M84488 D 5.1 14.0 7.6
6 Structure & Tissue remodeling
Arpc1b Actin-related protein complex 1b AF083269 L 1.4 4.1 3.2
Bfsp1 Filensin AB003104 L (1.1) 20.1 27.7
Ctsh Cathepsin H M38135 L (1.0) 2.5 2.4
Ctss Cathepsin S L03201 L (1.1) 2.6 5.8
Fmod Fibromodulin X82152 L 1.2 3.9 5.4
Fuca Fucosidase alpha-L-1 tissue X16145 D, L 1.4 2.3 1.9
Grifin Galectin-related inter-fiber AF082160 L 1.1 11.1 13.9
IMPG2 Proteoglycan 10.2 U76717 D 3.5 6.0 2.1
Krt1-14* Keratin complex-1, acidic, gene 14* AI639415 E 2.4 1.9 2.5
Lim2 Lens intrinsic membrane protein 2 S55224 D 1.1 2.5 2.0
Lip1 Lysosomal acid lipase S81497 D, L (1.5) 2.4 1.8
Lyz Lysozyme AA892775 L 4.8 37.4 31.3
Mgp Matrix Gla protein AI012030 L 1.3 3.0 5.5
Myo5b Myosin Vb U60416 L 2.2 2.7 2.2
Nedd4a Ubiquitin ligase U50842 L 1.5 1.9 1.9
Plat Plasminogen activator tissue M23697 E 7.8 2.5 1.9
Tpm3 Tropomyosin 3 gamma L24776 E 3.8 2.2 1.7
Tpm3 Tropomyosin isoform 3 S82383 L 1.5 2.0 1.9
Tubb1 Tubulin, beta 5 AB011679 D 1.2 2.3 1.5
7 Crystallins
Cryaa Crystallin alpha A U47921 L 1.0 6.5 8.3
Cryab Crystallin alpha B M55534 L 1.9 6.0 4.7
Cryba1 Crystallin beta A1/A3 AF013248 L 1.1 6.0 6.2
Cryba4 Crystallin beta A4§ AF013247 (1.1) 5.9 8.8
Crybb1 Crystallin beta B1§ X06377 (1.2) 6.5 7.2
Crybb2 Crystallin beta B2 X83671 L 1.3 7.4 14.7
Crybb3 Crystallin beta B3§ M15901 1.3 4.9 7.4
Crygc Crystallin gamma C§ J00717 (1.6) 5.6 14.3
Crygd Crystallin gamma D X57169 L (1.8) 5.0 15.1
Cryge Crystallin gamma E M19357 L (1.4) 3.6 9.0
Differentially expressed genes that met the clustering criteria (see Figure 3.2 and Table B.4) were
classified into 11 functional categories. The list here illustrates the major changes in gene
expression, and excludes genes in the following functional categories: signal transduction,
metabolism and transport/transmission, and unknown. The early fold change represents the
expression change at 4 hours.  The delayed fold change corresponds to the average change at 1
and 3 days.  The late change is the averaged fold change at 7 and 30 days.
* Expressed sequence tags (ESTs) whose identity was defined by gene homology.
† Clusters E, D, and L represent the early, delayed, and late response, respectively.
§ Differentially expressed genes that are at the margin of filtering threshold and discussed in the
Results and Discussion sections.
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Table C.1. Wound-healing genes modulated by chromosome 12 locus.
U34 Probe Set ID Symbol Early Delayed Chronic Muller Astrocyte Neuron U74 Probe Set ID
rc_AI639153_at Acrv1 (1.2) (1.6) (2.2) + - + 92897_at
L14680_g_at bcl2 (1.4) (1.4) (1.2) + + + 98868_at
U49930_at casp3 1.8 4.6 1.8 - ++ ++ 98436_s_at
U22414_at Ccl3 (Scya3) 3.4 (1.7) (1.8) ++ + ++ 102424_at
rc_AI103957_g_at Cd81 1.0 1.8 1.8 +++ ++ +++ 101495_at
U75405UTR#1_f_at Col1a1 1.5 12.5 37.8 + +++ +++ 103709_at
L33869_at Cp 2.0 10.1 9.4 +++ + ++ 92851_at
S66024_g_at Crem 2.7 1.7 1.5 ++ + + 160526_s_at
U02553cds_s_at Dusp1 (Ptpn16) 4.2 (1.7) (2.1) ++ +++ ++ 104598_at
rc_AI176662_s_at Egr1 3.4 (2.9) (3.4) ++ + ++ 161802_i_at
L20681_at Ets1 (1.8) (1.7) (2.2) + + + 94720_at
X06769cds_g_at Fos 2.6 (1.1) (1.1) +++ +++ +++ 160901_at
AF028784mRNA#1_s_at Gfap 1.3 10.4 19.1 +++ ++ + 94143_at
M57672mRNA#2_s_at Ggt1 (1.2) (1.5) (2.1) + + + 100085_at
D13418_at Hes3 (1.5) (2.0) (2.2) + + + 97156_at
D26393exon_s_at Hk2 (1.4) (3.3) (1.5) ++ + - 161313_at
rc_AI230256_at Id2 6.3 3.2 2.2 ++ +++ +++ 93013_at
rc_AI177366_at Itgb1 2.1 3.9 2.4 ++ +++ +++ 100123_f_at
X54686cds_at Junb 1.5 (2.3) (1.2) +++ + + 102362_i_at
X94551_at Lamc1 (1.2) (1.4) (1.7) + + - 102404_at
D90211_s_at Lamp2 1.8 3.3 1.9 ++ ++ +++ 101590_at
rc_AA892775_at Lyz 4.8 37.5 31.3 + - + 100611_at
rc_AA963674_at Map2k2 (1.1) (1.5) (1.3) +++ ++ ++ 92543_at
D82074_g_at Neurod1 1.7 2.4 1.3 + ++ + 92717_at
rc_AI176488_at Nfib (2.1) (1.2) (1.2) ++ +++ +++ 99440_at
U17254_at Nr4a1 2.7 (1.4) (1.3) ++ ++ ++ 102371_at
S74393_s_at Pax6 1.7 2.4 1.4 + ++ ++ 92271_at
U17013_at Pou2f1 (1.3) (2.1) (1.0) + + + 102893_at
U04740_at Ptafr 1.2 (1.3) (1.6) + ++ + 94158_f_at
rc_AI170268_at Ptgfr 1.5 4.8 5.9 +++ + + 161713_f_at
M83680_at Rab14 (2.4) (2.6) (1.5) + +++ +++ 97301_at
L19698_at Rala (1.7) (2.2) (1.5) + +++ ++ 94998_at
rc_AA799724_at Rpo1 (2.1) (1.9) (2.2) - ++ ++ 161347_r_at
S61865_s_at Sdc1 (56.5) (5.0) (7.2) + ++ + 161370_f_at
S59893_f_at Ssb 1.1 1.0 (1.6) + ++ ++ 92579_at
X91810_at Stat3 5.2 3.7 2.1 + ++ ++ 99099_at
U09228_at Tcf4 (1.6) (1.5) (1.2) ++ +++ +++ 160483_at
rc_H31287_g_at Trib3 (1.2) (2.7) 1.1 + + + 161067_at
AF048828_g_at Vdac1 1.6 (1.1) 1.7 ++ ++ ++ 98139_at
rc_AI136891_at Zfp36l1 2.5 1.5 1.7 +++ ++ +++ 93324_at
Fold Change Cellular Expression
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Activation De-differentiation Remodeling
Fos, Egr1, Nr4a1,
Junb, Dusp1, Stat3
Zfp36l1, Id2
Id2, Pax6, Neurod1, Crem,
Lamp2, Casp3, Itgb1
Ptgfr, Gfap, Cp, Col1a1,
Cd81, Lyz
Nfib, Rala, Rab14,  Bcl2, Hk2,
Tcf4, Pou2f1, Hes3, Ssb, Sox11
Proliferation
Differentiation Differentiation Maturation
Zfp36l1, Id2, Pax6,
Tcf4, Ssb1, Nfib,
Casp3, Sox11
Stat3, Gfap, Junb, Fos,
Ets1, Egr1, Pou2f1, Bcl2,
Hes3
Rala, Rab14,  Lamp2, Dusp,
Ssb1, Itgb1, Casp3, Lyzs
Crem, Lpin1, Cd81, Mapk2k2,
Nr4a1, Egr1, Neurod1
Trib3, Acrv1, Lamc1, Bcl2,
Rpo1-1, Fos, Rab14, Casp3
Retinal Injury
Retinal Development
Acute phase Sub-acute phase Chronic phase
P0 P4 P8       P10       P12       P14 P21   Adult
Figure C.1. Expression patterns for chromosome 12 network genes during retinal development
and retinal injury. A survey of temporal expression during retinal development [Dorell et al.,
2004] and wound healing [Vazquez-Chona et al., 2004] is helpful in establishing flows of action
within the network. For example the genes involved in regulating proliferation and migration in
the postnatal retina (postnatal days zero through four) include Id2, Zfp361l, Pax6, Tcf4, Ssb1,
Nfib, Casp3, and Rala; whereas genes involved in Muller glia differentiation (post-natal days
eight through fourteen) include the glial genes Stat3, Gfap, Ets1, and Hes3. The pattern of
expression in the injured retina reveal that most of the chromosome 12 network genes are
differentially expressed during the early acute and delayed subacute phases of wound healing.
Network genes underlying the acute phase include the transcription regulators Id2, Zfp36l1, Fos,
Egr1, Nr4a1, Junb, and Stat3. Network genes underlying the subacute response include xxxx. A
select number of network genes are also differentially expressed during the chronic response. The
chronic response is characterized by tissue remodeling including retinal re-wiring and the
formation of ectopic glial scar tissue. Chronic genes in the network include the glial markers
Gfap, Cp, and Cd81. Expression patterns of the network genes during development and wound
healing support the hypothesis that the chromosome 12 locus regulates early wound-healing
events such as the activation of pathways that lead to apoptosis, proliferation, and de-
differentiation of cells.
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Wild type Id2 null
Figure D.1. ID2 antibody control using retina from Id2-null mice.
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A2m Alpha-2-macroglobulin
Abi2 abl-interactor 2
Agtpbp1* ATP/GTP binding protein 1*
Aif1* Alograft inflamatory factor 1*
Akap11 A kinase anchor protein 11
Akap12 A kinase anchor protein 12
Ania4 Activity & neurotransmitter-induced  4
Anxa5 Annexin V
Ap3m1 Adaptor-related protein complex 3, mu 1
Apobec1 Apolipoprotein B editing protein 
Apoe Apolipoprotein E
Aprt Adenine phosphoribosyltransferase 
Arhgap7 Rho GTPase activating protein 7
Arl1 ADP-ribosylation factor-like 1 
Arl5 ADP-ribosylationfactor-like5
Arpc1b Actin-related protein complex 1b 
Atf3 Activating transcription factor 3 
Bax Bcl2-associated X protein
Bcl2 B-cell leukemia/lymphoma 2
Bfsp1 Filensin
Btg2 B-cell translocation gene 2 
C1qb Complement component 1qb  
C1r Complement component 1r*
C1s Complement component 1s
C3 Complement component 3
Camk2d Ca calmodulin-dependent protein kinase 2d 
Casp3 Caspase 3
Cbfb Core binding protein beta
Cd36l2 Cd36-like 2
Cd48 Cd48
Cd74 Cd74
Cd81 Cd81 (TAPA)
CD82 Cd82 (Kai1)
Cd9 Cd9
Cebpd CCAAT/enhancer binding protein delta 
Cish3 Cytokine inducible SH2-containing 3
Clu Clusterin
Cntf Cntf
Cntn1 Contactin 1
Cox7a Cytochrome oxidase subunit VIIa 
Cp Ceruloplasmin (ferroxidase)
Crem CAMP responsive element modulator 
Crot Carnitine O-octanoyltransferase
Cryaa Crystallin alpha A
Cryab Crystallin alpha B 
Cryba1 Crystallin beta A1/A3
Crybb2 Crystallin beta B2
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Crygd Crystallin gamma D 
Cryge Crystallin gamma-E
Cts4 Cystatin S
Ctsc Cathepsin C
Ctsh Cathepsin H
Ctsl Cathepsin L
Ctss Cathepsin S
D123 Cell cycle related D123
Dlg1 Discs-large homolog 1
Dnajb9 DnaJ (Hsp40) homolog, subfamily b9
Dpysl4 Dihydropyrimidinase-like 4
Drd5 Dopamine receptor D5 
Eef1a2 Eukaryotic translation elongation factor 1a2 
Egr1 Early growth response 1 (Krox-24)
Eif5 Eukaryotic initiation factor 5
Fcgr3 Fc receptor IgG, low affinity 3
Fos c-fos
Fosl1 Fos-like antigen 1 (Fra-1)
Fuca Fucosidase alpha-L-1 tissue 
Gfap Gfap
Gif Intrinsic factor
Gludins Glucose-dependent insulinotropic
Gp38 Gycoprotein 38
Gq-alpha Gq-alpha subunit
Grifin Galectin-related inter-fiber
Gsta1 Glutathione-S-transferase, alpha 1
Gtpi* Interferon-g induced GTPase*
Gucy2e Guanylyl cyclase 2e
Hes3 hairy and enhancer of split 3 (Drosophila)
Hsd17b4 Hydroxysteroid 17-b dehydrogenase 4
Id2 inhibitor of DNA binding 2
Idh2 Isocitrate dehydrogenase 2
Igf1 Insulin-like growth factor 1
Igfals IGF binding protein complex acid-labile
Il1b Interleukin 1, beta
Il6r Interleukin 6 receptor
Impa1 Inositol Monophosphatase
IMPG2 Proteoglycan 10.2 
Inpp4 Inositol polyphosphate 4-phosphatase IIa
Insig1 Growth response protein CL-6 
Irf1 Interferon regulatory factor 1
Itgb1 Integrin, beta 1
Jag1 Jagged 1
Kcnj Potassium inwardly-rectifying channel
Krt1-14* Keratin complex-1, acidic, gene 14*
Lamp2 Lysosomal membrane glycoprotein 2
Lcn2 Lipocalin 2
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Lhx2 LIM homeobox protein 2
Lim2 Lens intrinsic membrane protein 2 (19 kDa)
Lip1 Lysosomal acid lipase
Litaf * LPS-induced TNF-alpha factor* 
Lman1 Lectin mannose-binding 1 
Lyz Lysozyme
Lyzs lysozyme
Mak Male germ cell-associated kinase 
Mat2a Methionine adenosyltransferase IIa
Mgp Matrix Gla protein
Mllt4 Afadin 
Mt1a Metallothionein
Mx3 Myxovirus resistance 3
Nap1l1 Nucleosome assembly protein 1-like 1
Ndufa6* NADH dehydrogenase 1a6 *
Neurod1 neurogenic differentiation 1
Neurod2 neurogenic differentiation 2
Nfib nuclear factor I/B
Nfkb1 Nuclear factor kappa B p105 
Nr4a1 nuclear receptor subfamily 4, group A, member 1
Nr4a1 Nuclear receptor subfamily 4a1
Nup153 Nucleoporin 153kD
P2ry4 Pyrimidinergic receptor P2Y 4
P4hb Prolyl 4-hydroxylase beta  
p65 p65 protein
Pak3 p21 CDKN1A activated kinase 3 
Pax6 paired box gene 6
PDE4 cAMP phosphodiesterase (PDE4)
Pde4b Phosphodiesterase 4B cAMP-specific
PDP1 Pyruvate dehydrogenase phosphatase 1 
Pex11a Peroxisomal biogenesis factor 11A
Pik3r3 Phosphatidylinositol 3-kinase p55 
PLA2IR Phospholipase A2 receptor
Plat Plasminogen activator tissue 
Plrg1 Pleiotropic regulator 1 
Pmp22 Peripheral myelin protein 22
Pou2f1 POU domain, class 2, transcription factor 1
Ppap2b Phosphatidic acid phosphatase type 2B
Ppicap Peptidylprolyl isomerase C-associated 
Ppp2rb Phosphatase 2, regulatory subunit B
Prkacb cAMP-dependent protein kinase, beta
Prkr ElF2alpha kinase, interferon-inducible
Pros1 Protein S 
Ptgfr Prostaglandin F receptor
Ptn Pleiotrophin
Qpct Glutaminyl cyclase 
Rnf4 Ring finger protein 4 
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Robo1 roundabout homolog 1 (Drosophila)
Rpo1-1 RNA polymerase 1-1
RT1.Da u MHC class IIa RT1.u-D-alpha
RT1Aw2 MHC class Ib alpha (RT1Aw2)
RT1-Mb MHC class II DM beta
RT1-S3 MHC class Ib (RT1-S3)
RT-BM1 MHC class Ib BM1k antigen
Rtn4 reticulon 4
Scyb10 Small inducible cytokine B10
Scyb13 * Small inducible cytokine B13*
Slc1a4 Solute carrier family 1, member 4
Slc25a20 Solute carrier family 25, member 20
Slc2a3 Solute carrier family 2, member 3
Snca Synuclein 1
Snn Stannin 
Sparc Sparc
Spin2c Serine protease inhibitor
Ssb Sjogren syndrome antigen B
Stat3 Stat3
Stc1 Stanniocalcin 1 
Sv2b Synaptic vesicle glycoprotein 2b
Symbol Name
Tcf4 transcription factor 4
Tpm3 Tropomyosin 3 gamma
Trib3 tribbles homolog 3 (Drosophila)
Ttgn1 Trans-golgi network protein 1
Tubb1 Tubulin, beta 5
UGT1A7 UDP-glucuronosyltransferase 1A7
unr Unr protein
Vcam1 Vcam 1
Vhl Von Hippel-Lindau syndrome
Ywhae Tyrosine 3/tryptophan 5-monooxygenase E
Ywhaq Tyrosine 3/tryptophan 5-monooxygenase theta
Zfp36l1 Zinc finger protein 36, C3H type-like 1
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